12.07.2015 Views

Download Update 11 - Update in Anaesthesia - WFSA

Download Update 11 - Update in Anaesthesia - WFSA

Download Update 11 - Update in Anaesthesia - WFSA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

1234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789123456789012345678901234567890121234567890123456789012345678901212345678901234567891234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789123456789012345678901234567890121234567890123456789012345678901212345678901234567891234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789123456789012345678901234567890121234567890123456789012345678901212345678901234567891234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789123456789012345678901234567890121234567890123456789012345678901212345678901234567891234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789123456789012345678901234567890121234567890123456789012345678901212345678901234567891234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789123456789012345678901234567890121234567890123456789012345678901212345678901234567891234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>A UPDATE IN12345678901234567890123456789012123456789012345678901234567890121234567890123456789<strong>11</strong>2345678901234567890123456789012123456789012345678901234567890121234567890123456789123456789012345678901234567890121234567890123456789012345678901212345678901234567891234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789WUPDATE INANAESTHESIAANAESTHESIA1234567890123456789012345678901212345678901234567890123456789012123456789012345678912345678901234567890123456789012123456789012345678901234567890121234567890123456789A journal for anaesthetists <strong>in</strong> develop<strong>in</strong>g countriesWORLD ANAESTHESIAEDITORIALThe safety of patients undergo<strong>in</strong>g anaesthesia dependson a number of factors, the most vital of which is atra<strong>in</strong>ed anaesthetist with the patient at all times.Cl<strong>in</strong>ical monitor<strong>in</strong>g by the anaesthetist <strong>in</strong>cludes movementof the reservoir bag, colour of the lips and tongue,observation of the airway and pattern of respiration,strength and nature of the pulse, quality of the heart soundsand the blood pressure read<strong>in</strong>g. These signs have beenused for many years, and <strong>in</strong> many countries cont<strong>in</strong>ue to bethe only monitor<strong>in</strong>g available dur<strong>in</strong>g anaesthesia andsurgery.Over the past ten years equipment for monitor<strong>in</strong>g patientsdur<strong>in</strong>g anaesthesia has improved dramatically and at thesame time, mortality result<strong>in</strong>g from anaesthesia hasdecreased substantially. It is clear that the <strong>in</strong>formationprovided by these monitors supplements <strong>in</strong> a most valuableway the senses of the anaesthetist. Of all the monitorsdeveloped there is no doubt that the most useful is thepulse oximeter. Early detection of hypoxia and <strong>in</strong>adequateoxygen delivery has saved many lives and it is hoped thateventually every anaesthetist will have access to a pulseoximeter. Unfortunately, at present, most pulse oximeterscost over £1000, well beyond the budget of manyhospitals. If prices fall, then their use should become morewidespread.It is clear that modern technology, when available, has thepotential to <strong>in</strong>crease the safety and quality of ouranaesthetics. Nevertheless it is not the presence ofmonitor<strong>in</strong>g mach<strong>in</strong>ery which makes an anaesthetic safe,but the presence of a well-tra<strong>in</strong>ed alert anaesthetist - andsuch a person can produce high quality anaesthesia even<strong>in</strong> the absence of sophisticated mach<strong>in</strong>es. “Monitor” forus should be someth<strong>in</strong>g we do, rather than someth<strong>in</strong>g wehave!This article of <strong>Update</strong> conta<strong>in</strong>s advice on us<strong>in</strong>g monitor<strong>in</strong>gequipment, along with a selection of other articles. WeCONTENTSEditorialCardiovascular pharamacology<strong>Anaesthesia</strong> and renal failurePulse oximetryECG monitor<strong>in</strong>g <strong>in</strong> theatreMonitor<strong>in</strong>g blood pressureGas monitor<strong>in</strong>gMonitor<strong>in</strong>g dur<strong>in</strong>g Caesarean SectionCar<strong>in</strong>g for patients <strong>in</strong> recoveryEmergency eye anaesthesiaCase report - head <strong>in</strong>juryAnalgesia follow<strong>in</strong>g landm<strong>in</strong>e <strong>in</strong>juriesManag<strong>in</strong>g diabetes perioperativelyPaediatric anaesthesiaPharmacology of the volatile agentsExtracts from the JournalsSelf Assessment sectionTechniques from around the worldAnswers to Self AssessmentNo <strong>11</strong> 2000ISSN 1353-4882Pa<strong>in</strong> and rehabilitation for landm<strong>in</strong>e <strong>in</strong>jurieswelcome letters <strong>in</strong> response to any of our articles and weare also delighted to receive requests for specific topicsthat readers would like to see covered. If you would liketo contribute to <strong>Update</strong> please contact the editor by email(ia<strong>in</strong>.wilson5@virg<strong>in</strong>.net) to discuss your suggestion.


2<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>CARDIOVASCULAR PHARMACOLOGY FOR ANAESTHETISTSDr Ute Schröeter, formerly of Spitalzentrum, Biel, Switzerland and Dr James Rogers, Frenchay Hospital, Bristol,UK.INTRODUCTIONThe subject of cardiovascular pharmacology is diverse,and this article concentrates on areas relevant to theanaesthetist. The pathophysiology of common diseases ofthe heart and circulation is discussed before consider<strong>in</strong>gthe drugs used for treatment.In general, the action of drugs is either by (a) alteration ofmyocardial contractility or heart rate, (b) alteration ofconduction of the cardiac action potential or, (c)vasodilatation or vasoconstriction of coronary andperipheral vessels. This article aims to build on subjectscovered <strong>in</strong> previous issues, <strong>in</strong> particular: “The AutonomicNervous System” 1995;5: 3-6, “CardiovascularPhysiology” 1999; 10: 2-8, and “Pharmacology ofVasopressors and Inotropes” 1999; 10: 14-17.ANGINAPathophysiologyThe normal myocardium accounts for <strong>11</strong> % of the totalbody oxygen consumption, but the coronary circulationreceives only 4 % of the cardiac output. In other words,consider<strong>in</strong>g its metabolic demands, the myocardium is oneof the more poorly perfused tissues <strong>in</strong> the body. As aconsequence, any pathological disturbance that changesthe myocardial oxygen balance can result <strong>in</strong> myocardialischaemia. This balance of myocardial oxygen supplyaga<strong>in</strong>st demand is dependent on the follow<strong>in</strong>g:The most common cause of ang<strong>in</strong>a is the build up ofatheroma, composed of cholesterol and other lipids, <strong>in</strong>larger coronary arteries. The obstruction to blood flowmay become so severe that not enough blood can passthrough the arteries to supply the myocardium when oxygendemand <strong>in</strong>creases, for example dur<strong>in</strong>g exercise. Theischaemic muscle produces the characteristic symptomsof ang<strong>in</strong>a pectoris, probably because metabolitesproduced by myocardial contraction accumulate <strong>in</strong> thepoorly perfused tissue. These symptoms <strong>in</strong>cluderetrosternal chest pa<strong>in</strong> or tightness, which often radiatesto the arms. The pa<strong>in</strong> is usually caused or <strong>in</strong>creased byexercise, and relieved by rest and treatment with nitrates.Anti-ang<strong>in</strong>al drugsTreatment of patients with significant coronary arterydisease aims to achieve an “even” myocardial oxygenbalance. Drugs are used to; (a) reduce preload (nitrates),(b) reduce heart rate, myocardial work and oxygenconsumption (beta-blockers), (c) maximise coronaryvasodilatation (calcium channel blockers).Nitrates are the drugs of first choice. Their ma<strong>in</strong> action isperipheral vasodilation, either venous (low doses), or bothvenous and arterial (higher doses). This vasodilation ismediated by production of nitric oxide (NO), and <strong>in</strong>creasedlevels of <strong>in</strong>tracellular guanos<strong>in</strong>e 3',5'-monophosphate(cGMP) <strong>in</strong> vascular smooth muscle. The result<strong>in</strong>g pool<strong>in</strong>gof blood <strong>in</strong> the capacitance vessels (ve<strong>in</strong>s) reduces venousreturn and decreases ventricular volume. This reduction <strong>in</strong>distension of the heart wall decreases oxygen demand andMyocardial oxygen supplyMyocardial oxygen demandHeart rateCoronary perfusion pressureArterial oxygen contentCoronary artery diameterHeart rateVentricular preload and afterloadContractility


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 3the pa<strong>in</strong> of ang<strong>in</strong>a is relieved quickly. At the same timenitrates improve myocardial oxygen supply by <strong>in</strong>creas<strong>in</strong>gthe coronary blood flow to the endocardium. Cardiacoutput is usually unchanged or decreased slightly, and areflex tachycardia occurs <strong>in</strong> normal subjects. However <strong>in</strong>patients with heart failure, who have a high systemicvascular resistance, cardiac output may <strong>in</strong>crease and thereis little change <strong>in</strong> the heart rate.Glyceryl tr<strong>in</strong>itrate (GTN) is a short-act<strong>in</strong>g nitrate, witha duration of action of 30 m<strong>in</strong>utes. It is more useful <strong>in</strong>prevent<strong>in</strong>g attacks of ang<strong>in</strong>a than <strong>in</strong> stopp<strong>in</strong>g them oncethey have begun. It may be given by a subl<strong>in</strong>gual,transdermal or <strong>in</strong>travenous route. In the latter case,between 40-80% of the dose may be absorbed by theplastic giv<strong>in</strong>g set. Longer act<strong>in</strong>g nitrates are more stableand may be effective for several hours, depend<strong>in</strong>g on thedrug and formulation used. (eg. isosorbide d<strong>in</strong>itrate,isosorbide mononitrate).Unwanted effects of nitrates <strong>in</strong>clude dilation of cranialvessels caus<strong>in</strong>g headaches, which can limit the dose used.More serious side effects are tachycardia and hypotension.These result respectively <strong>in</strong> <strong>in</strong>creased myocardial oxygendemand and decreased coronary perfusion, both of whichhave an adverse effect on myocardial oxygen balance.Another well recognised problem is the development oftolerance to nitrates. Blood vessels become hypo- or nonreactiveto the drugs, particularly when large doses,frequent dos<strong>in</strong>g regimes and long act<strong>in</strong>g formulations areused. To avoid this, nitrates are best used <strong>in</strong>termittently,allow<strong>in</strong>g a few hours without treatment <strong>in</strong> each 24 hoursperiod.Beta blockers These are used to prevent ang<strong>in</strong>a as wellas to treat hypertension, by block<strong>in</strong>g beta 1 receptors <strong>in</strong>the heart. In addition to this block<strong>in</strong>g action, some betablockerscan actually stimulate the receptors at a low level.This so called <strong>in</strong>tr<strong>in</strong>sic activity can be a disadvantage whentreat<strong>in</strong>g ang<strong>in</strong>a. Drugs such as atenolol and metoprolol arethe drugs of choice, because they are cardioselective, i.e.only work on beta-1 receptors, and not the beta-2receptors elsewhere <strong>in</strong> the body.Most side effects of beta blockers are the consequenceof their block<strong>in</strong>g action. Bronchoconstriction (mediatedby beta-2 receptors) is normally of little importance.However <strong>in</strong> asthmatics it can be life-threaten<strong>in</strong>g, and betablockers should not be used <strong>in</strong> these patients. Coldextremities, worsen<strong>in</strong>g of peripheral vascular disease,hypoglycaemia and impotence are also caused byblockade of beta-2 receptors. Some patients with heartdisease need a sympathetic “drive” to the heart to ma<strong>in</strong>ta<strong>in</strong>adequate cardiac output, and blockade of beta-1 receptors<strong>in</strong> these patients can cause heart failure.Calcium antagonists These drugs act by block<strong>in</strong>g thecalcium channels which open <strong>in</strong> response to depolarisationof the cell membrane (voltage sensitive channels). Suchchannels occur <strong>in</strong> many different cells of the body, but theimportant pharmacological effects of these drugs arerestricted to cardiac and smooth muscle. Calciumantagonists are divided <strong>in</strong>to three sub-groups based ontheir chemical structure;(a) papaver<strong>in</strong>e derivatives e.g. verapamil(b) benzothiazep<strong>in</strong>es e.g. diltiazem(c) dihydropyrid<strong>in</strong>es e.g. nifedip<strong>in</strong>e, amlodip<strong>in</strong>eCalcium antagonists reduce afterload (by arterialvasodilation), dilate coronary arteries, and reduce cardiacwork, thus improv<strong>in</strong>g myocardial oxygen balance.Verapamil and diltiazem also have an anti-arrhythmic effect,whereas the dihydropyrid<strong>in</strong>es predom<strong>in</strong>antly affectvascular smooth muscle. Adverse effects of calciumantagonists <strong>in</strong>clude postural hypotension, flush<strong>in</strong>g,peripheral oedema and constipation. All calciumantagonists have a negative <strong>in</strong>otropic effect, especiallyverapamil, and should not be used <strong>in</strong> patients <strong>in</strong> cardiacfailure.CARDIAC FAILUREIntroductionCardiac failure is common and the <strong>in</strong>cidence is <strong>in</strong>creas<strong>in</strong>g<strong>in</strong> many countries. Despite adequate ventricular fill<strong>in</strong>g, thefail<strong>in</strong>g heart is unable to deliver as much blood as the tissuesrequire, even when myocardial contractility is <strong>in</strong>creasedby the sympathetic nervous system. The causes of heartfailure are numerous, but can be classified as follows: (a)endocardial disease, (b) myocardial disease, (c) pericardialdisease and, (d) congenital heart disease. Cardiac failuremay be precipitated by the factors listed below:


4<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Disturbance of heart rate or rhythmDrugsAnaemiaInfection or feverPulmonary embolismFluid overloadHypertensionPregnancyHyper- or hypothyroidismPathophysiologyCardiac output is the product of heart rate and strokevolume (CO = HR x SV). Stroke volume is determ<strong>in</strong>edby three factors; preload, afterload and contractility.The effect of changes <strong>in</strong> any of these variables can beillustrated graphically by the “Starl<strong>in</strong>g curve”. In cardiacfailure the Starl<strong>in</strong>g curve is displaced downwards, mean<strong>in</strong>gthat <strong>in</strong>creases <strong>in</strong> end-diastolic ventricular fill<strong>in</strong>g volumes(preload) are required to ma<strong>in</strong>ta<strong>in</strong> performance.There are adaptive mechanisms to improve cardiac output,<strong>in</strong>clud<strong>in</strong>g sodium and water retention by activation of theren<strong>in</strong>-angiotens<strong>in</strong>-aldosterone system. This <strong>in</strong>creasesblood volume, and thereby preload, but may <strong>in</strong> turn causeunwanted oedema <strong>in</strong> both peripheral tissues and the lung.A rise <strong>in</strong> catecholam<strong>in</strong>e release leads to <strong>in</strong>creased heartrate and contractility, but also an <strong>in</strong>crease <strong>in</strong> systemicvascular resistance (afterload). In long stand<strong>in</strong>g cardiacfailure there is hypertrophy of the muscle mass andenlargement of the ventricles.Drugs used <strong>in</strong> heart failureWhere possible, underly<strong>in</strong>g disease and the precipitat<strong>in</strong>gfactors mentioned above should be <strong>in</strong>vestigated andtreated. The treatment of heart failure aims to:Diuretics <strong>in</strong>crease the excretion of sodium and water. Byreduc<strong>in</strong>g the circulat<strong>in</strong>g volume they reduce preload andoedema. Loop diuretics such as frusemide are often used<strong>in</strong> acute as well as chronic heart failure. Low serum levelsof potassium, calcium and magnesium are a common sideeffect.At high parenteral doses frusemide may cause renalfailure (<strong>in</strong>terstitial nephritis) and deafness (auditory nervedamage), especially when it is given rapidly. Toxic effectsare more common when frusemide is given <strong>in</strong> comb<strong>in</strong>ationwith am<strong>in</strong>oglycoside antibiotics or to patients with impairedrenal function.Nitrates These are used <strong>in</strong> the overdistended, acutelyfail<strong>in</strong>g heart to reduce preload, pulmonary venous pressureand oedema. Their mode of action is discussed above.Inotropic drugsDigox<strong>in</strong> is used to treat heart failure, especially whenassociated with atrial fibrillation. It is discussed <strong>in</strong> detailbelow. Sympathomimetic agents such as dopam<strong>in</strong>e anddobutam<strong>in</strong>e are given by <strong>in</strong>travenous <strong>in</strong>fusion <strong>in</strong> severe,acute heart failure. Phosphodiesterase <strong>in</strong>hibitors such asmilr<strong>in</strong>one improve contractility by <strong>in</strong>creas<strong>in</strong>g myocardial<strong>in</strong>tracellular calcium. They are given <strong>in</strong> severe heart failureunresponsive to other drugs.Angiotens<strong>in</strong> convert<strong>in</strong>g enzyme (ACE) <strong>in</strong>hibitorsDrugs such as captopril are potent arterial and venousvasodilators. They block the ren<strong>in</strong>-angiotens<strong>in</strong> system andreduce both preload and afterload, with a result<strong>in</strong>g <strong>in</strong>crease<strong>in</strong> cardiac output. Despite the fall <strong>in</strong> arterial pressure thesympathetic system is not activated, and the decrease <strong>in</strong>heart rate improves the myocardial oxygen balance.Increased renal blood flow and reduced release ofaldosterone causes an <strong>in</strong>creased excretion of sodium andwater, thus reduc<strong>in</strong>g circulat<strong>in</strong>g volume. ACE <strong>in</strong>hibitorsare the most appropriate vasodilators for the long termtreatment of heart failure.(a) optimise ventricular fill<strong>in</strong>g pressures DiureticsNitrates(b) improve contractility (<strong>in</strong>otropic drugs) Digox<strong>in</strong>Sympathomimetic agentsPhosphodiesterase <strong>in</strong>hibitors(c) reduce cardiac work by reduc<strong>in</strong>g afterload ACE <strong>in</strong>hibitors(vasodilators)Prazos<strong>in</strong>


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 5Prazos<strong>in</strong> dilates coronary arteries, peripheral arteriolesand ve<strong>in</strong>s by block<strong>in</strong>g alpha-1 receptors. Afterload isreduced, cardiac output <strong>in</strong>creases and there is little reflextachycardia.ARRHYTHMIASPathophysiologyCardiac arrhythmias are common <strong>in</strong> the peri-operativeperiod (see also page 16) but most are benign and causeno harm to the patient. Arrhythmogenic factors <strong>in</strong>cludedrugs, ischaemia and altered biochemical and physiologicalstates. Disturbances of cardiac rhythm, although complex,can be classified on the basis of electrophysiology asfollows:(a) Arrhythmias of s<strong>in</strong>us orig<strong>in</strong>: electrical conductionfollows the normal pathway but can be either toofast, too slow or irregular.(b) Ectopic rhythms: these can be due to eitherabnormal automaticity (spontaneous discharge) orre-entry. In the former, s<strong>in</strong>gle or multiple groups ofmyocardial cells take over as the pacemaker, giv<strong>in</strong>geither atrial or ventricular ectopic rhythms. Re-entrytachycardias <strong>in</strong>volve the cardiac impulse be<strong>in</strong>gtransmitted to a functional “r<strong>in</strong>g” of conduct<strong>in</strong>gtissue, one side of which has a unidirectional (oneway)block. In this situation the impulse is conducted<strong>in</strong> a circular fashion <strong>in</strong> the r<strong>in</strong>g, re-excit<strong>in</strong>g theneighbour<strong>in</strong>g myocardium immediately after itsrefractory (unresponsive) period. Re-entrymechanisms are implicated <strong>in</strong> atrial flutter and bothsupraventricular and ventricular tachycardias.(c) Conduction blocks: these can occur at the levelof either the atrioventricular node (first, second andthird degree blocks) or the His-Purk<strong>in</strong>je fibres(bundle branch blocks).(d) Pre-excitation syndromes: <strong>in</strong> this situation thenormal delay at the atrioventricular node is bypassedby an accessory pathway, lead<strong>in</strong>g to prematureventricular depolarisation. Wolf-Park<strong>in</strong>son-Whiteand Lown-Ganong-Lev<strong>in</strong>e are the two mostcommon pre-excitation syndromes.Anti-arrhythmic drugsThe Vaughan-Williams classification of anti-arrhythmicdrugs is on the basis of mechanism of action. Althoughwidely used, it does not <strong>in</strong>clude digox<strong>in</strong> and adenos<strong>in</strong>e,which both have useful anti-arrhythmic actions.Class IMembrane stabilis<strong>in</strong>g drugs: fast depolarisation of thecell membrane is <strong>in</strong>hibited by block<strong>in</strong>g the <strong>in</strong>ward flux ofsodium ions. This class is further sub-divided <strong>in</strong>to threegroups based on the effect on duration of the actionpotential. Lignoca<strong>in</strong>e is the most widely used drug <strong>in</strong> thisclass, and can be used for all forms of ventriculararrhythmia. Other membrane stabilis<strong>in</strong>g drugs <strong>in</strong>cludequ<strong>in</strong>id<strong>in</strong>e, proca<strong>in</strong>amide, mexilet<strong>in</strong>e and fleca<strong>in</strong>ide.Class IIBeta-blockers: these drugs reduce automaticity, and<strong>in</strong>crease the action potential duration <strong>in</strong> the ventricles aswell as the refractory period at the atrioventricular node.Examples <strong>in</strong>clude propranolol, metoprolol and the shorteract<strong>in</strong>g esmolol.Class IIIProlongation of action potential and refractoryperiod: amiodarone is the drug of choice, althoughbretylium is also used. They have an anti-fibrillatory effectby <strong>in</strong>creas<strong>in</strong>g electrical stability.Class IVCalcium antagonists: verapamil is the only useful agent,and slows conduction at the atrioventricular node <strong>in</strong> thetreatment of supraventricular arrhythmias.Digox<strong>in</strong> is a cardiac glycoside, and sometimes classifiedas a Class V drug. It is the only anti-arrhythmic drugavailable for the treatment of atrial fibrillation that doesnot have negative <strong>in</strong>otropic or vasodilator effects. It istherefore used widely for heart failure as well asarrhythmias. Its direct action is to block the sodium/potassium ion exchange pump <strong>in</strong> the cell membrane. Thiseventually causes a rise <strong>in</strong> calcium ions with<strong>in</strong> the cell,which <strong>in</strong>creases contractility. Digox<strong>in</strong> slows the conductionof the action potential, mostly at the atrioventricular node,but also <strong>in</strong> other parts of the heart. Digox<strong>in</strong> also acts<strong>in</strong>directly by <strong>in</strong>creas<strong>in</strong>g parasympathetic activity via thevagus nerve, further slow<strong>in</strong>g atrioventricular nodeconduction. The drug is used to control the heart rate <strong>in</strong>atrial fibrillation, by limit<strong>in</strong>g the ventricular response to atrialdischarge.High doses of digox<strong>in</strong> can cause serious arrhythmias, suchas complete heart block and ventricular ectopic beats,


6<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>which may lead to ventricular tachycardia or fibrillation.Less serious side-effects are nausea, vomit<strong>in</strong>g, visualdisturbance and headache, but these may precede toxicity.Plasma levels can be measured to ensure therapeutic levelsare not exceeded. Some factors enhance toxicity, such ashypokalaemia, hypomagnesaemia, hypercalcaemia,hypoxia, acidosis and myocardial ischaemia. The dose ofdigox<strong>in</strong> must be reduced <strong>in</strong> renal failure, and if there is aknown drug <strong>in</strong>teraction (e.g. amiodarone, verapamil,qu<strong>in</strong>id<strong>in</strong>e).Adenos<strong>in</strong>e is a naturally occurr<strong>in</strong>g molecule which is ametabolite of adenos<strong>in</strong>e monophosphate. It acts via specificadenos<strong>in</strong>e receptors to cause coronary vasodilation andreduced conduction at the s<strong>in</strong>o-atrial and atrioventricularnodes. It is particularly useful <strong>in</strong> treat<strong>in</strong>g re-entrysupraventricular tachycardias, but has no effect onventricular tachycardia. It has a very short half-life (10seconds), and is given by rapid <strong>in</strong>travenous <strong>in</strong>jection. Theshort duration of action and low <strong>in</strong>cidence of adverseeffects makes adenos<strong>in</strong>e useful <strong>in</strong> diagnos<strong>in</strong>g broadcomplex tachycardias as either supraventricular orventricular <strong>in</strong> orig<strong>in</strong>.HYPERTENSIONPathophysiologyIn most patients with raised blood pressure there is noobvious cause; this is called essential hypertension. Thepathogenesis of hypertension is complex but the follow<strong>in</strong>gfactors have been implicated: (a) <strong>in</strong>creased sympatheticactivity, (b) sodium retention and an <strong>in</strong>creased circulat<strong>in</strong>gvolume, (c) <strong>in</strong>creased vascular rigidity and reactivity, (d)<strong>in</strong>creased circulat<strong>in</strong>g catecholam<strong>in</strong>es and activation of theren<strong>in</strong>-angiotens<strong>in</strong>-aldosterone system, and (e) abnormalbaroreceptor responses. High blood pressure is associatedwith a reduced life expectancy, because of an <strong>in</strong>creasedrisk of stroke and coronary artery disease; also other endorgandisease, such as ret<strong>in</strong>opathy and renal failure.Anti-hypertensive drugsArterial pressure <strong>in</strong>creases with age and therefore there isno absolute value at which treatment should be started.Untreated hypertension leads to <strong>in</strong>creased perioperativemorbidity and mortality. In the presence of othercardiovascular risk factors such as diabetes,hyperlipidaemia or smok<strong>in</strong>g, the threshold for treatmentshould be lower. As a general rule elective surgery shouldbe delayed if the rest<strong>in</strong>g diastolic pressure is greater than<strong>11</strong>0 mm Hg.Based on the pathogenesis of essential hypertensiondescribed above, there are different classes of antihypertensivedrugs. They are used alone or <strong>in</strong> variouscomb<strong>in</strong>ations. Diuretics (either thiazide or loop diuretics)reduce sodium and extracellular volume and are often thefirst-l<strong>in</strong>e drugs. Another important group are thevasodilators, such as ACE-<strong>in</strong>hibitors, calciumantagonists, and the direct vasodilator hydralaz<strong>in</strong>e.Adrenergic block<strong>in</strong>g agents such as beta-blockers andthe alpha 1-receptor antagonist prazos<strong>in</strong> are also widelyused.Treatment of severe hypertensionAlthough severe hypertension (e.g. diastolic pressure above140 mmHg) can often be managed with oral treatment,this may not be suitable for the peri-operative patient, orwhen there are life threaten<strong>in</strong>g complications such asencephalopathy or heart failure. In these situations bloodpressure can be controlled with the <strong>in</strong>travenous agentsdescribed below, which have the advantage of a rapidonset of action. The dose should be titrated aga<strong>in</strong>st theresponse, because rapid falls <strong>in</strong> blood pressure can causereduced cerebral perfusion and <strong>in</strong>farction. Before start<strong>in</strong>gsuch treatments <strong>in</strong> the peri-operative patient, factors whichmay be aggravat<strong>in</strong>g the hypertension should be identifiedand treated. These <strong>in</strong>clude <strong>in</strong>adequate analgesia,hypothermia, hypoxia and withdrawal of normal antihypertensivedrugs.Labetalol This drug is both an alpha-1 and beta adrenergicreceptor blocker, with a ratio of alpha:beta activity of about1:5. As well as emergency treatment of severehypertension, it is also used <strong>in</strong> the treatment of preeclampsiaand to provide hypotension for certa<strong>in</strong> surgicalprocedures. Labetalol has a half-life of between three andsix hours depend<strong>in</strong>g on the dose given, and can causehepatic damage, even after short periods of treatment. Itis given <strong>in</strong>travenously <strong>in</strong> <strong>in</strong>crements of 5-10mg up to amaximum of 200mg.Hydralaz<strong>in</strong>e is an arteriolar vasodilator and thus reducessystemic vascular resistance, caus<strong>in</strong>g a reflex tachycardia.It is widely used <strong>in</strong> hypertension associated with preeclampsia,but its onset of action may be up to 20 m<strong>in</strong>utes.Headache, nausea, vomit<strong>in</strong>g, and flush<strong>in</strong>g are common sideeffects, and it can cause ang<strong>in</strong>a <strong>in</strong> patients with ischaemicheart disease. In the obstetric patient the aim is to keepthe blood pressure below 170/<strong>11</strong>0 mmHg, us<strong>in</strong>g doses of5-10mg which can be repeated after 30 m<strong>in</strong>utes ifnecessary.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 7Sodium Nitroprusside (SNP) This acts directly onvascular smooth muscle and causes arteriolar and venousdilation. As a consequence blood pressure falls and a reflextachycardia occurs. SNP acts very rapidly and the durationof action is only a few m<strong>in</strong>utes. The drug can producetoxicity by production of cyanide, and there are maximumrecommended doses for both acute and longer term use.GTN, which is discussed elsewhere, can also be used forrapid control of high blood pressure.CARDIOVASCULAR EFFECTS OFANAESTHETICSInhalational agentsAll volatile agents depress myocardial contractility, but thiseffect is most marked with halothane and enflurane. Withthe exception of halothane they all decrease systemicvascular resistance, contribut<strong>in</strong>g further to the fall <strong>in</strong> bloodpressure and result<strong>in</strong>g <strong>in</strong> a reflex tachycardia. Dur<strong>in</strong>ghalothane anaesthesia systemic vascular resistance isunchanged and, due to vagal stimulation, bradycardias andnodal rhythms are common. Unlike other volatile agentshalothane sensitises the heart to the arrhythmogenic effectsof catecholam<strong>in</strong>es, and ventricular ectopics are often seen.High levels of circulat<strong>in</strong>g catecholam<strong>in</strong>es can causeventricular tachycardia or ventricular fibrillation, especially<strong>in</strong> the presence of hypercarbia, which can occur <strong>in</strong> a patientspontaneously breath<strong>in</strong>g halothane. Ether causessympathetic stimulation, catecholam<strong>in</strong>e release and, to acerta<strong>in</strong> degree, vagus nerve blockade. As a result there isan <strong>in</strong>crease <strong>in</strong> cardiac output, heart rate and systemicvascular resistance, so blood pressure is well ma<strong>in</strong>ta<strong>in</strong>ed.Intravenous <strong>in</strong>duction agentsMost <strong>in</strong>duction agents are cardiovascular depressants. Thegreatest effect is seen with propofol, which may cause amarked fall <strong>in</strong> blood pressure, systemic vascular resistanceand heart rate, the latter due to central vagal stimulation.Thiopentone has similar effects, although less pronounced,and there is a reflex tachycardia mediated by thebaroreceptor reflex. This can result <strong>in</strong> <strong>in</strong>creased myocardialoxygen consumption and a consequent <strong>in</strong>crease <strong>in</strong>coronary blood flow. Benzodiazep<strong>in</strong>es such as midazolamand diazepam are associated with cardiovascular stability,and only high doses will cause cardiovascular depression.Etomidate provides the most cardiovascular stability, withonly slight changes <strong>in</strong> haemodynamic variables. Etomidatehas little effect on myocardial oxygen balance. Ketam<strong>in</strong>e,<strong>in</strong> contrast to other <strong>in</strong>duction agents, is a potentcardiovascular stimulant by <strong>in</strong>creas<strong>in</strong>g sympathetic nervousdischarge, although its direct effect on the myocardium isnegatively <strong>in</strong>otropic. On <strong>in</strong>duction there is a marked rise<strong>in</strong> heart rate and blood pressure caused by central nervousstimulation and an <strong>in</strong>crease <strong>in</strong> circulat<strong>in</strong>g catecholam<strong>in</strong>es.ANAESTHESIA AND CHRONIC RENAL FAILUREDr Penny Stewart, Sydney, Australia and Dr Debbie Harris, Frenchay Hospital, UKChronic Renal Failure (CRF) may be caused by primaryrenal disease or by systemic diseases which also affectthe kidney. A decrease <strong>in</strong> nephron function occurs andcan lead to a typical cl<strong>in</strong>ical pattern. CRF only becomesbiochemically evident when less than 40% of the nephronsare function<strong>in</strong>g. Dialysis (either peritoneal or haemodialysis)is generally not required until less than 10% of nephronsare function<strong>in</strong>g. Patients with CRF are more likely to haveassociated atheroma formation and hypertension.Preoperative Assessment and Treatment of MedicalProblems <strong>in</strong> Renal FailureThe follow<strong>in</strong>g factors should be considered when assess<strong>in</strong>ga patient for anaesthesia prior to either an elective oremergency procedure.Fluid balance In CRF sodium and water excretion isrelatively fixed and often reduced. The kidneys can havedifficulty handl<strong>in</strong>g both large fluid loads and dehydration.The degree of hydration should be assessed <strong>in</strong> the usualway us<strong>in</strong>g sk<strong>in</strong> turgor, exam<strong>in</strong>ation of the mucousmembranes, jugular venous pressure, presence ofdependent oedema and presence of pulmonary oedemaon auscultation. Invasive measurement of central venouspressure may occasionally be <strong>in</strong>dicated. Many patientson dialysis regimens will know their normal hydrated weightand their fluid allowance per day.The patient must be normovolaemic prior to surgery. Fluidresuscitation should normally be with normal sal<strong>in</strong>e but ifthere has been blood loss this might also have to bereplaced.


8<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Biochemical balance Although numerous biochemicalabnormalities can exist and the potassium can be low, themost significant biochemical problems related to severeuncorrected renal disease are hyperkalaemia and acidosis.Hyperkalaemia is def<strong>in</strong>ed as a serum potassium of morethan 5 mmol/l. ECG changes become apparent at 6-7mmol/l and immediate treatment is needed if the serumpotassium is over 7 mmol/l. ECG changes <strong>in</strong>clude tallpeaked T waves, shortened QT <strong>in</strong>tervals, widened QRScomplexes and loss of P waves. Eventually the QRScomplexes merge <strong>in</strong>to the T waves to produce a s<strong>in</strong>e wavepattern. Ventricular fibrillation may occur at serumconcentrations over 10 mmol/l.Methods of treat<strong>in</strong>g a high serum potassium <strong>in</strong> anemergency <strong>in</strong>clude:a) Adm<strong>in</strong>istration of 0.5ml/kg of 10% calciumgluconate (max 20 ml). This has an immediate buttransient stabilis<strong>in</strong>g effect on the myocardial cells.b) 50mls of 50% glucose as an <strong>in</strong>travenous bolus or<strong>in</strong>fusion. Glucose and <strong>in</strong>sul<strong>in</strong> will produce animmediate migration of potassium <strong>in</strong>to the cells thusreduc<strong>in</strong>g the serum level. Blood glucose levelsshould be closely monitored but unless the patientis diabetic, endogenous <strong>in</strong>sul<strong>in</strong> will be secreted andma<strong>in</strong>ta<strong>in</strong> normal glycaemia. Alternatively 5-10 unitsof soluble <strong>in</strong>sul<strong>in</strong> may be added to the <strong>in</strong>fusion. Apartfrom the risk of errors which may occur, the patientmay also become hypoglycaemic as secretion ofendogenous <strong>in</strong>sul<strong>in</strong> is also stimulated.c) Adm<strong>in</strong>istration of 1-2 mmol/kg sodium bicarbonate<strong>in</strong>travenously over 5-10 m<strong>in</strong>utes. This provides alarge sodium and fluid load which may not bedesirable.d) Nebulised salbutamol 2.5 - 5mg will assist <strong>in</strong> mov<strong>in</strong>gK + <strong>in</strong>to the cells.Total body potassium levels can then be reduced:a) By dialysis.b) With calcium resonium (0.5 g/kg) 8 hourly eitherrectally or orally. This takes approximately 12 hoursto produce an effect.c) By the <strong>in</strong>troduction of a low potassium diet.Acidosis can best be improved by dialysis. Adm<strong>in</strong>istrationof bicarbonate solution should only be considered whenthe pH is


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 9excreted the half life <strong>in</strong>creases slowly with deteriorat<strong>in</strong>grenal function until severe nephron loss at which po<strong>in</strong>t thehalf life <strong>in</strong>creases sharply with further reductions <strong>in</strong> renalfunction. Dialysis can only usually replace a small part ofthe excretory capacity of the healthy kidney.Induction agents Their effect is term<strong>in</strong>ated byredistribution. All of these agents are myocardialdepressants and should be adm<strong>in</strong>istered cautiously <strong>in</strong>patients with heart disease.Muscle relaxants Suxamethonium should be avoidedif hyperkalaemia is present.Some non-depolaris<strong>in</strong>g muscle relaxants depend on thekidney for elim<strong>in</strong>ation. Atracurium is the agent of choiceas it undergoes spontaneous Hoffman degradation at bodytemperature.Vecuronium and mivacurium are safe to use <strong>in</strong> renalfailure as only small percentages are excreted renally.Gallam<strong>in</strong>e should be avoided and pancuronium,alcuronium, pipecuronium, curare and doxacuriumshould be used with caution. Potentiation of neuromuscularblockade may occur <strong>in</strong> the presence of a metabolicacidosis, hypokalaemia, hypermagnesaemia, orhypocalcaemia and with medications such asam<strong>in</strong>oglycosides. Monitor neuromuscular blockadewhenever possible.Opioids Morph<strong>in</strong>e is metabolised <strong>in</strong> the liver to morph<strong>in</strong>e-6-glucuronide which has about half the sedative effect ofmorph<strong>in</strong>e with a markedly prolonged half life. Pethid<strong>in</strong>e ispartially metabolised to norpethid<strong>in</strong>e which is less analgesicand has excitatory and convulsant properties. Both ofthese metabolites may accumulate <strong>in</strong> renal failure afterrepeated doses or with <strong>in</strong>fusions. Standard <strong>in</strong>traoperativeuse will not usually cause problems. When available,morph<strong>in</strong>e is preferable to pethid<strong>in</strong>e.Fentanyl and alfentanil can be used as normal.Benzodiazep<strong>in</strong>es can be used <strong>in</strong> renal failure.Inhalational agents There is decreased elim<strong>in</strong>ation ofthe fluoride ions which are significant metabolites ofenflurane, sevoflurane and methoxyflurane which canworsen renal function, so these <strong>in</strong>halational agents shouldbe avoided especially if used at low flows.Non steroidal anti <strong>in</strong>flammatory agents (NSAIDS)should be avoided as all decrease renal blood flow andmay precipitate complete renal failure.Conduct of <strong>Anaesthesia</strong>Premedication Oral sedatives such as diazepam ortemazepam may be used. H 2antagonists or non particulateantacids (e.g. sodium citrate) should be given ifoesophageal reflux is a problem.<strong>Anaesthesia</strong> Venous access may be difficult. If futurehaemodialysis is planned it is important to preserve AVfistulas and potential fistula sites. Forearm and antecubitalve<strong>in</strong>s should be avoided if possible <strong>in</strong> these patients.Full monitor<strong>in</strong>g must be established prior to <strong>in</strong>duction ofanaesthesia, with special attention be<strong>in</strong>g paid to the ECGand blood pressure. The patient should be kept welloxygenated and haemodynamically stable. Hypovolaemiaand hypotension worsen renal function therefore bloodand other fluid losses should be carefully replaced. Ifpossible the shorter act<strong>in</strong>g sedative agents should be used.If sp<strong>in</strong>al or epidural anaesthesia is be<strong>in</strong>g performed fluidpreload<strong>in</strong>g should be kept to a m<strong>in</strong>imum andvasoconstrictors used to ma<strong>in</strong>ta<strong>in</strong> the blood pressure.Otherwise postoperative fluid overload may necessitatedialysis.Postoperatively Postoperative fluid balance must bemeticulous and prompt action taken to limit vomit<strong>in</strong>g andreplace any fluids lost. Some patients may requirehaemodialysis for fluid overload postoperatively but thisshould be delayed if possible as the patient will have to behepar<strong>in</strong>ised. Some patients may become drowsy onrelatively low doses of analgesics.Oxygen (2-3 litres/m<strong>in</strong>ute nasally or 3-4 litres/m<strong>in</strong>ute viaface mask) should be adm<strong>in</strong>istered for 48 hours after majorabdom<strong>in</strong>al or thoracic surgery and 24 hours after<strong>in</strong>termediate surgery.PREVENTING ACUTE RENAL FAILUREPreviously healthy patients most at risk of develop<strong>in</strong>g acuterenal tubular necrosis are those with massive haemorrhage,multiple trauma, sepsis, extensive burns and crush <strong>in</strong>juries,especially if they already have some degree of renalimpairment. Renal failure is diagnosed when ur<strong>in</strong>e outputis persistently


10<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>measured hourly and should be ma<strong>in</strong>ta<strong>in</strong>ed above 1 ml/kg/hr.Only after the patient is well resuscitated with fluid shouldvasoactive drugs be used to ma<strong>in</strong>ta<strong>in</strong> an adequate meanarterial blood pressure for the patient (this will depend onthe patients preoperative blood pressure). If the patientbecomes oliguric (ur<strong>in</strong>e output < 0.5 ml/kg/hr) despiteadequate hydration and blood pressure adm<strong>in</strong>istration offrusemide can be considered, up to 240 mg <strong>in</strong>travenouslyover 1 hour. If no diuresis develops further adm<strong>in</strong>istrationof frusemide is useless. Dopam<strong>in</strong>e and mannitol both<strong>in</strong>crease ur<strong>in</strong>e output but also <strong>in</strong>crease the oxygen demandof the kidney so frusemide is preferred. Low dosedopam<strong>in</strong>e has not been shown to have any protective effecton the kidney.All nephrotoxic drugs should be avoided if possible.These <strong>in</strong>clude NSAIDS and ACE <strong>in</strong>hibitors. Ifam<strong>in</strong>oglycosides are essential their serum levels must bemonitored.Electrolytes <strong>in</strong>clud<strong>in</strong>g potassium, sodium andbicarbonate must be measured at least daily dur<strong>in</strong>g theperioperative period. Adequate calorie <strong>in</strong>take is essentialand must be established as soon as possible postoperatively.Table 1:Preoperative assessment of the patient <strong>in</strong> chronic renal failureFluid balanceBiochemistry and acid base statusAssociated illnessesAssociated medicationsDialysis regimenTable 2:Common biochemical and haematological abnormalities <strong>in</strong> chronic renal failureHyper- (or hypo-)kalaemiaHypo- (or hyper-)natraemiaHyperphosphataemiaHypocalcaemiaMetabolic acidosisNormochromic normocytic anaemiaTable 3:Treatment of the acutely oliguric patientControl the underly<strong>in</strong>g cause if knownEnsure the patient is well hydrated us<strong>in</strong>g <strong>in</strong>vasive monitor<strong>in</strong>g if necessaryEnsure the blood pressure is normal or above normal for that patientAfter fluid resuscitation try frusemide 240 mg over 1 hourAvoid all non-essential nephrotoxic drugsAdjust doses of renally excreted drugsMeasure sodium, potassium, bicarbonate and urea and/or creat<strong>in</strong><strong>in</strong>e twice dailyEstablish low potassium nutrition as soon as possible


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> <strong>11</strong>PRACTICAL APPLICATIONS OF PULSE OXIMETRYDr E Hill, Dr MD Stoneham, Nuffield Department of Anaesthetics, Oxford Radcliffe NHS HospitalsHead<strong>in</strong>gton , Oxford OX3 9DU, Email: mark@stoneham1.freeserve.co.ukINTRODUCTIONPulse oximetry is a useful method of monitor<strong>in</strong>g patients <strong>in</strong>many circumstances,and <strong>in</strong> the face of limited resources,the pulse oximeter may represent a wise choice of monitor,as with tra<strong>in</strong><strong>in</strong>g it allows for the assessment of severaldifferent patient parameters.Pulse oximeters are now a standard part of perioperativemonitor<strong>in</strong>g which give the operator a non-<strong>in</strong>vasive<strong>in</strong>dication of the patient’s cardio-respiratory status. Hav<strong>in</strong>gbeen successfully used <strong>in</strong> <strong>in</strong>tensive care, the recovery roomand dur<strong>in</strong>g anaesthesia, they have been <strong>in</strong>troduced <strong>in</strong> otherareas of medic<strong>in</strong>e such as general wards apparently withoutstaff undergo<strong>in</strong>g adequate tra<strong>in</strong><strong>in</strong>g <strong>in</strong> their use (1) . Thetechnique of pulse oximetry does have pitfalls andlimitations and it is possible that patient safety may becompromised with untra<strong>in</strong>ed staff. This article is therefore<strong>in</strong>tended for the ‘occasional’ user of pulse oximetry.Pulse oximeters measure the arterial oxygen saturation ofhaemoglob<strong>in</strong>. The technology <strong>in</strong>volved (2) is complicatedbut there are two basic physical pr<strong>in</strong>ciples. First, theabsorption of light at two different wavelengths byhaemoglob<strong>in</strong> differs depend<strong>in</strong>g on the degree ofoxygenation of haemoglob<strong>in</strong>. Second, the light signalfollow<strong>in</strong>g transmission through the tissues has a pulsatilecomponent, result<strong>in</strong>g from the chang<strong>in</strong>g volume of arterialblood with each pulse beat. This can be dist<strong>in</strong>guished bythe microprocessor from the non-pulsatile componentresult<strong>in</strong>g from venous, capillary and tissue light absorption.The function of a pulse oximeter is affected by manyvariables, <strong>in</strong>clud<strong>in</strong>g: ambient light; shiver<strong>in</strong>g; abnormalhaemoglob<strong>in</strong>s; pulse rate and rhythm; vasoconstriction andcardiac function. A pulse oximeter gives no <strong>in</strong>dication of apatient’s ventilation, only of their oxygenation, and thuscan give a false sense of security if supplemental oxygen isbe<strong>in</strong>g given. In addition, there may be a delay betweenthe occurrence of a potentially hypoxic event such asrespiratory obstruction and a pulse oximeter detect<strong>in</strong>g lowoxygen saturation. However, oximetry is a useful non<strong>in</strong>vasivemonitor of a patient’s cardio-respiratory system,which has undoubtedly improved patient safety <strong>in</strong> manycircumstances.What does a pulse oximeter measure?1. The oxygen saturation of haemoglob<strong>in</strong> <strong>in</strong> arterialblood - which is a measure of the average amountof oxygen bound to each haemoglob<strong>in</strong> molecule.The percentage saturation is given as a digitalreadout together with an audible signal vary<strong>in</strong>g <strong>in</strong>pitch depend<strong>in</strong>g on the oxygen saturation.2. The pulse rate - <strong>in</strong> beats per m<strong>in</strong>ute, averaged over5 to 20 seconds.A pulse oximeter gives no <strong>in</strong>formation on any of theseother variables:The oxygen content of the bloodThe amount of oxygen dissolved <strong>in</strong> the bloodThe respiratory rate or tidal volume i.e. ventilation The cardiac output or blood pressureSystolic blood pressure can be estimated by not<strong>in</strong>g thepressure at which the plethysmograph trace reappearsdur<strong>in</strong>g deflation of a proximal non-<strong>in</strong>vasive blood pressurecuff.Pr<strong>in</strong>ciples of modern pulse oximetryOxygen is carried <strong>in</strong> the bloodstream ma<strong>in</strong>ly bound tohaemoglob<strong>in</strong>. One molecule of haemoglob<strong>in</strong> can carry upto four molecules of oxygen, which is then 100% saturatedwith oxygen. The average percentage saturation of apopulation of haemoglob<strong>in</strong> molecules <strong>in</strong> a blood sample isthe oxygen saturation of the blood. In addition, a verysmall quantity of oxygen is carried dissolved <strong>in</strong> the blood,which can become important if the haemoglob<strong>in</strong> levels areextremely low. The latter, however, is not measured bypulse oximetry.The relationship between the arterial partial pressure ofoxygen (PaO 2 ) and the oxygen saturation is described bythe haemoglob<strong>in</strong>-oxygen dissociation curve (see figure 1).The sigmoid shape of this curve facilitates unload<strong>in</strong>g ofoxygen <strong>in</strong> the peripheral tissues where the PaO 2 is lowand oxygen is required for respiration. The curve may beshifted to the left or right by various patient characteristicse.g. recent blood transfusion, pyrexia.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 13 Read off the displayed oxygen saturation and pulserate.* Be cautious <strong>in</strong>terpret<strong>in</strong>g figures where there has beenan <strong>in</strong>stantaneous change <strong>in</strong> saturation - for example99% fall<strong>in</strong>g suddenly to 85%. This is physiologicallynot possible. If <strong>in</strong> doubt, rely on your cl<strong>in</strong>ical judgement, ratherthan the value the mach<strong>in</strong>e gives.Alarms If the Low Oxygen Saturation alarm sounds, checkthat the patient is conscious if that is appropriate.Check the airway and make sure the patient isbreath<strong>in</strong>g adequately. Lift the ch<strong>in</strong> or apply otherairway manoeuvres as appropriate. Give oxygen ifnecessary. Call for help.If the Pulse Not Detected alarm sounds, look forthe displayed waveform on the pulse oximeter. Feelfor a central pulse. If there is no pulse, call for help,start the procedures for Basic and Advanced LifeSupport. If there is a pulse, try reposition<strong>in</strong>g theprobe, or put the probe on a different digit. On most pulse oximeters, the alarm limits for oxygensaturation and pulse rate can be altered accord<strong>in</strong>gto your needs. However, do not alter an alarm justto stop it sound<strong>in</strong>g - it could be tell<strong>in</strong>g you someth<strong>in</strong>gimportant!Uses of pulse oximetry Simple, portable “all-<strong>in</strong>-one” monitor ofoxygenation, pulse rate and rhythm regularity,suitable for “field” use.As a safe, non-<strong>in</strong>vasive monitor of the cardiorespiratorystatus of high-dependency patients - <strong>in</strong>the emergency department, dur<strong>in</strong>g general andregional anaesthesia, postoperatively and <strong>in</strong><strong>in</strong>tensive care. This <strong>in</strong>cludes procedures such asendoscopy, where often frail patients are givensedative drugs such as midazolam. Pulse oximetersdetect the presence of cyanosis more reliably thaneven the best doctors when us<strong>in</strong>g their cl<strong>in</strong>icaljudgement.Dur<strong>in</strong>g the transport of patients - especially whenthis is noisy - for example <strong>in</strong> aircraft, helicopters orambulances. The audible tone and alarms may notbe heard, but if a waveform can be seen togetherwith an acceptable oxygen saturation, this gives aglobal <strong>in</strong>dication of a patient’s cardio-respiratorystatus.To assess the viability of limbs after plastic andorthopaedic surgery and, for example, follow<strong>in</strong>gvascular graft<strong>in</strong>g, or where there is soft tissue swell<strong>in</strong>gor aortic dissection. As a pulse oximeter requires apulsatile signal under the sensor, it can detectwhether a limb is gett<strong>in</strong>g a blood supply.As a means of reduc<strong>in</strong>g the frequency of blood gasanalysis <strong>in</strong> <strong>in</strong>tensive care patients- especially <strong>in</strong>paediatric practice where vascular (arterial) accessmay be more difficult.To limit oxygen toxicity <strong>in</strong> premature neonatessupplemental oxygen can be tapered to ma<strong>in</strong>ta<strong>in</strong> anoxygen saturation of 90% - thus avoid<strong>in</strong>g thedamage to the lungs and ret<strong>in</strong>as of neonates.Although pulse oximeters are calibrated for adulthaemoglob<strong>in</strong>, HbA, the absorption spectra of HbAand HbF are almost identical over the range used <strong>in</strong>pulse oximetry, so the technique rema<strong>in</strong>s reliable <strong>in</strong>neonates.Dur<strong>in</strong>g thoracic anaesthesia - when one lung is be<strong>in</strong>gcollapsed down - to determ<strong>in</strong>e whether oxygenationvia the rema<strong>in</strong><strong>in</strong>g lung is adequate or whether<strong>in</strong>creased concentrations of oxygen must be given. Fetal oximetry- a develop<strong>in</strong>g technique that usesreflectance oximetry, us<strong>in</strong>g LEDs of 735nm and900nm. The probe is placed over the temple orcheek of the fetus, and needs to be sterile andsterilisable. They are difficult to secure and theread<strong>in</strong>gs are variable, for physiological and technicalreasons. Hence the trend is more useful than theabsolute value.Limitations of pulse oximetryNot a monitor of ventilation A recent casereport (3,4) highlighted the false sense of securityprovided by pulse oximetry. An elderlywoman postoperatively <strong>in</strong> the recovery room wasreceiv<strong>in</strong>g oxygen by face mask. She became<strong>in</strong>creas<strong>in</strong>gly drowsy, despite hav<strong>in</strong>g an oxygensaturation of 96%. The reason was that herrespiratory rate and m<strong>in</strong>ute volume were low dueto residual neuromuscular block and sedation, yetshe was receiv<strong>in</strong>g high concentrations of <strong>in</strong>spiredoxygen, so her oxygen saturation was ma<strong>in</strong>ta<strong>in</strong>ed.She ended up with an arterial carbon dioxideconcentration of 280 mmHg (normal 40 mmHg) andwas ventilated for 24 hours on <strong>in</strong>tensive care. Thusoximetry gives a good estimation of adequate


14<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>(i)(ii)(iii)(iv)(v)(vi)oxygenation, but no direct <strong>in</strong>formation aboutventilation, particularly as <strong>in</strong> this case, whensupplemental oxygen is be<strong>in</strong>g adm<strong>in</strong>istered.Critically ill patients It may be less effective <strong>in</strong>very sick patients, because tissue perfusion may bepoor and thus the oximeter probe may not detect apulsatile signal.Waveform presence If there is no waveformvisible on a pulse oximeter, any percentage saturationvalues obta<strong>in</strong>ed are mean<strong>in</strong>gless.Inaccuracies Bright overhead light<strong>in</strong>g, shiver<strong>in</strong>gand motion artefact may give pulsatile waveformsand saturation values when there is no pulse.Abnormal haemoglob<strong>in</strong>s such asmethaemoglob<strong>in</strong>aemia, for example follow<strong>in</strong>goverdose of priloca<strong>in</strong>e, cause read<strong>in</strong>gs to tendtowards 85%.Carboxyhaemoglob<strong>in</strong>, caused by carbon monoxidepoison<strong>in</strong>g, causes saturation values to tend towards100%. A pulse oximeter is extremely mislead<strong>in</strong>g <strong>in</strong>cases of carbon monoxide poison<strong>in</strong>g for this reasonand should not be used. CO-oximetry is the onlyavailable method of estimat<strong>in</strong>g the severity of carbonmonoxide poison<strong>in</strong>g.Dyes and pigments, <strong>in</strong>clud<strong>in</strong>g nail varnish, may giveartificially low values.Vasoconstriction and hypothermia cause reducedtissue perfusion and failure to register a signal.Rare cardiac valvular defects such as tricuspidregurgitation cause venous pulsation and thereforevenous oxygen saturation is recorded by theoximeter.Oxygen saturation values less than 70% are<strong>in</strong>accurate as there are no control values to comparethem to.(vii) Cardiac arrhythmias may <strong>in</strong>terfere with the oximeterpick<strong>in</strong>g up the pulsatile signal properly and withcalculation of the pulse rate.NB. Age, sex, anaemia, jaundice and dark-sk<strong>in</strong> havelittle or no effects on oximeter function.Lag monitor This means that the partial pressureof oxygen can have fallen a great deal before theoxygen saturation starts to fall. If a healthy adultpatient is given 100% oxygen to breathe for a fewm<strong>in</strong>utes and then ventilation ceases for any reason,several m<strong>in</strong>utes may elapse before the oxygensaturation starts to fall. A pulse oximeter <strong>in</strong> thesecircumstances warns of a potentially fatalcomplication several m<strong>in</strong>utes after it has happened.The pulse oximeter has been described as “a sentrystand<strong>in</strong>g at the edge of the cliff of desaturation.”because of this fact. The explanation of this lies <strong>in</strong>the sigmoid shape of the haemoglob<strong>in</strong> / oxygendissociation curve (figure 1).Response delay due to signal averag<strong>in</strong>g. Thismeans that there is a delay after the actual oxygensaturation starts to drop because the signal isaveraged out over 5 to 20 seconds. Patient safety there have been one or two casereports of sk<strong>in</strong> burns or pressure damage under theprobe because some early probes had a heater unitto ensure adequate sk<strong>in</strong> perfusion. The probe shouldbe correctly sized, and should not exert excessivepressure. Special probes are now available forpaediatric use.The penumbra effect re-emphasises the importanceof correct probe position<strong>in</strong>g. This effect causesfalsely low read<strong>in</strong>gs and occurs when the probe isnot symmetrically placed, such that the pathlengthbetween the two LEDs and the photodetector isunequal, caus<strong>in</strong>g one wavelength to be“overloaded”. Reposition<strong>in</strong>g of the probe often leadsto sudden improvement <strong>in</strong> saturation read<strong>in</strong>gs. Thepenumbra effect may be compounded by thepresence of variable blood flow through cutaneouspulsatile venules. Note that the waveform mayappear normal despite the penumbra effect as itmeasures predom<strong>in</strong>antly one wavelength only.Alternatives to pulse oximetry?Bench CO-oximetry is the gold standard - and isthe classic method by which a pulse oximeter iscalibrated. The CO-oximeter calculates the actualconcentrations of haemoglob<strong>in</strong>, deoxyhaemoglob<strong>in</strong>,carboxyhaemoglob<strong>in</strong> and methaemoglob<strong>in</strong> <strong>in</strong> thesample and hence calculates the actual oxygensaturation. CO-oximeters are much more accuratethan pulse oximeters - to with<strong>in</strong> 1%, but they give a‘snapshot’ of oxygen saturation, are bulky, expensiveand require constant ma<strong>in</strong>tenance as well as requir<strong>in</strong>ga sample of arterial blood to be taken.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 15Blood gas analysis - requires an <strong>in</strong>vasive sample ofarterial blood. It gives the ‘full picture’, <strong>in</strong>clud<strong>in</strong>garterial partial pressure of oxygen and carbondioxide, arterial pH, actual and standardised baseexcess and actual and standardised bicarbonateconcentrations. Many blood gas analysers reporta calculated saturation which is less accurate thanthat provided by the pulse oximeter.Lag monitor - time delay between potentiallyhypoxic event such as respiratory obstruction anda pulse oximeter detect<strong>in</strong>g low oxygen saturation.Inaccuracies: ambient light; shiver<strong>in</strong>g andvasoconstriction; abnormal haemoglob<strong>in</strong>s; andalterations <strong>in</strong> pulse rate and rhythm.Advances <strong>in</strong> microprocessor have led to improvedsignal process<strong>in</strong>g.SUMMARY POINTSPulse oximeters give non-<strong>in</strong>vasive estimation of thearterial haemoglob<strong>in</strong> oxygen saturation.Useful <strong>in</strong>: anaesthesia, recovery, <strong>in</strong>tensive care(<strong>in</strong>clud<strong>in</strong>g neonatal), patient transport.2 pr<strong>in</strong>ciples <strong>in</strong>volved:(1) Differential light absorption by haemoglob<strong>in</strong> andoxyhaemoglob<strong>in</strong>.(2) Identification of pulsatile component of signal.No direct <strong>in</strong>dication of a patient’s ventilation, onlyof their oxygenation.Further Read<strong>in</strong>g1. Stoneham MD, Saville GM, Wilson IH. Knowledge about pulseoximetry among medical and nurs<strong>in</strong>g staff. Lancet 1994:334:1339-1342.2. Moyle JTB. Pulse oximetry. Pr<strong>in</strong>ciples and Practice Series.Editors: Hahn CEW and Adams AP. BMJ Publish<strong>in</strong>g, London,1994.3. Davidson JAH, Hosie HE. Limitations of pulse oximetry:respiratory <strong>in</strong>sufficiency - a failure of detection. BMJ 1993;307:372-373.4. Hutton P, Clutton-Brock T. The benefits and pitfalls of pulseoximetry. BMJ 1993;307:457-458.


16<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>ECG MONITORING IN THEATREDr Juliette Lee, Royal Devon And Exeter Hospital, Exeter, UK - Previously: Ngwelezana hospital, Empangeni,Kwa-zulu Natal, RSACardiac arrhythmias dur<strong>in</strong>g anaesthesia and surgery occur<strong>in</strong> up to 86% of patients. Many are of cl<strong>in</strong>ical significanceand therefore their detection is of considerable importance.This article will discuss the basic pr<strong>in</strong>ciples of us<strong>in</strong>g theECG monitor <strong>in</strong> the operat<strong>in</strong>g theatre. It will describe thema<strong>in</strong> rhythm abnormalities and give practical guidance onhow to recognise and treat them.The cont<strong>in</strong>uous oscilloscopic ECG is one of the mostwidely used anaesthetic monitors, and <strong>in</strong> addition todisplay<strong>in</strong>g arrhythmias it can also be used to detectmyocardial ischaemia, electrolyte imbalances, and assesspacemaker function. A 12 lead ECG record<strong>in</strong>g will providemuch more <strong>in</strong>formation than is available on a theatre ECGmonitor, and should where possible, be obta<strong>in</strong>ed preoperatively<strong>in</strong> any patient with suspected cardiac disease.The ECG is a record<strong>in</strong>g of the electrical activity of theheart. It does not provide <strong>in</strong>formation about the mechanicalfunction of the heart and cannot be used to assess cardiacoutput or blood pressure. Cardiac function underanaesthesia is usually estimated us<strong>in</strong>g frequentmeasurements of blood pressure, pulse, oxygen saturation,peripheral perfusion and end tidal CO 2 concentrations.Cardiac performance is occasionally measured directly <strong>in</strong>theatre us<strong>in</strong>g Swan Ganz catheters or oesophageal Dopplertechniques, although this is uncommon.The ECG monitor should always be connected to thepatient before <strong>in</strong>duction of anaesthesia or <strong>in</strong>stitution of aregional block. This will allow the anaesthetist to detectany change <strong>in</strong> the appearance of the ECG complexes dur<strong>in</strong>ganaesthesia.Connect<strong>in</strong>g an ECG monitorAlthough an ECG trace may be obta<strong>in</strong>ed with theelectrodes attached <strong>in</strong> a variety of positions, conventionallythey are placed <strong>in</strong> a standard position each time so thatabnormalities are easier to detect. Most monitors have 3leads and they are connected as follows:Red - right arm, (or second <strong>in</strong>tercostal spaceon the right of the sternum)Yellow - left arm (or second <strong>in</strong>tercostal spaceon the left of the sternum)Black (or Green) - left leg (or more often <strong>in</strong>the region of the apex beat.)Figure 1. The Cardiac Muscle Action PotentialStage O = depolarisation, open<strong>in</strong>g of voltage gated sodiumchannelsStage I = <strong>in</strong>itial rapid repolarisation, closure of sodiumchannels and chloride <strong>in</strong>flux.Stage 2 = plateau - open<strong>in</strong>g of voltage gated calciumchannels.Stage 3 = repolarisation, potassium efflux.Stage 4 = diastolic pre potential drift.This will allow the Lead I, II or III configurations to beselected on the ECG monitor. Lead II is the most commonlyused. (See page 18 for other lead positions and their uses).The cables from the electrodes usually term<strong>in</strong>ate <strong>in</strong> a s<strong>in</strong>glecable which is plugged <strong>in</strong>to the port on the ECG monitor.A good electrical connection between the patient and theelectrodes is required to m<strong>in</strong>imise the resistance of thesk<strong>in</strong>. For this reason gel pads or suction caps with electrodejelly are used to connect the electrodes to the patientssk<strong>in</strong>. However when the sk<strong>in</strong> is sweaty the electrodes maynot stick well, result<strong>in</strong>g <strong>in</strong> an unstable trace. Whenelectrodes are <strong>in</strong> short supply they may be reused aftermoisten<strong>in</strong>g with sal<strong>in</strong>e or gel before be<strong>in</strong>g taped to thepatient’s chest. Alternatively, an empty 1000ml iv <strong>in</strong>fusionbag may be cut open to allow it to lie flat (<strong>in</strong> the form of aflat piece of plastic) on the patient’s chest. If 3 small


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 17holes are made <strong>in</strong> 3 of the corners electrodes may be stuckon one side of the plastic allow<strong>in</strong>g the electrode gel tomake contact with the sk<strong>in</strong>. This device can be cleaned atthe end of the operation and laid on the next patient allow<strong>in</strong>gelectrodes to be used repeatedly.Pr<strong>in</strong>ciples of the ECGThe ECG is a record<strong>in</strong>g of the electrical activity of theheart. An electrical record<strong>in</strong>g made from one myocardialmuscle cell will record an action potential (the electricalactivity which occurs when the cell is stimulated). The ECGrecords the vector sum (the comb<strong>in</strong>ation of all electricalsignals) of all the action potentials of the myocardium andproduces a comb<strong>in</strong>ed trace.At rest the potential difference across the membrane of amyocardial cell is -90mv (figure 1). This is due to a high<strong>in</strong>tracellular potassium concentration which is ma<strong>in</strong>ta<strong>in</strong>edby the sodium/potassium pump. Depolarisation of acardiac cell occurs when there is a sudden change <strong>in</strong> thepermeability of the membrane to sodium. Sodium floods<strong>in</strong>to the cell and the negative rest<strong>in</strong>g voltage is lost (stage0). Calcium follows the sodium through the slower calciumchannels result<strong>in</strong>g <strong>in</strong> b<strong>in</strong>d<strong>in</strong>g between the <strong>in</strong>tracellularprote<strong>in</strong>s act<strong>in</strong> and myos<strong>in</strong> which results <strong>in</strong> contraction ofthe muscle fibre (stage 2). The depolarisation of amyocardial cell causes the depolarisation of adjacent cellsand <strong>in</strong> the normal heart the depolarisation of the entiremyocardium follows <strong>in</strong> a co-ord<strong>in</strong>ated fashion. Dur<strong>in</strong>grepolarisation potassium moves out of the cells (stage 3)and the rest<strong>in</strong>g negative membrane potential is restored.THE CONDUCTING SYSTEM OF THE HEARTThe specialised cardiac conduct<strong>in</strong>g system (figure 2)consists of :The S<strong>in</strong>oatrial (SA) node, <strong>in</strong>ternodal pathways,Atrioventricular (AV) node, bundle of HIS with right andleft bundle branches and the Purk<strong>in</strong>je system. The leftbundle branch also divides <strong>in</strong>to anterior and posteriorfascicles. Conduct<strong>in</strong>g tissue is made up of modified cardiacmuscle cells which have the property of automaticity, thatis they can generate their own <strong>in</strong>tr<strong>in</strong>sic action potentials aswell as respond<strong>in</strong>g to stimulation from adjacent cells. Theconduct<strong>in</strong>g pathways with<strong>in</strong> the heart are responsible forthe organised spread of action potentials with<strong>in</strong> the heartand the result<strong>in</strong>g co-ord<strong>in</strong>ated contraction of both atriaand ventricles.In pacemaker tissue, after repolarisation has occurred, themembrane potential gradually rises to the threshold levelfor channel open<strong>in</strong>g, at which po<strong>in</strong>t sodium floods <strong>in</strong>to thecell and <strong>in</strong>itiates the next action potential (figure 3). Thisgradual rise is called the pacemaker (or pre-potential) andis due to a decrease <strong>in</strong> the membrane permeability topotassium ions which result <strong>in</strong> the <strong>in</strong>side of the cell becom<strong>in</strong>gless negative. The rate of rise of the pacemaker potentialis the ma<strong>in</strong> determ<strong>in</strong>ant of heart rate and is <strong>in</strong>creased byadrenal<strong>in</strong>e (ep<strong>in</strong>ephr<strong>in</strong>e) and sympathetic stimulation anddecreased by vagal stimulation and hypothermia.Pacemaker activity normally only occurs <strong>in</strong> the SA andAV nodes, but there are latent pacemakers <strong>in</strong> other partsof the conduct<strong>in</strong>g system which take over when fir<strong>in</strong>g fromthe SA or AV nodes is depressed. Atrial and ventricularmuscle fibres do not have pacemaker activity and dischargespontaneously only when damaged or abnormal.Figure 2: Conduct<strong>in</strong>g system of the heartFigure 3: Action Potential <strong>in</strong> Pacemaker Tissue


18<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>GRAPHICAL RECORDINGOn a paper trace the ECG is usually recorded on a timescale of 0.04 seconds/mm on the horizontal axis and avoltage sensitivity of 0.1mv/mm on the vertical axis (figure4). Therefore, on standard ECG record<strong>in</strong>g paper,1 smallsquare represents 0.04seconds and one large square 0.2seconds. In the normal ECG waveform the P waverepresents atrial depolarisation, the QRS complexventricular depolarisation and the T wave ventricularrepolarisation.The Q -T <strong>in</strong>terval is taken from the start of theQRS complex to the end of the T wave. Thisrepresents the time taken to depolarise andrepolarise the ventricles.The S - T segment is the period between theend of the QRS complex and the start of the Twave. All cells are normally depolarised dur<strong>in</strong>gthis phase. The ST segment is changed bypathology such as myocardial ischaemia orpericarditis.Figure 4: Graphical Record<strong>in</strong>gThe P- R <strong>in</strong>terval is taken from the start of theP wave to the start of the QRS complex. It isthe time taken for depolarisation to pass fromthe SA node via the atria, AV node and His -Purk<strong>in</strong>je system to the ventricles.The QRS represents the time taken fordepolarisation to pass through the His - Purk<strong>in</strong>jesystem and ventricular muscles. It is prolongedwith disease of the His - Purk<strong>in</strong>je system.LEAD POSITIONSThe ECG may be used <strong>in</strong> two ways. A 12 lead ECG maybe performed which analyses the cardiac electrical activityfrom a number of electrodes positioned on the limbs andacross the chest. A wide range of abnormalities may bedetected <strong>in</strong>clud<strong>in</strong>g arrhythmias, myocardial ischaemia, leftventricular hypertrophy and pericarditis.Dur<strong>in</strong>g anaesthesia, however, the ECG is monitored us<strong>in</strong>gonly 3 (or occasionally 5) electrodes which provide a morerestricted analysis of the cardiac electrical activity andcannot provide the same amount of <strong>in</strong>formation that maybe revealed by the 12 lead ECG.The term ‘lead’ when applied to the ECG does not describethe electrical cables connected to the electrodes on thepatient. Instead it refers to the position<strong>in</strong>g of the 2 electrodesbe<strong>in</strong>g used to detect the electrical activity of the heart. Athird electrode acts as a neutral. Dur<strong>in</strong>g anaesthesia oneof 3 possible ‘leads’ is generally used. These leads arecalled bipolar leads as they measure the potential difference(electrical difference) between two electrodes. Electricalactivity travell<strong>in</strong>g towards an electrode is displayed as apositive (upward) deflection on the screen, and electricalactivity travell<strong>in</strong>g away as a negative (downward)deflection. The leads are described by convention asfollows:ECG Normal ValuesP - R <strong>in</strong>terval 0.12 - 0.2 seconds (3-5 small squares of standard ECG paper )QRS complex duration less than or equal to 0.1 seconds ( 2.5 small squares )Q - T <strong>in</strong>tervalless than or equal to 0.44 secondscorrected for heart rate ( QTc )QTc = QT/ RR <strong>in</strong>terval


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 19Lead I - measures the potential differencebetween the right arm electrode and the left armelectrode. The third electrode (left leg) acts asneutral.Lead II - measures the potential differencebetween the right arm and left leg electrode. Lead III - measures the potential differencebetween the left arm and left leg electrode.Most monitors can only show one lead at a time andtherefore the lead that gives as much <strong>in</strong>formation as possibleshould be chosen. The most commonly used lead is leadII (figure 5) - a bipolar lead with electrodes on the rightarm and left leg as above. This is the most useful lead fordetect<strong>in</strong>g cardiac arrhythmias as it lies close to the cardiacaxis ( the overall direction of electrical movement ) andallows the best view of P and R waves.For detection of myocardial ischaemia the CM5 lead isuseful (figure 6). This is a bipolar lead with the right armelectrode placed on the manubrium and left arm electrodeplaced at the surface mark<strong>in</strong>g of the V5 position (justabove the 5th <strong>in</strong>terspace <strong>in</strong> the anterior axillary l<strong>in</strong>e). Theleft leg lead acts as a neutral and may be placed anywhere- the C refers to ‘clavicle’ where it is often placed. Toselect the CM5 lead on the monitor, turn the selector dialto ‘lead I’. This position allows detection of up to 80%of left ventricular episodes of ischaemia, and as it alsodisplays arrhythmias it can be recommended for use<strong>in</strong> most patients. The CB5 lead is another bipolarlead which has one electrode positioned at V5 and theother over the right scapula. This results <strong>in</strong> improvedQRS and P wave voltages allow<strong>in</strong>g easier detectionof arrhythmias and ischaemia. Many other electrodepositions have been described <strong>in</strong>clud<strong>in</strong>g some useddur<strong>in</strong>g cardiac surgery, for example oesophageal and<strong>in</strong>tracardiac ECG’s.CARDIAC ARRHYTHMIASThe detection of cardiac arrhythmias and the determ<strong>in</strong>ationof heart rate is the most useful function of the <strong>in</strong>traoperativeECG. <strong>Anaesthesia</strong> and surgery may cause any type ofarrhythmia <strong>in</strong>clud<strong>in</strong>g:Transient supraventricular and ventriculartachycardias due to sympathetic stimulation dur<strong>in</strong>glaryngoscopy and <strong>in</strong>tubation.Bradycardias produced by surgical manipulationresult<strong>in</strong>g <strong>in</strong> vagal stimulation. Severe bradycardiaand asystole may result. It is more common <strong>in</strong>children because the sympathetic <strong>in</strong>nervation ofthe heart is immature and vagal tone predom<strong>in</strong>ates.Bradycardias are most commonly seen <strong>in</strong>ophthalmic surgery due to the oculocardiac reflex.Generally the heart rate will improve when thesurgical stimulus is removed. Atrial fibrillation is common dur<strong>in</strong>g thoracicFigure 5: Lead II - electrode connectionsFigure 6: CM5 - electrode connections


20<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>surgery.Drugs may also cause changes <strong>in</strong> cardiac rhythm eg; Halothane and nitrous oxide may cause junctionalrhythms - (these will be detailed later). Halothanehas a direct effect on the SA node and conduct<strong>in</strong>gsystem lead<strong>in</strong>g to a slow<strong>in</strong>g <strong>in</strong> impulse generationand conduction and predisposes to re-entryphenomena. Catecholam<strong>in</strong>es also have potenteffects on impulse conduction, so the <strong>in</strong>teractionof halothane and exogenous or endogenouscatecholam<strong>in</strong>es may cause ventricular arrhythmias.Ventricular ectopic beats are common. Howeverrhythm disturbances such as ventriculartachycardia or rarely ventricular fibrillation mayoccur. The presence of cardiac disease, hypoxia,acidosis, hypercarbia (raised CO 2level) orelectrolyte disturbances will <strong>in</strong>crease the likelihoodof these arrhythmias. Arrhythmias occurr<strong>in</strong>g dur<strong>in</strong>g halothane anaesthesiacan often be resolved by reduc<strong>in</strong>g theconcentration of halothane, ensur<strong>in</strong>g adequateventilation thereby prevent<strong>in</strong>g hypercarbia,<strong>in</strong>creas<strong>in</strong>g the <strong>in</strong>spired oxygen concentration andprovid<strong>in</strong>g an adequate depth of anaesthesia forthe surgical procedure. Tachyarrhythmias <strong>in</strong> thepresence of halothane anaesthesia are uncommonif ventilation is adequate, and the use ofadrenal<strong>in</strong>e <strong>in</strong>filtration for haemostasis is limitedto solutions of 1:100,000 or less and the dose <strong>in</strong>adults is not greater than 0.1mg <strong>in</strong> 10 m<strong>in</strong>utes or0.3mg per hour ). Drugs <strong>in</strong>creas<strong>in</strong>g heart rate <strong>in</strong>clude ketam<strong>in</strong>e,ether, atrop<strong>in</strong>e and pancuronium. Drugsdecreas<strong>in</strong>g heart rate <strong>in</strong>clude opioids, betablockers and halothane.Action Plan - when faced with an abnormal rhythmon the ECG monitorAssess the vital signs - A.B.C. Check the airway is patent Check the patient is breath<strong>in</strong>g adequately or isbe<strong>in</strong>g ventilated correctlyListen for equal air entry <strong>in</strong>to both lungsCirculation - check pulse, blood pressure, oxygensaturation. Is there haemodynamic compromise?Does the abnormal rhythm on the monitor matchthe pulse that you can feel?Consider the follow<strong>in</strong>g: Increase the <strong>in</strong>spired oxygen concentration Reduce the <strong>in</strong>spired volatile agent concentration Ensure that ventilation is adequate to preventCO 2build up. Check end tidal CO 2where thismeasurement is availableConsider what the surgeon is do<strong>in</strong>g - is this thecause of the problem? Eg: traction on theperitoneum or eye caus<strong>in</strong>g a vagal response. Ifso ask them to stop while you treat thearrhythmia.If the arrhythmia is caus<strong>in</strong>g haemodynamic<strong>in</strong>stability, rapid recognition and treatment isrequired. However, many abnormal rhythmsencountered <strong>in</strong> every day practice will respondto the above basic measures - sometimes evenbefore identification of the exact rhythmabnormality is possible.PRACTICAL INTERPRETATION ANDMANAGEMENT OF ARRHYTHMIASWhen <strong>in</strong>terpret<strong>in</strong>g arrhythmias a paper strip is ofteneasier to read than an ECG monitor. Where this is notpossible from the theatre monitor it may be possibleto obta<strong>in</strong> a paper trace by connect<strong>in</strong>g a defibrillator,most of which have a facility for pr<strong>in</strong>t<strong>in</strong>g a rhythmstrip. The follow<strong>in</strong>g basic po<strong>in</strong>ts should be considered:Exam<strong>in</strong><strong>in</strong>g an ECG strip:1. What is the ventricular rate?2. Is the QRS complex of normal duration or widened?3. Is the QRS regular or irregular?4. Are P waves present and are they normally shaped?5. How is atrial activity related to ventricular activity?1. What is the ventricular rate? Arrhythmias maybe classified as fast or slow: Tachyarrhythmias - rate greater than100/m<strong>in</strong> Bradyarrhythmias - rate less than 60/m<strong>in</strong> Calculate approximate ventricular rate on apaper strip by count<strong>in</strong>g the number of largesquares between each QRS complex anddivid<strong>in</strong>g this number <strong>in</strong>to 300 which willgive the rate <strong>in</strong> beats/m<strong>in</strong>ute.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 212. Is the QRS complex of normal duration orwidened? Arrhythmias may be due toabnormal impulses aris<strong>in</strong>g from the: atria = a supraventricular ryhthm AV node = a nodal or junctionalrhythm or the ventricles = a ventriculararrhythmiaSupraventricular and nodal rhythms arise froma focus above the ventricles. S<strong>in</strong>ce the ventriclesstill depolarise via the normal His-Purk<strong>in</strong>je system the QRS complexes are ofnormal width (< 0.1sec - 2.5 small squares) -and are therefore termed ‘narrow complex’rhythms. Arrhythmias aris<strong>in</strong>g from the ventricleswill be ‘broad complex’ with a QRSwidth of >0.1sec. The QRS complexes arewidened <strong>in</strong> these patients s<strong>in</strong>ce depolarisationis via the ventricular muscle rather than theHis-Purk<strong>in</strong>je system and takes longer. In a fewcases where thereis an abnormal conductionpathway from atria to ventricles a supraventricularrhythm may have broad complexes.This is called ‘aberrant conduction’.3. Is the QRS regular or irregular?The presence of an irregular rhythm will tend tosuggest ectopic beats (either atrial orventricular), atrial fibrillation, atrial flutter withvariable block or second degree heart blockwith variable block - see page 29.4. Are there P waves present and are theynormally shaped?The presence of P waves <strong>in</strong>dicates that the atriahave depolarised and gives a clue to the likelyorig<strong>in</strong> of the rhythm. Absent P waves associatedwith an irregular ventricular rhythm suggest atrialfibrillation whilst a saw tooth pattern of P wavesis characteristic of atrial flutter. If the P wavesare upright <strong>in</strong> leads II and AVF they haveorig<strong>in</strong>ated from the s<strong>in</strong>oatrial node. However,if the P waves are <strong>in</strong>verted <strong>in</strong> these leads, it<strong>in</strong>dicates that the atria are be<strong>in</strong>g activated <strong>in</strong>a retrograde direction ie: the rhythm isjunctional or ventricular.5. How is atrial activity related to ventricularactivity?Normally there will be one P wave per QRScomplex. Any change <strong>in</strong> this ratio <strong>in</strong>dicates ablockage to conduction at some po<strong>in</strong>t <strong>in</strong> thepathway from the atria to the ventricles.CLASSIFICATION OF ARRHYTHMIASArrhythmias may be divided <strong>in</strong>to narrow complex andbroad complex for the purpose of rapid recognition andmanagement.Narrow complex arrhythmias - arise above thebifurcation of the bundle of His. The QRS duration is lessthan 0.1s (2.5 small squares) durationBroad complex arrhythmias - usually arise either fromthe ventricles or less commonly are conducted abnormallyfrom a site above the ventricles so that delay occurs (thisis called aberrant conduction). The QRS duration is greaterthan 0.1s (2.5 small squares).NARROW COMPLEX RHYTHMS: S<strong>in</strong>us arrhythmia S<strong>in</strong>us tachycardia S<strong>in</strong>us bradycardia Junctional / AV nodal tachycardia Atrial tachycardia, atrial flutter Atrial fibrillation Atrial ectopicsBROAD COMPLEX RHYTHMS Ventricular ectopics Ventricular tachycardia Supraventricular tachycardia with aberrantconduction Ventricular fibrillationNARROW COMPLEX ARRHYTHMIASS<strong>in</strong>us arrhythmia This is irregular spac<strong>in</strong>g of normalcomplexes associated with respiration. There is a constantP-R <strong>in</strong>terval with beat to beat change <strong>in</strong> the R-R <strong>in</strong>terval.It is a normal f<strong>in</strong>d<strong>in</strong>g especially <strong>in</strong> young people.S<strong>in</strong>us tachycardia (figure 7). There is a rate greater than100/m<strong>in</strong> <strong>in</strong> adults. Normal P-QRS-T complexes areevident. Causes <strong>in</strong>clude: Inadequate depth of anaesthesia Pa<strong>in</strong> / surgical stimulation Fever / sepsis Hypovolaemia Anaemia


22<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Figure 7: S<strong>in</strong>us tachycardiaHeart failureThyrotoxicosis Drugs eg atrop<strong>in</strong>e, ether, ketam<strong>in</strong>e, catecholam<strong>in</strong>esManagement : correction of any underly<strong>in</strong>g cause wherepossible. Beta blockers may be useful if tachycardia causesmyocardial ischaemia <strong>in</strong> patients with ischaemic heartdisease, but should be avoided <strong>in</strong> asthma and used withcaution <strong>in</strong> patients with heart failure.S<strong>in</strong>us bradycardia (figure 8).This is def<strong>in</strong>ed as a heart rate of less then 60 beats/m<strong>in</strong>ute<strong>in</strong> an adult.It may be normal <strong>in</strong> athletic patients and may also be dueto vagal stimulation dur<strong>in</strong>g surgery - see above.Other causes <strong>in</strong>clude: Drugs eg; beta blockers, digox<strong>in</strong>,antichol<strong>in</strong>esterase drugs, halothane, second doseof suxamethonium (occasionally first dose <strong>in</strong>children)Myocardial <strong>in</strong>farctionSick s<strong>in</strong>us syndromeRaised <strong>in</strong>tracranial pressureHypothyroidism HypothermiaManagement It is often not necessary to correct a s<strong>in</strong>usbradycardia <strong>in</strong> a fit young person, unless the rate is lessthan 45 - 50 beats per m<strong>in</strong>ute, and / or there ishaemodynamic compromise. However consider:Correct<strong>in</strong>g the underly<strong>in</strong>g cause eg: stop the surgicalstimulus Atrop<strong>in</strong>e up to 20 mcg/kg iv or glycopyrolate 10mcg/kg iv. (Atrop<strong>in</strong>e works more rapidly and isusually given <strong>in</strong> doses of 300-400mcg and repeatedif required).Patients on beta blockers may be resistant toatrop<strong>in</strong>e - occasionally an isoprenal<strong>in</strong>e <strong>in</strong>fusion maybe required. Alternatively glucagon (2-10mg)can be used <strong>in</strong> addition to atrop<strong>in</strong>e.ARRHYTHMIAS DUE TO RE- ENTRY (Circularmovement of electrical impulses).These arrythmias occur where there is an anatomicalbranch<strong>in</strong>g and re-jo<strong>in</strong><strong>in</strong>g of a conduction pathway.Normally conduction would occur down both limbsequally. But if one limb is slower than the other, an impulsemay pass normally down one limb but be blocked <strong>in</strong> theother. Where the pathways rejo<strong>in</strong> the impulse can thenFigure 8: S<strong>in</strong>us bradycardia


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 23ExcitationConduction,slow orblockedRe-entryFigure 9: A Re-entry circuitspread backwards up the abnormal pathway. If it arrivesat a time when the first pathway is no longer refractory toactivation it can pass right round the circuit repeatedlyactivat<strong>in</strong>g it and result<strong>in</strong>g <strong>in</strong> a tachycardia (figure 9.) Theclassical example of this is the Wolf Park<strong>in</strong>son Whitesyndrome where there is a relatively large anatomical‘accessory’ conduction pathway between the atria andthe ventricles. This is called a ‘macro re-entry’ circuit.Other macro re-entry circuits can occur with<strong>in</strong> the atrialand ventricular myocardium and are responsible forparoxysmal atrial flutter, atrial fibrillation and ventriculartachycardia. In junctional or AV nodal tachycardia thereare ‘micro re-entry’circuits with<strong>in</strong> the AV node itself.JUNCTIONAL / AV NODAL TACHYCARDIA(figure 10)The term Supraventricular Tachycardia ( SVT ) applies toall tachyarrhythmias aris<strong>in</strong>g from a focus above theventricles. However it is often used to describe junctional(AV nodal) tachycardias aris<strong>in</strong>g from micro re-entry circuits<strong>in</strong> or near the AV node, or as <strong>in</strong> the Wolf Park<strong>in</strong>son Whitesyndrome from an accessory conduction pathway betweenthe atria and the ventricles. The ECG appearance is of anarrow complex tachycardia (QRS


24<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Gentle pressure on the <strong>in</strong>ternal carotid artery at this levelmay result <strong>in</strong> a slow<strong>in</strong>g of the heart rate and occasionallyterm<strong>in</strong>ation of a re-entry supraventricular tachycardia. Itshould NEVER be attempted on both sides at once asthis may result <strong>in</strong> asystole and occlusion of the ma<strong>in</strong> arterialblood supply to the bra<strong>in</strong>.) It is contra-<strong>in</strong>dicated <strong>in</strong> patientswith a history of cerebrovascular disease.3. Adenos<strong>in</strong>e - this slows AV conduction and is especiallyuseful for term<strong>in</strong>at<strong>in</strong>g re-entry SVTs of the Wolf Park<strong>in</strong>sonWhite type. Give 3mg iv rapidly preferably via a centralor large peripheral ve<strong>in</strong> - followed by a sal<strong>in</strong>e flush. Furtherdoses of 6mg and then 12mg may be given at 2 m<strong>in</strong> <strong>in</strong>tervalsif there is no response to the first dose. The effects ofadenos<strong>in</strong>e last only 10 -15 seconds. It should be avoided<strong>in</strong> asthma.4.Verapamil, beta blockers or other drugs such asamiodarone or fleca<strong>in</strong>ide may control the rate or convertto s<strong>in</strong>us rhythm.Verapamil 5 -10mg iv slowly over 2 m<strong>in</strong>utes. Afurther 5mg may be given after 10 m<strong>in</strong>utes ifrequired. Avoid giv<strong>in</strong>g concurrently with betablockers as this may precipitate hypotension andasystole. Beta blockers eg: propranolol 1 mg over 1 m<strong>in</strong>uterepeated if necessary at 2 m<strong>in</strong>ute <strong>in</strong>tervals(maximum 5mg), or sotalol 100mg over 10m<strong>in</strong>utes repeated 6 hourly if neccesary. Esmolol- a relatively cardio-selective beta blocker with avery short duration of action may be given by<strong>in</strong>fusion at 50 - 200 mcg/kg/m<strong>in</strong>ute.Digox<strong>in</strong> should be avoided - it facilitates conductionthrough the AV accessory pathway <strong>in</strong> the Wolf Park<strong>in</strong>sonWhite syndrome and may worsen the tachycardia. Notethat atrial fibrillation <strong>in</strong> the presence of an accessorypathway may allow very rapid conduction which candegenerate to ventricular fibrillation.ATRIAL TACHYCARDIA AND ATRIALFLUTTER (figure <strong>11</strong>)This is due to an ectopic focus depolaris<strong>in</strong>g from anywherewith<strong>in</strong> the atria. The atria contract faster than 150 bpmand P waves can be seen superimposed on the T wavesof the preced<strong>in</strong>g beats. The AV node conducts at amaximum rate of 200 bpm, therefore if the atrial rate isfaster than this, AV block will occur. If the atrial rate isgreater than 250 beats/m<strong>in</strong> and there is no flat basel<strong>in</strong>ebetween P waves, then the typical ‘saw tooth ‘ pattern ofatrial flutter waves will be seen.Atrial tachycardia and flutter may occur with any k<strong>in</strong>d ofblock:Eg: 2:1, 3:1, or 4:1.Atrial tachycardia is typically a paroxysmal arrhythmia,present<strong>in</strong>g with <strong>in</strong>termittent tachycardia and palpitations,and may be precipitated by anaesthesia and surgery. It isassociated <strong>in</strong> particular with rheumatic valvular disease aswell as ischaemic and hypertensive heart disease and maybe seen with mitral valve prolapse. It may precede theonset of permanent atrial fibrillation. Atrial tachycardiawith 2:1 block is characteristic of digitalis toxicity.ManagementThis arrhythmia is very sensitive to synchroniseddirect current cardioversion - there is a nearly100% success rate. Therefore <strong>in</strong> the anaesthetisedpatient with any degree of cardiovascularcompromise this should be the first l<strong>in</strong>e treatment.Carotid s<strong>in</strong>us massage and adenos<strong>in</strong>e will slowAV conduction and reveal the underly<strong>in</strong>g rhythmand block where there is doubt.Other drug treatment is as for atrial fibrillation. (seepage 25).Figure <strong>11</strong>: Atrial tachycardia


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 25ATRIAL FIBRILLATION (AF - figure 12)A common arrhythmia encountered <strong>in</strong> anaesthetic andsurgical practice. There is chaotic and unco-ord<strong>in</strong>atedatrial depolarisation, an absence of P waves on the ECG,with an irregular basel<strong>in</strong>e and a completely irregularventricular rate. Transmission of atrial activity to theventricles via the AV node depends on the refractoryperiod of the conduct<strong>in</strong>g tissue. In the absence of drugtreatment or disease which slows conduction, theventricular response rate will normally be rapid ie: 120 -200 beats/m<strong>in</strong>.Common causes of AF <strong>in</strong>clude: Ischaemia Myocardial disease / pericardial disease /mediast<strong>in</strong>itisMitral valve diseaseSepsisElectrolyte disturbance (particularly hypokalaemiaor hypomagnesaemia)Thyrotoxicosis Thoracic surgeryS<strong>in</strong>ce contraction of the atria contributes up to 30% of thenormal ventricular fill<strong>in</strong>g, the onset of AF may result <strong>in</strong> asignificant fall <strong>in</strong> cardiac output. Fast AF may precipitatecardiac failure, pulmonary oedema and myocardialischaemia. Systemic thrombo-embolism may occur if bloodclots <strong>in</strong> the fibrillat<strong>in</strong>g atria and subsequently embolises<strong>in</strong>to the circulation. There is a 4% risk per year of anembolic cerebro-vascular episode (CVE = stroke). Thetreatment of AF is aimed at the restoration of s<strong>in</strong>us rhythmwhenever possible. Where this is not possible, the aim iscontrol of the ventricular rate to


26<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>adm<strong>in</strong>istration of fleca<strong>in</strong>ide 50 - 100mg slowly ivmay restore s<strong>in</strong>us rhythm. However fleca<strong>in</strong>ideshould only be used where the arrhythmia is lifethreaten<strong>in</strong>g and no other options are open. Itshould be avoided if left ventricular function is pooror there is evidence of ischaemia. Beta blockers are sometimes used to control theventricular rate but may precipitate heart failure <strong>in</strong>the presence of an impaired myocardium,thyrotoxicosis or calcium channel blockers, andshould be used with caution.2. Chronic AF with a ventricular rate of greater than100/m<strong>in</strong>. Aim to control the ventricular rate to less than100/m<strong>in</strong>ute. This allows time for adequate ventricular fill<strong>in</strong>gand helps ma<strong>in</strong>ta<strong>in</strong> the cardiac output.Digitalisation - if patient not already tak<strong>in</strong>g it.Consider extra digox<strong>in</strong> if not fully loaded - bewaresigns of digox<strong>in</strong> toxicity, nausea, anorexia,headache, visual disturbances etc, and arrhythmiasespecially ventricular ectopics and atrialtachycardia with 2:1 block. Beta blockers or verapamil AmiodaroneWhen AF has been present for more than a few hoursanticoagulation is necessary before DC cardioversion toprevent the risk of embolisation. Usually patients shouldbe warfar<strong>in</strong>ised for 3 weeks prior to elective DCcardioversion, with regular monitor<strong>in</strong>g of their prothromb<strong>in</strong>time. An INR of 2 or more is a satisfactory value at whichto proceed with cardioversion. Warfar<strong>in</strong> should then becont<strong>in</strong>ued for 4 weeks afterwards. Occasionally when apatient develops AF and is compromised by it, DCcardioversion has to be considered even whereanticoagulation is contra<strong>in</strong>dicated (eg recent surgery).ATRIAL ECTOPIC BEATS (figure 13)An abnormal P wave is followed by a normal QRScomplex. The P wave is not always easily visible on theECG trace. The term ‘ectopic’ <strong>in</strong>dicates that depolarisationorig<strong>in</strong>ated <strong>in</strong> an abnormal place, ie not the SA node hencethe abnormal shape of the P wave. If such a focusdepolarises early the beat produced is called anextrasystole or premature contraction and may be followedby a compensatory pause. If the underly<strong>in</strong>g SA node rateis slow, sometimes a focus <strong>in</strong> the atria takes over and therhythm is described as an atrial escape, as it occurs after asmall delay. Extrasystoles and escape beats have the sameQRS appearance on the ECG, but extrasystoles occurearly whereas escape beats occur late.Causes: Often occur <strong>in</strong> normal hearts May occur with any heart disease Ischaemia, hypoxia Light anaesthesia Sepsis Shock Anaesthetic drugs are common causesManagement: Correction of any underly<strong>in</strong>g cause. Specific treatment of atrial ectopic beats isunnecessary unless runs of atrial tachycardia occur- see above.BROAD COMPLEX ARRHYTHMIASVentricular Ectopic Beats (figure 14)Depolarisation spreads from a focus <strong>in</strong> the ventricles byan abnormal, and therefore slow, pathway so the QRSEctopic beatFigure 13: Atrial Ectopic Beats


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 27complex is wide and abnormal. The T wave is alsoabnormal <strong>in</strong> shape.In the absence of structural heart disease these are usuallybenign. They may be related to associated abnormalitiesespecially hypokalaemia. They are common dur<strong>in</strong>g dentalprocedures and anal stretches particularly with halothane,or whenever there is raised CO 2, light anaesthesia or noanalgesia associated with halothane anaesthesia. In fityoung patients under anaesthesia, they are often of littlesignificance and respond readily to manipulation of theanaesthetic as described <strong>in</strong> ‘first l<strong>in</strong>e management’. Smalldoses of <strong>in</strong>travenous beta blockers are very commonlyeffective <strong>in</strong> this situation.However they may herald the onset of runs of ventriculartachycardia, and should be taken more seriously where:There is a bigem<strong>in</strong>al rhythm ( one ectopic beatwith every normal beat ). If they occur <strong>in</strong> runs of 2 or more, or where thereare more than 5/m<strong>in</strong>ute. Where they are multifocal (aris<strong>in</strong>g from differentfoci with<strong>in</strong> the ventricles and hence hav<strong>in</strong>g differentshapes). Those where the R wave is superimposed on theT wave (‘R on T ‘phenomenon).The value of prophylactic treatment has been questionedas it is not known whether this <strong>in</strong>fluences the f<strong>in</strong>al outcome.However most would recommend treatment <strong>in</strong> the abovefour situations or where ventricular tachycardia has alreadyoccurred.Management: Correction of any contribut<strong>in</strong>g causes identifiedwith the anaesthetic ensur<strong>in</strong>g adequate oxygenation,normocarbia and analgesia. A small dose of betablocker is worth try<strong>in</strong>g as mentioned above. If the underly<strong>in</strong>g s<strong>in</strong>us rhythm is slow


28<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Figure 15: Ventricual TachycardiaManagement:Synchronised direct current cardioversion is thefirst l<strong>in</strong>e treatment if the patient ishaemodynamically unstable. This is safe andeffective and will restore s<strong>in</strong>us rhythm <strong>in</strong> virtually100% of cases. If the VT is pulseless or veryrapid, synchronisation is unnecessary. Butotherwise synchronisation is used to avoid a ‘shockon T ‘ phenomenon which may <strong>in</strong>itiate VF. If thepatient lapses back <strong>in</strong>to VT, drugs such aslignoca<strong>in</strong>e or amiodarone may be given to susta<strong>in</strong>s<strong>in</strong>us rhythm. Lignoca<strong>in</strong>e given as a 100mg bolus restores s<strong>in</strong>usrhythm <strong>in</strong> up to 60% and may be followed by ama<strong>in</strong>tenance <strong>in</strong>fusion as above. Verapamil is <strong>in</strong>effective <strong>in</strong> ventricular tachycardiaand may worsen hypotension and precipitatecardiac failure .Other drugs which may be used if lignoca<strong>in</strong>e fails: Amiodarone 300mg iv - via a central venouscatheter over 1 hour followed by <strong>in</strong>fusion of 900mgover 23 hours.Proca<strong>in</strong>amide 100mg iv over 5 m<strong>in</strong>utes followedby one or two further boluses before commenc<strong>in</strong>g<strong>in</strong>fusion at 3mg/m<strong>in</strong>.Mexilet<strong>in</strong>e 100 - 250mg iv at 25mg/m<strong>in</strong> followedby <strong>in</strong>fusion 250mg over 1 hour, 125mg/hour for2 hours, then 500mcg/m<strong>in</strong>. Bretylium tosylate 400 - 500 mg diluted <strong>in</strong> 5%dextrose over 10 m<strong>in</strong>utesPropranolol 0.5 - 1.0mg iv and repeated ifnecessary particularly if the underly<strong>in</strong>g pathologyis myocardial ischaemia or <strong>in</strong>farction.Sotalol 100mg iv over 5 m<strong>in</strong>utes. This wasshown to be better than lignoca<strong>in</strong>e for acuteterm<strong>in</strong>ation of ventricular tachycardia. Overdrive pac<strong>in</strong>g can be used to suppress VTby <strong>in</strong>creas<strong>in</strong>g the heart rate.Supraventricular tachycardia with aberrantconductionWhen there is abnormal conduction from the atria to theventricles, a supraventricular tachycardia (SVT) may bebroad complex as discussed above. This may occur forexample if there is a bundle branch block. Sometimes thebundle branch block may be due to ischaemia and mayonly appear at high heart rates. SVTs may be due to anabnormal or accessory pathway (as <strong>in</strong> the Wolf Park<strong>in</strong>sonWhite syndrome), but dur<strong>in</strong>g the tachycardia the complexis of normal width as conduction <strong>in</strong> the accessory pathwayis retrograde, ie; it is the normal pathway that <strong>in</strong>itiates theQRS complex. Adenos<strong>in</strong>e may be used diagnostically toslow AV conduction and will often reveal the underly<strong>in</strong>grhythm if it arises from above the ventricles. In the case ofSVT it may also result <strong>in</strong> conversion to s<strong>in</strong>us rhythm. Inpractice however the differentiation of the two is notimportant, and all such tachycardias should be treated asventricular tachycardia if there is any doubt.Ventricular Fibrillation (figure 16)This results <strong>in</strong> cardiac arrest. There is chaotic anddisorganised contraction of ventricular muscle and no QRScomplexes can be identified on the ECG.ManagementImmediate direct current cardioversion as per establishedresuscitation protocol. (See <strong>Update</strong> 10).


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 29Figure 16: Ventricular FibrillationDISTURBANCES OF CONDUCTIONThe wave of cardiac excitation which spreads from thes<strong>in</strong>oatrial node to the ventricles via the conductionpathways may be delayed or blocked at any po<strong>in</strong>t.First Degree Block (figure 17)There is a delay <strong>in</strong> the conduction from the s<strong>in</strong>oatrial nodeto the ventricles, and this appears as a prolongation of thePR <strong>in</strong>terval ie greater than 0.2 seconds. It is normallybenign but may progress to second degree block - usuallyof the Mobitz type I. First degree heart block is not usuallya problem dur<strong>in</strong>g anaesthesia.Second Degree Block - Mobitz Type I (Wenkebach)(figure 18)There is progressive lengthen<strong>in</strong>g of the PR <strong>in</strong>terval andthen failure of conduction of an atrial beat. This is followedby a conducted beat with a short PR <strong>in</strong>terval and then thecycle repeats itself. This occurs commonly after an <strong>in</strong>feriormyocardial <strong>in</strong>farction, and tends to be self limit<strong>in</strong>g. It doesnot normally require treatment although a 2:1 type blockmay develop with haemodynamic <strong>in</strong>stability.Second Degree Block - Mobitz Type II (figure 19)If excitation <strong>in</strong>termittently fails to pass through the AVnode or the bundle of HIS, this is the Mobitz type IIphenomenon. Most beats are conducted normally butoccasionally there is an atrial contraction without asubsequent ventricular contraction. This often progressesto complete heart block and if recognised preoperativelywill need expert assessment..Second Degree Block - 2:1 TypeThere may be alternate conducted and non-conductedFigure 17: 1st degree heart blockFigure 18: 2nd Degree Block - The Wenkebach phenomenon


30<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Failure of conductionto ventriclesFigure 19: Second degree blockbeats, result<strong>in</strong>g <strong>in</strong> 2 P waves for every QRS complex -this is 2:1 block. A 3:1 block may also occur, with oneconducted beat and two non-conducted beats. This mayalso herald complete heart block, and <strong>in</strong> some situationsthe plac<strong>in</strong>g of a temporary transvenous pac<strong>in</strong>g wire preoperativelywould be recommended.Complete Heart Block (figure 20)There is complete failure of conduction between the atriaand the ventricles. The ventricles are therefore excited bya slow escape mechanism from a focus with<strong>in</strong> the ventricles.There is no relationship between the P waves and the QRScomplexes, and the QRS complexes are abnormallyshaped. This may occur occasionally as a transientphenomenon <strong>in</strong> theatre as a result of vagal stimulation, <strong>in</strong>which case it often responds to stopp<strong>in</strong>g surgery and<strong>in</strong>travenous atrop<strong>in</strong>e. When it occurs <strong>in</strong> association withacute <strong>in</strong>ferior myocardial <strong>in</strong>farction, it is due to AV nodalischaemia and is often transient. Very rarely it may becongenital! However if it occurs with anterior myocardial<strong>in</strong>farction it <strong>in</strong>dicates more extensive damage <strong>in</strong>clud<strong>in</strong>g tothe HIS - Purk<strong>in</strong>je system. It may also occur as a chronicstate usually due to fibrosis around the bundle of HIS.Management Isoprenal<strong>in</strong>e given by <strong>in</strong>travenous <strong>in</strong>fusion can beused to <strong>in</strong>crease the ventricular rate In the acute situation a temporary transvenouspac<strong>in</strong>g wire may be required. A permanentpacemaker will be required <strong>in</strong> the longer term ifthe block is chronic and before contemplat<strong>in</strong>gelective surgery.Bundle Branch Block (figure 21)If the electrical impulse from the SA and AV nodes reachesthe <strong>in</strong>terventricular septum normally the PR <strong>in</strong>terval willbe normal. However if there is a subsequent delay <strong>in</strong>depolarisation of the right or left bundle branches, therewill be a delay <strong>in</strong> depolarisation of part of the ventricularmuscle and the QRS complex will be wide and abnormal.A wide complex rhythm which is present at the start ofsurgery on <strong>in</strong>itial attachment of the ECG monitor is usuallydue to bundle branch block (BBB), and is not an <strong>in</strong>dicationfor cancell<strong>in</strong>g the operation. However this does <strong>in</strong>dicatethe importance of attach<strong>in</strong>g the ECG monitor before<strong>in</strong>duction of anaesthesia, particularly where a preoperativeECG is not available. Any changes on the ECGdur<strong>in</strong>g anaesthesia and surgery can then easily be comparedto the patients ‘ normal’ ie pre-anaesthetic ECG trac<strong>in</strong>g.The def<strong>in</strong>ition of which bundle is blocked can only beachieved by analys<strong>in</strong>g a full 12 lead ECG. Two types ofBBB are recognised.Figure 20: Complete heart block


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 31AV nodeRight Bundle Branch(ii)HIS bundle(iii)Left Bundle BranchAnterior fascicle(i)Figure 21: The Conduct<strong>in</strong>g SystemPosterior FascicleRight Bundle Branch Block (i). This may <strong>in</strong>dicateproblems with the right side of the heart, but aright bundle branch block type pattern with anormal axis and QRS duration is not uncommon<strong>in</strong> normal <strong>in</strong>dividuals. Left Bundle Branch Block (ii). This often<strong>in</strong>dicates heart disease and makes further<strong>in</strong>terpretation of the ECG other than rate andrhythm impossible.Other forms of BBBBi-Fascicular Block (i and iii). This is a diagnosis whichcan only be made on a formal 12 lead ECG, and is <strong>in</strong>cludedfor completeness. It is the comb<strong>in</strong>ation of right bundlebranch block and block of the left anterior or posteriorfascicle and appears on the ECG as a RBBB pattern withaxis deviation. This progresses to complete heart block <strong>in</strong>a few patients.Tri-Fascicular Block This is the term sometimes usedto <strong>in</strong>dicate the presence of a prolonged PR <strong>in</strong>tervaltogether with a bi-fascicular block.PRE - OPERATIVE PROPHYLACTICPACEMAKER INSERTIONWhere facilities allow, pacemakers are sometimes <strong>in</strong>sertedprior to surgery <strong>in</strong> patients who are at risk of develop<strong>in</strong>gcomplete heart block perioperatively. Those at risk ofthis complication have recently been described by theAmerican college of cardiology and the American heartassociation. A pacemaker should be considered for:3rd degree AV block which is symptomatic orhas a ventricular escape rate of less than 40 beatsper m<strong>in</strong>ute. Where the rate is greater than 40, thereis conflict<strong>in</strong>g evidence of benefit but the weight ofop<strong>in</strong>ion is <strong>in</strong> favour of pac<strong>in</strong>g.2nd degree AV block of any type if there issymptomatic bradycardia.Asymptomatic 2nd degree heart block or firstdegree block with symptoms suggestive of sicks<strong>in</strong>us syndrome (<strong>in</strong>termittent tachycardia andbradycardia) plus documented relief of symptomswith a temporary pac<strong>in</strong>g wire. In both of thesecases the weight of current op<strong>in</strong>ion favours pac<strong>in</strong>g.Any type of bundle branch block with <strong>in</strong>termittentsecond or third degree block, or syncope shouldbe paced. Bifascicular block is relatively common <strong>in</strong> theelderly and does not require pac<strong>in</strong>g.DETECTION OF MYOCARDIAL ISCHAEMIA(figure 22).Cardiac events are the ma<strong>in</strong> cause of death follow<strong>in</strong>ganaesthesia and surgery. Perioperative myocardialischaemia is predictive of <strong>in</strong>tra and post operativemyocardial <strong>in</strong>farction. The likelihood of detection ofischaemia <strong>in</strong>traoperatively on the ECG is <strong>in</strong>creased by theuse of the CM5 lead as discussed above. This lead hasthe highest probability of detect<strong>in</strong>g ischaemia, particularly<strong>in</strong> the lateral wall of the left ventricle which is the zone atgreatest risk. Lead II is more likely to detect <strong>in</strong>feroposteriorischaemia and is therefore useful <strong>in</strong> those patientswhose pre-operative ECG shows evidence of <strong>in</strong>ferior orposterior ischaemia or <strong>in</strong>farction.The ECG should always be recorded from before the startof the anaesthetic so that any subsequent changes can beobserved. ST segment depression of 1mm or more belowthe isoelectric l<strong>in</strong>e with or without T wave changes <strong>in</strong>dicatesmyocardial ischaemia. The magnitude of ST depressioncorrelates with the severity but not the extent of the


32<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Figure 22: Myocardial ischaemiaischaemia. The ST segment depression movesprogressively from up-slop<strong>in</strong>g to horizontal to down-slop<strong>in</strong>gas ischaemia worsens. Down-slop<strong>in</strong>g ST segmentdepression may <strong>in</strong>dicate transmural ischaemia (through thefull wall thickness).On a 12 lead ECG full thickness myocardial <strong>in</strong>farctionresults <strong>in</strong> ST segment elevation often with the subsequentdevelopment of pathological Q waves (greater than 1 mmthick and 2mm deep). In subendocardial <strong>in</strong>farction -typically there is deep symmetrical T wave <strong>in</strong>version. Insubepicardial <strong>in</strong>farction - there is loss of R wave amplitudewithout development of Q waves.Management If ST segment depression develops dur<strong>in</strong>ganaesthesia, 100% oxygen should be given, thevolatile agent decreased and the blood pressureand heart rate normalised as far as possible. It isimportant to ma<strong>in</strong>ta<strong>in</strong> diastolic blood pressure andsystemic vascular resistance, <strong>in</strong> order to ma<strong>in</strong>ta<strong>in</strong>coronary atery perfusion. In this situationmethoxam<strong>in</strong>e (if available) <strong>in</strong> 2mg iv <strong>in</strong>crementstitrated to effect may be useful.Postoperative management <strong>in</strong> a high careenvironment should be considered where possible,with oxygen therapy, adequate analgesia andcorrection of fluid and electrolyte balance be<strong>in</strong>gof great importance. Monitor<strong>in</strong>g should becont<strong>in</strong>ued <strong>in</strong>to the postoperative period as this isthe time when further (often silent ) ischaemia and<strong>in</strong>farction may occur. Oxygen should be given toall high risk patients post operatively, ideally for atleast 48 hours.OTHER ECG CHANGES SEEN IN THEATREOccasionally the ECG changes shape slightly with a change<strong>in</strong> position of the patient or dur<strong>in</strong>g different phases ofmechanical ventilation. This usually causes a slight change<strong>in</strong> the position of the heart and results <strong>in</strong> the ECG be<strong>in</strong>grecorded from a different angle. It is not usually ofimportance.ECG APPEARANCE OF ABNORMALPOTASSIUM CONCENTRATIONS.The ECG trace may develop characteristic changes withalterations <strong>in</strong> the concentration of various electrolytes. Itis rarely possible to diagnose these from the ECG alonebut the read<strong>in</strong>g may give arise to a suspicion which shouldbe confirmed by the laboratory.Hyperkalaemia Tall peaked T waves Reduced P waves with widened QRS complexes Ultimately a s<strong>in</strong>e wave pattern - pre-cardiac arrest Cardiac arrest <strong>in</strong> diastoleHypokalaemia Increased myocardial excitability - any arrhythmiamay occurProlonged PR <strong>in</strong>tervalProm<strong>in</strong>ent U wavesEnhancement of digitalis toxicityFURTHER READING AND REFERENCES1. Ganong WF. A Review of Medical Physiology. Stamford:Appleton and Lange,1997.2. Hutton P, Prys-Roberts C. Monitor<strong>in</strong>g <strong>in</strong> <strong>Anaesthesia</strong> andIntensive Care. London: WB Saunders Company Ltd,1994.3. H<strong>in</strong>ds CJ, Watson D. Intensive Care - A ConciseTextbook.London: W.B Saunders Company Ltd,1996.4. The 1998 ERC Guidel<strong>in</strong>es for Adult Advanced Life Support.Resuscitation 1998;37:81-905. Hampton J. The ECG made easy. London: ChurchillLiv<strong>in</strong>gstone, 1986.6. Mangano DT. Perioperative Cardiac Morbidity.Anaesthesiology 1990; 72:153-84.7. Nathanson MH, Gajraj NM. The PerioperativeManagement of Atrial Fibrillation. <strong>Anaesthesia</strong> 1998; 53:665-76.8. Gregoratos G et al. ACC/AHA guidel<strong>in</strong>es for implantationof cardiac pacemakers and antiarrhythmia devices. Executivesummary. Circulation 1998; 97: 1325-35.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 33MEASURING THE BLOOD PRESSUREDr Peter Hambly, Consultant Anaesthetist, Oxford, UKAdequate blood pressure is essential to ma<strong>in</strong>ta<strong>in</strong> the bloodsupply and function of vital organs. Measurement of bloodpressure is therefore a key part of the monitor<strong>in</strong>g of patientsdur<strong>in</strong>g anaesthesia and critical care.What is normal blood pressure?‘Normal’ or ‘acceptable’ blood pressure varies with age,state of health and cl<strong>in</strong>ical situation. At birth, a typical bloodpressure is 80/50 mmHg. It rises steadily throughoutchildhood, so that <strong>in</strong> a young adult it might be 120/80mmHg. As we get older, blood pressure cont<strong>in</strong>ues to riseand a rule of thumb is that normal systolic pressure is age<strong>in</strong> years + 100. Blood pressure is lower <strong>in</strong> late pregnancyand dur<strong>in</strong>g sleep.From this, you can see that a systolic pressure of160mmHg for an elderly man or 90 mmHg for a pregnantwoman may be quite normal. To judge whether anyparticular read<strong>in</strong>g is too high or too low, we must comparethe read<strong>in</strong>g with the ‘normal’ for that patient.Techniques of measurementRough estimates without us<strong>in</strong>g any equipment at allIt is not possible to derive a numerical value for bloodpressure without some equipment, but a crude assessmentof the circulation can still be obta<strong>in</strong>ed. If you can feel aradial pulse the systolic blood pressure is usually at least80 mmHg. The character of the pulse, i.e. bound<strong>in</strong>g orthready, gives a further clue. In most cases, shocked patientshave cold hands and feet. (The most important exceptionto this is a patient who is shocked because of severesepsis). Capillary refill time is another simple test ofcirculatory adequacy: press firmly on the patient’s nail bedwith your thumb; release your thumb and see how long ittakes for blood to return. A refill time of greater than 2seconds suggests an <strong>in</strong>adequate circulation.Manual non-<strong>in</strong>vasive blood pressure measurementThis requires, at the very least, an <strong>in</strong>flatable cuff with apressure gauge (sphygmomanometer). W<strong>in</strong>d the cuff roundthe arm (which should be at about heart level) and <strong>in</strong>flateit to a pressure higher than the expected blood pressure.Then deflate the cuff slowly. With a stethoscope, listenover the brachial artery. When the cuff reaches systolicpressure, a clear tapp<strong>in</strong>g sound is heard <strong>in</strong> time with theheart beat. As the cuff deflates further, the sounds becomequieter, but become louder aga<strong>in</strong> before disappear<strong>in</strong>galtogether. The po<strong>in</strong>t at which the sounds disappear is thediastolic pressure. If you have no stethoscope, the systolicblood pressure can be found by palpat<strong>in</strong>g the brachialartery and not<strong>in</strong>g the pressure <strong>in</strong> the cuff at which it returns.The sounds heard while measur<strong>in</strong>g blood pressure <strong>in</strong> thisway are called the Korotkoff sounds, and undergo 5phases:.I <strong>in</strong>itial ‘tapp<strong>in</strong>g’ sound (cuff pressure = systolicpressure)II sounds <strong>in</strong>crease <strong>in</strong> <strong>in</strong>tensityIII sounds at maximum <strong>in</strong>tensityIV sounds become muffledV sounds disappearMost <strong>in</strong>accuracies result from the use of the wrong size ofcuff. A narrow cuff wrapped round a fat arm will give anabnormally high read<strong>in</strong>g, and vice versa. The World HealthOrganisation recommends a 14cm cuff for use <strong>in</strong> adults.Smaller cuffs for <strong>in</strong>fants and children are available. Inoccasional patients, the read<strong>in</strong>g obta<strong>in</strong>ed from one armcan be different from that obta<strong>in</strong>ed from the other arm.An appropriate size of cuff can be applied to the calf, andpressure estimated by palpation of the posterior tibial pulse.OscillotonometryThe Von Reckl<strong>in</strong>ghausen Oscillotonometer is a devicewhich allows both systolic and diastolic blood pressure tobe read without a stethoscope. It consists of twooverlapp<strong>in</strong>g cuffs (one large, one small) a large dial forread<strong>in</strong>g pressure, a bleed valve and a control lever. Thelarge cuff performs the usual function of thesphygmomanometer cuff. The job of the smaller cuff isbasically to amplify the pulsations which occur as the largercuff is deflated, so that <strong>in</strong>stead of listen<strong>in</strong>g for the Korotkoffsounds, they are seen as oscillations of the needle on thepressure gauge. The lever simply switches the dial betweenthe two cuffs.Wrap the cuff round the arm <strong>in</strong> the usual way, and <strong>in</strong>flateit. Adjust the bleed valve so that the pressure falls slowly.Pull the control lever towards you. The needle will jumpslightly <strong>in</strong> time with the pulse. As the cuff pressureapproaches systolic, the needle suddenly starts to jump


34<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>more vigorously. At this po<strong>in</strong>t, let go of the lever, and theneedle will display systolic pressure. Pull the lever forwardaga<strong>in</strong>. As the pressure is reduced, the needle jumps morevigorously. If the lever is released at the po<strong>in</strong>t of maximumneedle oscillations, the dial will read the mean arterialpressure. If it is released at the po<strong>in</strong>t when the needlejumps get suddenly smaller, the dial reads diastolicpressure.Automatic non-<strong>in</strong>vasive blood pressure measurementAutomatic devices which essentially apply the samepr<strong>in</strong>ciple as the oscillotonometer have been produced (e.g.the ‘D<strong>in</strong>amap’ made by Critikon). They require a supplyof electricity. A s<strong>in</strong>gle cuff is applied to the patients arm,and the mach<strong>in</strong>e <strong>in</strong>flates it to a level assumed to be greaterthan systolic pressure. The cuff is deflated gradually. Asensor then measures the t<strong>in</strong>y oscillations <strong>in</strong> the pressureof the cuff caused by the pulse. Systolic is taken to bewhen the pulsations start, mean pressure is when they aremaximal, and diastolic is when they disappear. They canproduce fairly accurate read<strong>in</strong>gs and free the hands of theanaesthetist for other tasks. There are important sourcesof <strong>in</strong>accuracy, however. Such devices tend to over-readat low blood pressure, and under-read very high bloodpressure. The cuff should be an appropriate size. The patientshould be still dur<strong>in</strong>g measurement. The technique reliesheavily on a constant pulse volume, so <strong>in</strong> a patient with anirregular heart beat (especially atrial fibrillation) read<strong>in</strong>gscan be <strong>in</strong>accurate. Sometimes an automatic blood pressuremeasur<strong>in</strong>g device <strong>in</strong>flates and deflates repeatedly “hunt<strong>in</strong>g”without display<strong>in</strong>g the blood pressure successfully. If thepulse is palpated as the cuff is be<strong>in</strong>g <strong>in</strong>flated and deflatedthe blood pressure may be estimated by palpation andread<strong>in</strong>g the cuff pressure on the display.Invasive arterial pressure measurementThis technique <strong>in</strong>volves direct measurement of arterialpressure by plac<strong>in</strong>g a cannula <strong>in</strong> an artery (usually radial,femoral, dorsalis pedis or brachial). The cannula must beconnected to a sterile, fluid-filled system, which isconnected to an electronic monitor. The advantage of thissystem is that pressure is constantly monitored beat-bybeat,and a waveform (a graph of pressure aga<strong>in</strong>st time)can be displayed. Patients with <strong>in</strong>vasive arterial monitor<strong>in</strong>grequire very close supervision, as there is a danger ofsevere bleed<strong>in</strong>g if the l<strong>in</strong>e becomes disconnected. It isgenerally reserved for critically ill patients where rapidvariations <strong>in</strong> blood pressure are anticipated.RESPIRATORY GAS ANALYSIS IN THEATREDr J.G.McFadyen, Royal Devon and Exeter Hospital , Exeter, UK. Previously: Edendale Hospital,Kwazulu-Natal, South Africa.CAPNOGRAPHYCapnography is the measurement of carbon dioxide (CO 2 )<strong>in</strong> each breath of the respiratory cycle. The capnographdisplays a waveform of CO 2 (measured <strong>in</strong> kiloPascals ormillimetres of mercury) and it displays the value of theCO 2 at the end of exhalation, which is known as the endtidalCO 2 .It is useful to measure CO 2 to assess the adequacy ofventilation, to detect oesophageal <strong>in</strong>tubation, to <strong>in</strong>dicatedisconnection of the breath<strong>in</strong>g system or ventilator, and todiagnose circulatory problems and malignant hyperthermia.Applications of CapnographyProvided the patient has a stable cardiac status, stablebody temperature, absence of lung disease and a normalcapnograph trace, end-tidal carbon dioxide (ETCO 2 )approximates to the partial pressure of CO 2 <strong>in</strong> arterialblood (PaCO 2 .) Normal PaCO 2 is 5.3kPa (40mmHg).In these patients, ETCO 2 can be used to assess adequacyof ventilation i.e. hypo-, normo-, or hyperventilation.ETCO 2 is not as reliable <strong>in</strong> patients who have respiratoryfailure. The <strong>in</strong>creased V/Q mismatch is associated with awidened P(a-ET) gradient, and can lead to erroneousETCO 2 values.The capnograph is the gold standard for detect<strong>in</strong>goesophageal <strong>in</strong>tubation. No or very little CO 2 is detectedif the oesophagus has been <strong>in</strong>tubated.The capnograph is also useful <strong>in</strong> the follow<strong>in</strong>gcircumstances: As a disconnection alarm for a ventilator or abreath<strong>in</strong>g system. There is sudden absence of thecapnograph trace.May detect air embolism as a suddendecrease <strong>in</strong> ETCO 2 , assum<strong>in</strong>g that the arterial bloodpressure rema<strong>in</strong>s stable.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 35To recognise sudden circulatory collapse as asudden decrease <strong>in</strong> ETCO 2. To diagnose malignant hyperthermia as a gradual<strong>in</strong>crease <strong>in</strong> ETCO 2.Techniques of MeasurementMost analysers <strong>in</strong> theatre work us<strong>in</strong>g 2 pr<strong>in</strong>ciples:Infrared absorption spectroscopy is the most commonlyused technique <strong>in</strong> anaesthesia. Gases of molecules thatconta<strong>in</strong> at least two dissimilar atoms absorb <strong>in</strong>fraredradiation. Us<strong>in</strong>g this property, carbon dioxide concentrationcan be measured cont<strong>in</strong>uously throughout the respiratorycycle to give a capnograph trace.CO 2 absorbs <strong>in</strong>frared radiation particularly at a wavelengthof 4.3 µm. A photodetector measures radiation reach<strong>in</strong>git from a light source at this wavelength. The amount of<strong>in</strong>frared radiation absorbed is proportional to the numberof CO 2 molecules (partial pressure of CO 2 ) present <strong>in</strong> thechamber, accord<strong>in</strong>g to the Beer-Lambert Law. This allowsthe calculation of CO 2 values.Photo-acoustic spectroscopy The sample gas isirradiated with pulsatile <strong>in</strong>frared radiation, of a suitablewavelength. The periodic expansion and contractionproduces a pressure fluctuation of audible frequency thatcan be detected by a microphone. The advantages ofphoto-acoustic spectrometry over conventional <strong>in</strong>fraredabsorption spectrometry are: The photo-acoustic technique is extremely stableand its calibration rema<strong>in</strong>s constant over much longerperiods of time. The very fast rise and fall times give a much truerrepresentation of any change <strong>in</strong> CO 2 concentration.Other techniques for measur<strong>in</strong>g CO 2 <strong>in</strong>clude Ramanscatter<strong>in</strong>g and mass spectrometry.Position of Sampl<strong>in</strong>gGas from the breath<strong>in</strong>g system can be sampled either by asidestream or a ma<strong>in</strong>stream analyser.Sidestream: Gas is drawn from the breath<strong>in</strong>g system bya 1.2mm <strong>in</strong>ternal diameter tube. The tube is connected toa lightweight adapter near the patient’s end of the breath<strong>in</strong>gsystem. It delivers the gas to the sample chamber. It ismade of Teflon so it is impermeable to CO 2 and does notreact with anaesthetic agents. Only the precise tub<strong>in</strong>grecommended by the manufacturer should be used, andonly of the recommended length. Typical <strong>in</strong>frared<strong>in</strong>struments sample at a flow rate between 50 and 150 ml/m<strong>in</strong>ute. When low fresh gas flows are used the sampledgas may be returned to the breath<strong>in</strong>g circuit. It is importantthat the tip of the sampl<strong>in</strong>g tube should always be as nearas possible to the patient’s trachea, but the sampled gasmixture must not be contam<strong>in</strong>ated by <strong>in</strong>spired gas dur<strong>in</strong>gthe expiratory phase.Ma<strong>in</strong>stream: The sample chamber is positioned with<strong>in</strong>the patient’s gas stream near the patient’s end of thebreath<strong>in</strong>g system. Although heavier and more cumbersome,it does have advantages over sidestream sampl<strong>in</strong>g: thereis no delay <strong>in</strong> the rise and fall times of gas compositionchanges, no gas is lost from the attachment, no mix<strong>in</strong>goccurs along the capillary tube before analysis, and thereare fewer problems with water vapour condensation.The capnograph trace1: Inspiratory basel<strong>in</strong>e2: Expiratory upstroke3: Expiratory plateau4: Inspiratory downstrokeEnd-tidal CO 2 (ETCO 2 )The first phase occurs dur<strong>in</strong>g <strong>in</strong>spiration. The second phaseis the onset of expiration, which results <strong>in</strong> a rapid <strong>in</strong>crease<strong>in</strong> CO 2 . The third phase, the expiratory plateau, occurs asthe CO 2 is exhaled from all the alveoli. The highest po<strong>in</strong>tof the plateau is known as the end-tidal CO 2 (ETCO 2 ).This marks the end of expiration. Phase four is the onsetof <strong>in</strong>spiration.


36<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Abnormal Traces1. Rebreath<strong>in</strong>g3. Cardiac oscillationsA waveform that does not return to the basel<strong>in</strong>e dur<strong>in</strong>g<strong>in</strong>spiration <strong>in</strong>dicates that rebreath<strong>in</strong>g of exhaled gas isoccurr<strong>in</strong>g.Causes: Fresh gas flow too low <strong>in</strong> non-rebreath<strong>in</strong>gsystem. Soda lime depleted <strong>in</strong> circle system.Cause: Cardiac impulses transmitted to capnograph.Explanation The oscillations reflected on the capnographtrace result from transmission of cardiac impulses to theairways.4. “Curare cleft”2. Slop<strong>in</strong>g PlateauCause: Obstructive airways disease, because of impairmentof V/Q ratio.Explanation In patients with obstructive airways disease,the lungs are perfused with blood as normal, but the alveoliare unevenly ventilated. CO 2 that is transferred to thealveoli from the bloodstream may take longer to exhalebecause of the narrowed bronchi. This delayed empty<strong>in</strong>gof the alveoli varies <strong>in</strong> different parts of the lungs. Thisresults <strong>in</strong> the slop<strong>in</strong>g plateau on the capnograph trace, asthe CO 2 from those parts of the lungs with more severebronchial narrow<strong>in</strong>g is exhaled later than those parts withless severe narrow<strong>in</strong>g.Cause: Reversal of neuromuscular blockade <strong>in</strong> a ventilatedpatient.Explanation When a paralysed patient starts tak<strong>in</strong>g smallbreaths as the neuromuscular block<strong>in</strong>g agent reverses, deep“clefts” are seen on the capnograph trace.OXYGEN CONCENTRATION ANALYSERSIt is important to measure the oxygen concentration <strong>in</strong> thegas mixture delivered to the patient dur<strong>in</strong>g anaesthesia.There are three techniques of measur<strong>in</strong>g the <strong>in</strong>spiredoxygen concentration (FiO 2 ): galvanic, polarographic, andparamagnetic techniques. The paramagnetic method ismost widely used <strong>in</strong> anaesthesia. These analysers measurethe oxygen partial pressure <strong>in</strong> a gas sample but they display


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 37a percentage. Regular calibration of oxygen analysersis vital.Paramagnetic oxygen analysers Oxygen possesses theproperty of paramagnetism, which means that it is attractedto a magnetic field. This is because it has two electrons <strong>in</strong>unpaired orbits. Most of the gases used <strong>in</strong> anaesthesia arerepelled by a magnetic field (diamagnetism).The sample gas is delivered to the analyser via a sampl<strong>in</strong>gtube, which should be placed as close as possible to thepatient’s trachea. The analyser has two chambers separatedby a sensitive pressure transducer. The sample gas isdelivered to one chamber. Room air is delivered to thereference chamber. An electromagnet is rapidly switchedon and off creat<strong>in</strong>g a chang<strong>in</strong>g magnetic field to which thesample gas is subjected. The magnetic field causes theoxygen molecules to be attracted and agitated. This results<strong>in</strong> changes <strong>in</strong> pressure on either side of the pressuretransducer. The pressure difference across the transduceris proportional to the oxygen partial pressure differencebetween the sample gas and the reference gas (room air).Paramagnetic oxygen analysers are very accurate andhighly sensitive. The analysers should function cont<strong>in</strong>uouslywithout any service breaks. They have a rapid responseallow<strong>in</strong>g measurement of <strong>in</strong>spiratory and expiratory oxygenon a breath-to-breath basis. They are affected by watervapour and have a water trap <strong>in</strong>corporated <strong>in</strong>to theirdesign.The Galvanic Oxygen Analyser (Fuel Cell) Thegalvanic analyser is placed on the <strong>in</strong>spiratory limb of thebreath<strong>in</strong>g system. Oxygen molecules diffuse across amembrane and an electrolyte solution to a silvercathode, which is connected through an electrolytesolution to a lead anode. An electrical current isgenerated which is proportional to the partial pressureof oxygen <strong>in</strong> the <strong>in</strong>spired gas.The galvanic analyser has a response time of approximately20 seconds. It is accurate to with<strong>in</strong> 3%. Calibration isachieved us<strong>in</strong>g 100% oxygen and room air (21% O 2).Water vapour does not affect its performance. It isdepleted by cont<strong>in</strong>uous exposure to oxygen due toexhaustion of the cell, so limit<strong>in</strong>g its life span to about oneyear.The Polarographic Oxygen Analyser (ClarkElectrode) The polarographic analyser has similarpr<strong>in</strong>ciples to the galvanic analyser. Oxygen moleculesdiffuse across a Teflon membrane. Current flows betweena silver cathode and a plat<strong>in</strong>um anode, which isproportional to the partial pressure of oxygen <strong>in</strong> the<strong>in</strong>spiratory gas. A battery powers it. Its life expectancy islimited to about three years because of deterioration ofthe Teflon membrane.Further read<strong>in</strong>g1. Williamson JA, Webb RK, Cock<strong>in</strong>gs J, Morgan C. The Australia<strong>in</strong>cident monitor<strong>in</strong>g study. The capnograph: applications andlimitations - an analysis of 2000 <strong>in</strong>cident reports. <strong>Anaesthesia</strong> &Analgesia 1993; 21: 551-72. Schmitz BD, Shapiro BA. Capnography. Respiratory Care Cl<strong>in</strong>icsof North America. 1995; 1: 107-173. Al-Shaikh B, Essentials of Anaesthetic Equipment. ChurchillLiv<strong>in</strong>gstone 1995.MONITORING DURING CAESAREAN SECTIONDr James Eldridge, Consultant Anaesthetist, Queen Alexandra Hospital, Portsmouth, UKRecommendations for monitor<strong>in</strong>g dur<strong>in</strong>g Caesareansection (CS) have been developed by the American Boardof Anesthesiologists and the Obstetric AnaesthetistsAssociation (OAA) <strong>in</strong> the UK. The OAA’srecommendations are reproduced <strong>in</strong> full <strong>in</strong> Box 1. Not allanaesthetists have access to complex equipment, but everyanaesthetist should be aware of the potential problemsthat may be encountered and make appropriate use of themonitors they do have. The requirements for regional andgeneral anaesthetics are different and so consideredseparately. All obstetric patients undergo<strong>in</strong>g CS shouldbe positioned with left lateral tilt to avoid aorto-cavalcompression. (See <strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 1999).Regional anaesthesiaMost of the monitor<strong>in</strong>g is cl<strong>in</strong>ical s<strong>in</strong>ce awake mothers areexcellent monitors of their own physiology. The anaesthetistshould be cont<strong>in</strong>uously present from the start of anaesthesiato the completion of surgery.Assessment of analgesiaA major cause of maternal compla<strong>in</strong>t is pa<strong>in</strong> dur<strong>in</strong>g CSunder regional anaesthesia. For CS, a block should extendfrom S4 to the upper thoracic dermatomes. One commonreason for <strong>in</strong>adequate pa<strong>in</strong> relief is a failure of the block tospread to the sacral dermatomes. Although this happensmore frequently with epidural than sp<strong>in</strong>al anaesthesia,


38<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>whichever technique is used, always test the back of thelegs (S2 and S3) to confirm that the sacral dermatomesare blocked before surgery starts.How high a regional block must extend <strong>in</strong>to the thoracicdermatomes to achieve <strong>in</strong>traoperative analgesia, rema<strong>in</strong>scontroversial. Recommendations from T10 to T4 havebeen made, although the method of test<strong>in</strong>g the block isoften unspecified and the need for supplemental analgesicsnot mentioned. The three most commonly used methodsof assessment are:loss of temperature sensationloss of p<strong>in</strong>prick sensation loss of light touch sensation.These may differ by as much as 10 dermatomes, withtemperature sensation lost first and light touch sensationlast. Experimental data suggests that <strong>in</strong>traoperativeanalgesia is most reliably predicted by block<strong>in</strong>g light touchsensation (the hub of a needle lightly applied to the sk<strong>in</strong>)to T5 (just beneath the nipples).Haemodynamic consequences of regional anaesthesiaExtensive epidural and sp<strong>in</strong>al blocks cause a temporarysympathectomy which makes the patient susceptible tohypotension. In pregnant women, this is made worse bythe uterus compress<strong>in</strong>g the aorta and <strong>in</strong>ferior vena cava(aorto-caval occlusion). Hypotension may develop rapidly.Therefore, blood pressure should be measured at leastevery two m<strong>in</strong>utes from start<strong>in</strong>g a regional block untilBox 1: Recommendations for monitor<strong>in</strong>g dur<strong>in</strong>gcaesarean sectionFor operative delivery under regional blockCont<strong>in</strong>uous pulse oximetry, non <strong>in</strong>vasive bloodpressure and cont<strong>in</strong>uous ECG dur<strong>in</strong>g <strong>in</strong>duction,ma<strong>in</strong>tenance and recovery.The fetal heart rate should be recorded dur<strong>in</strong>g <strong>in</strong>itiationof regional block and until abdom<strong>in</strong>al sk<strong>in</strong> preparation<strong>in</strong> emergency caesarean section.Dur<strong>in</strong>g general anaesthesiaCont<strong>in</strong>uous <strong>in</strong>spired oxygen and end-tidal carbondioxide concentration should be monitored, as wellas pulse oximetry, non-<strong>in</strong>vasive blood pressure andECG.delivery. Nausea dur<strong>in</strong>g onset of a regional block is usuallyan <strong>in</strong>dication of hypotension.Blocks above T4 cause a loss of sympathetic <strong>in</strong>nervationto the heart which may be associated with bradycardiaparticularly if aorto-caval occlusion is present. Becauseof this cont<strong>in</strong>uous monitor<strong>in</strong>g of the pulse is essential.Respiratory consequences of regional anaesthesiaPregnant women are prone to hypoxia because of areduction <strong>in</strong> functional residual capacity (FRC) of the lungsand an <strong>in</strong>creased oxygen consumption. This is compoundeddur<strong>in</strong>g regional blocks by abdom<strong>in</strong>al and <strong>in</strong>tercostal muscleweakness which causes a further reduction <strong>in</strong> FRC. Pulseoximetry not only monitors the pulse but also provides acont<strong>in</strong>uous non-<strong>in</strong>vasive monitor of the saturation of arterialhaemoglob<strong>in</strong>. It is simple and accurate; always use it ifyou can.When the thoracic dermatomes are blocked, patients oftencompla<strong>in</strong> of a strange sensation when breath<strong>in</strong>g, usuallyas they realise that they cannot produce a forceful cough.This is normal and a result of <strong>in</strong>tercostal paralysis and thepatient can be reassured. However difficulty <strong>in</strong> speak<strong>in</strong>grepresents diaphragmatic paralysis develop<strong>in</strong>g and needsvery careful assessment of the level of block. Furtherspread of local anaesthetic must be m<strong>in</strong>imised. Ifhyperbaric local anaesthetic has been used, this can bedone by careful elevation of the head and neck. Howeverbe prepared to <strong>in</strong>tubate and support these patient’sventilation.Unexpected high blocks“Total sp<strong>in</strong>als” or very high blocks may follow excessivespread of a deliberate <strong>in</strong>trathecal <strong>in</strong>jection of localanaesthetic or be caused by an epidural catheter that ismisplaced <strong>in</strong> the subarachnoid space. Misplaced epiduralcatheters can be detected by attempt<strong>in</strong>g to aspirate CSFthrough the catheter and carefully assess<strong>in</strong>g the effectproduced by a test dose. An appropriate test dose willproduce detectable changes <strong>in</strong> sensory and motor functionwith<strong>in</strong> five m<strong>in</strong>utes of <strong>in</strong>jection if the catheter is <strong>in</strong> thesubarachnoid space and no significant effect if the catheteris <strong>in</strong> the epidural space.The spread of deliberate <strong>in</strong>trathecal <strong>in</strong>jections of hyperbaric(heavy) local anaesthetics can be controlled by keep<strong>in</strong>gthe upper thoracic and cervical sp<strong>in</strong>e elevated. As sp<strong>in</strong>alblocks sometimes extend very rapidly, you must checkthe spread of the block with<strong>in</strong> 4 m<strong>in</strong>utes of <strong>in</strong>jection andreposition the patient if necessary.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 39Symptoms of high blocks are predictable. As the blockextends the hands become warm and dry, then loss ofhand and arm movement follows. Loss of abduction ofthe shoulder may be rapidly followed by diaphragmaticparalysis. At the same time sensation is lost over the upperchest, hands, arms, shoulder and neck. If the block extendsfurther, consciousness may be lost and the pupils maybecome fixed and dilated. However all these signs willreverse provided cardiovascular and respiratory supportare provided.Regional blocks may cont<strong>in</strong>ue to extend for at least 30m<strong>in</strong>utes after local anaesthetic has been <strong>in</strong>jected, so theanaesthetist must rema<strong>in</strong> vigilant for symptoms of highblocks even after surgery has started.Monitor<strong>in</strong>g the <strong>in</strong>jection of local anaestheticAccidental <strong>in</strong>travenous <strong>in</strong>jection of local anaesthetics mayoccur with epidural anaesthesia and although deaths arerare, convulsions occur <strong>in</strong> 1 <strong>in</strong> 500 - 9000 patients. Thisrisk can be m<strong>in</strong>imised by carefully aspirat<strong>in</strong>g before each<strong>in</strong>jection, by assess<strong>in</strong>g the effect of a small <strong>in</strong>itial test doseof local anaesthetic and by splitt<strong>in</strong>g all large doses of localanaesthetics <strong>in</strong>to several small portions. Every dose mustbe assessed for symptoms of <strong>in</strong>travenous <strong>in</strong>jection (Table1) even when previous doses have been uncomplicated.Table 1: Symptoms of <strong>in</strong>travenous <strong>in</strong>jection of local anaestheticT<strong>in</strong>gl<strong>in</strong>g around the mouthT<strong>in</strong>nitus (r<strong>in</strong>g<strong>in</strong>g <strong>in</strong> the ears)Visual disturbanceConfusionSlurred speechAltered conscious stateConvulsionsComaCardiovascular collapseCardiac arrhythmiasGeneral anaesthesiaPatients undergo<strong>in</strong>g CS performed under generalanaesthesia should be monitored <strong>in</strong> the same way as withany general anaesthetic. The obstetric anaesthetist shouldbe particularly aware of airway problems and episodes ofhyper- or hypotension.Monitors of <strong>in</strong>tubationFailure of <strong>in</strong>tubation and oxygenation rema<strong>in</strong>s one of thecommonest causes of anaesthetic related maternal deaths.Confirmation of the correct placement of an endotracheal(ET) tube is crucial. Various monitors are available to helpthe anaesthetist, but see<strong>in</strong>g the ET tube pass through theglottis rema<strong>in</strong>s the most valuable. However the presenceof bilateral breath sounds should always be checked and,when possible, the presence of expired CO2 confirmed.Figure 1 shows ten simple cl<strong>in</strong>ical tests of correct placementof a tracheal tube.The oesophageal detection device is a useful additionalmonitor. It is cheap and easily constructed us<strong>in</strong>g a 50 mlsyr<strong>in</strong>ge or a self <strong>in</strong>flat<strong>in</strong>g bulb. If a negative pressure isapplied by the syr<strong>in</strong>ge to a correctly positionedendotracheal (ET) tube, gas can be aspirated because thetrachea is supported by rigid cartilage. However if the ETtube is misplaced <strong>in</strong> the oesophagus and a negativepressure applied, the oesophagus will obstruct the tip ofthe ET tube and gas cannot be aspirated. (see <strong>Update</strong>number 1997;7)Monitors of ventilationAs with regional anaesthesia the pregnant mother isvulnerable to hypoxia; look at the patient’s colour and atmovement of the chest wall. If you are ventilat<strong>in</strong>g by handfeel for any changes <strong>in</strong> resistance to ventilation - if you areus<strong>in</strong>g a lung ventilator look regularly at and make a note ofthe <strong>in</strong>flation pressure. Always use a pulse oximeter if youhave one.Haemodynamic consequences of general anaesthesiaAorto-caval occlusion means that mothers are vulnerableto hypotension, while hypertension may occur withlaryngoscopy and surgical stimulus. Pre-eclamptic mothersare particularly vulnerable to hypertension on laryngoscopy.So, as with regional anaesthesia, blood pressure must bemeasured at least every two m<strong>in</strong>utes until delivery and thepulse cont<strong>in</strong>uously.Monitors for awarenessTo reduce fetal depression and uter<strong>in</strong>e relaxation,anaesthetists have sometimes used low doses of anaestheticagents <strong>in</strong> a paralysed mother dur<strong>in</strong>g CS. This has resulted<strong>in</strong> some mothers be<strong>in</strong>g awake and <strong>in</strong> severe pa<strong>in</strong>. No s<strong>in</strong>glemonitor reliably predicts awareness, although signs ofsympathetic stimulation - sweat<strong>in</strong>g, tachycardia,hypertension and pupillary dilation - should always beregarded with concern.


40<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>The most reliable method of ensur<strong>in</strong>g the mother is asleep,is to give adequate doses of <strong>in</strong>duction agents and an <strong>in</strong>itialoverpressure of <strong>in</strong>halational agents (ie twice MAC for 5m<strong>in</strong>, 1.5 times MAC for the next 5 m<strong>in</strong> and 0.8 timesMAC thereafter).Neuromuscular blockadeWith modern short act<strong>in</strong>g muscle relaxants, reversal ofneuromuscular block at the end of caesarean section israrely a problem. The exception is if the mother has beentreated with magnesium sulphate. Magnesium enhancesthe action of non-depolaris<strong>in</strong>g muscle relaxants. So <strong>in</strong> thesepatients, assess<strong>in</strong>g neuromuscular function is important,ideally with a nerve stimulator but alternatively cl<strong>in</strong>icalmethods may be used, such as assessment of hand grip orhead lift.Fetal monitor<strong>in</strong>gVarious monitors of fetal condition are available. Fetal heartrate (FHR) monitor<strong>in</strong>g is the most common. The FHRmay be recorded <strong>in</strong>termittently with a stethoscope, byabdom<strong>in</strong>al ultrasound, or with a fetal scalp electrode. Anormal FHR has a 95% association with good fetalcondition, and a prolonged and cont<strong>in</strong>u<strong>in</strong>g bradycardia isalmost always associated with severe fetal distress.Dur<strong>in</strong>g CS, the FHR should be monitored from the startof anaesthesia until abdom<strong>in</strong>al sk<strong>in</strong> preparation especiallyif the fetus is already distressed. Know<strong>in</strong>g that the FHR isnot critical, may allow time for a regional technique to beused, when otherwise a general anaesthetic might have tobe performed. Knowledge of the FHR is also useful if afailed <strong>in</strong>tubation occurs dur<strong>in</strong>g general anaesthesia. TheFHR can <strong>in</strong>fluence the decision to either wake the motherFigure 1. 10 Cl<strong>in</strong>ical tests of tracheal <strong>in</strong>tubationTest Result Significance ReliabilityLook with Tube passes between cords Correct tracheal <strong>in</strong>tubation Certa<strong>in</strong>laryngoscopeListen/feel Breath<strong>in</strong>g through tube Correct tracheal <strong>in</strong>tubation ProbableTap sternum Air comes out through Correct tracheal <strong>in</strong>tubation Probabletracheal tubeInflate with SIB* Chest rises & falls Correct tracheal <strong>in</strong>tubation ProbableInflate with SIB* Gurgl<strong>in</strong>g noise Oesophageal <strong>in</strong>tubation Probable(REMOVE TUBE)Pass catheter down Patient coughs (if not Correct tracheal <strong>in</strong>tubation Probable<strong>in</strong>side tubeparalysed)Look Patient rema<strong>in</strong>s p<strong>in</strong>k Correct tracheal <strong>in</strong>tubation Probableafter <strong>in</strong>tubationLook Patient becomes Oesophageal <strong>in</strong>tubation Certa<strong>in</strong>cyanosed after <strong>in</strong>tubation (REMOVE TUBE)Stethoscope Air entry at both apices Correct tracheal <strong>in</strong>tubation Probableboth axillae & both basesStethoscope Air entry over Oesophageal <strong>in</strong>tubation Probablestomach(REMOVE TUBE)* = self <strong>in</strong>flat<strong>in</strong>g bag.The capnograph or an oesophageal detection device (see above) are the most useful pieces of equipmentto confirm <strong>in</strong>tubation


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 41and perform a regional technique, or cont<strong>in</strong>ue surgery witha face mask.Special problems.While the monitor<strong>in</strong>g requirements for uncomplicatedCaesarean deliveries are straight forward, additionalmonitors may be required if other pathologies are present.As haemorrhage, embolism, hypertensive disorders ofpregnancy and maternal cardiac conditions are associatedwith more than 50% of maternal deaths <strong>in</strong> the UK, theseconditions deserve special mention.Major haemorrhageMajor haemorrhage may be life threaten<strong>in</strong>g. Whenevermajor haemorrhage occurs, <strong>in</strong>vasive cardiovascularmonitor<strong>in</strong>g should be used if available. This should <strong>in</strong>cludehourly ur<strong>in</strong>e output measurement, temperature monitor<strong>in</strong>gand central venous pressure and <strong>in</strong>vasive arterial pressuremonitor<strong>in</strong>g.EmbolismThe triad of hypocapnia, hypoxia and hypotension shouldalert the anaesthetist to the possibility of an embolism. Airembolism, thromboembolism and amniotic fluid embolismmay all occur. M<strong>in</strong>or air embolism can be detected <strong>in</strong>almost every caesarean section. However it is extremelyunusual for this to have any cl<strong>in</strong>ical significance.Thromboembolism causes approximately 25% of UKmaternal deaths, but rarely presents dur<strong>in</strong>g surgery.Perioperatively, amniotic fluid embolism is the greatest risk.If embolism is suspected then <strong>in</strong>vasive cardiovascularmonitor<strong>in</strong>g should be considered and the clott<strong>in</strong>g cascadeassessed. Amniotic fluid embolism is often associated witha coagulopathy.Hypertensive disorders of pregnancySevere pre-eclampsia is associated with a reduced plasmavolume, while total body water is <strong>in</strong>creased. Laryngealoedema may make <strong>in</strong>tubation difficult and hypertensiveresponses to <strong>in</strong>tubation may be greatly <strong>in</strong>creased.Treatment with magnesium may prolong the action ofmuscle relaxants. (see <strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 1998;9)Renal failure may be present. Monitor<strong>in</strong>g should be tailoredto detect these problems and particular consideration givento <strong>in</strong>vasive monitor<strong>in</strong>g of central venous pressure, arterialblood pressure and hourly ur<strong>in</strong>e output.Maternal cardiac conditionsPregnancy stresses the cardiovascular system, particularlyat delivery, when large fluid shifts and rapid changes <strong>in</strong> thepre- and after-load of the heart occur. These changes maybe compounded by anaesthesia. Patients with cardiacdisease, especially significant shunts or stenotic valvularlesions, are vulnerable to these changes. Some patientswill require <strong>in</strong>vasive cardiac monitor<strong>in</strong>g throughout theperioperative period.ConclusionsCaesarean sections are so common that the risks are oftenignored. However <strong>in</strong> a recent survey, 82% of anaestheticrelated deaths occurred dur<strong>in</strong>g Caesarean section. Theobstetric anaesthetist can reduce the risk to his patientsby careful monitor<strong>in</strong>g. The monitors should be tailored todetect<strong>in</strong>g the problems that may be encountered so thatthey can be corrected before mother or fetus are harmed.


42<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>MONITORING IN THE RECOVERY ROOMDr Keith Allman, Royal Devon and Exeter Hospital, Exeter, UK, previously Royal Perth Hospital, Australia.The recovery room is the area where patients recover fromthe immediate effects of anaesthesia and surgery andprovides a sett<strong>in</strong>g for the detection and treatment of earlypost-operative complications. These areas varyconsiderably <strong>in</strong> the level of staff<strong>in</strong>g and monitor<strong>in</strong>g availablefrom the “ideal” fully staffed, fully equipped modernrecovery facility to the somewhat less than perfect dimlylit corridor just outside theatre.The commonest causes of recovery room mishaps all resultfrom unidentified changes <strong>in</strong> a patient’s airway, breath<strong>in</strong>gor circulation and these can almost always be rectified ifidentified at an early stage.In 1993 the Association of Anaesthetists of Great Brita<strong>in</strong>and Ireland published recommendations for the provisionof equipment necessary for a modern day recovery area.These are shown <strong>in</strong> table 1.These facilities may not all be available <strong>in</strong> many recoveryareas throughout the world and some thought is necessaryto determ<strong>in</strong>e the relative merits of each item on this longlist.Certa<strong>in</strong>ly the two most important pre-requisites of anyrecovery area should be the provision of good light<strong>in</strong>gtogether with a suitably tra<strong>in</strong>ed recovery nurse availableto recover each unconscious patient on a one-to-one basis.The nurse must be available to stay with the patientconstantly until awake and able to ma<strong>in</strong>ta<strong>in</strong> their ownairway.Cl<strong>in</strong>ical patient monitor<strong>in</strong>gCl<strong>in</strong>ical monitor<strong>in</strong>g can be divided <strong>in</strong>to assessment ofairway, breath<strong>in</strong>g and circulation.Table 1: Association of Anaesthetists of Great Brita<strong>in</strong> and Ireland Guidel<strong>in</strong>es 1993Position of recoverysituated as close as possible to the operat<strong>in</strong>g theatre to m<strong>in</strong>imise the risks of transport<strong>in</strong>gunstable patientsSize and temperaturean average of 1.5 recovery bays per operat<strong>in</strong>g theatre (9.3m 2 per bay)room temperature 21-22 o C, relative humidity 38 - 45% and fifteen changes of airper m<strong>in</strong>utegas scaveng<strong>in</strong>g system and six 13 ampere electricity outlets per baywell lit with light<strong>in</strong>g approximat<strong>in</strong>g to the daylight spectrumEquipment <strong>in</strong> each bayoxygen outlets, face masks and breath<strong>in</strong>g systemspulse oximetryavailability of blood pressure monitor<strong>in</strong>g and ECGsuction units with Yankaur endsa fully equipped anaesthetic mach<strong>in</strong>e with ventilatordrugs and <strong>in</strong>travenous fluidsa paediatric equipment trolley conta<strong>in</strong><strong>in</strong>g facemasks, airways, endotracheal tubes andconnectors <strong>in</strong> a range of paediatric sizes


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 43The patient’s airway can be assessed by observ<strong>in</strong>g forsigns of obstruction such as chest wall or supraclavicular<strong>in</strong>ward movement on <strong>in</strong>spiration and/or the presence ofnoisy breath<strong>in</strong>g. A patent airway is most easily ma<strong>in</strong>ta<strong>in</strong>edwith the patient <strong>in</strong> the left lateral (‘recovery’) position (figure1) as this allows the tongue and soft palate to fall forwardsaway from the oropharyngeal open<strong>in</strong>g. This will alsoprevent any blood or secretions pool<strong>in</strong>g <strong>in</strong> the oropharynxand caus<strong>in</strong>g aspiration or laryngospasm. In patients atrisk of further oropharyngeal soil<strong>in</strong>g, dra<strong>in</strong>age of secretionscan be <strong>in</strong>creased by plac<strong>in</strong>g a pillow beneath the patient’schest (‘tonsillar position’). If the patient has to rema<strong>in</strong>sup<strong>in</strong>e for any reason then the use of jaw thrust or anoropharyngeal (Guedel) airway can be <strong>in</strong>valuable <strong>in</strong> airwayma<strong>in</strong>tenance. Ma<strong>in</strong>tenance of a patent airway isprobably the s<strong>in</strong>gle most important aspect ofimmediate post-operative care. Although few patients<strong>in</strong> the UK are now taken to recovery with an endotrachealtube <strong>in</strong>-situ this depends to some extent on the anaestheticagents available. Where slowly elim<strong>in</strong>ated agents are used(ether and halothane) the endotracheal tube is sometimesbest left <strong>in</strong>-situ until full return of the laryngeal reflexes.When to extubate is a matter of cl<strong>in</strong>ical judgment, but as arule it is safer to leave the tube as long as possible as thisensures airway patency. In children it is common practiceto wait until they can remove it themselves. Suction<strong>in</strong>g ofthe oropharynx should be performed before tube removalto avoid aspiration of any blood or mucus present. Theanaesthetist should always be on hand until a patient isawake and ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g their own airway <strong>in</strong> case of severelaryngospasm necessitat<strong>in</strong>g re-<strong>in</strong>tubation.Respiration can be assessed by monitor<strong>in</strong>g abdom<strong>in</strong>alexcursion, chest movement or by feel<strong>in</strong>g for expiration witha cupped hand at the patient’s mouth or nose. Oxygenationcan also be assessed to some degree by exam<strong>in</strong><strong>in</strong>g thepatient’s colour. A dusky, bluish hue suggests hypoxia,and is often most easily noted around the lips or tongue.This does, however, require natural daylight or goodquality artificial light<strong>in</strong>g as some systems producemonochromatic light which makes the appreciation ofcolour difficult. Bradypnoea will usually be due to <strong>in</strong>traoperativeopioid use and if so will be associated withp<strong>in</strong>po<strong>in</strong>t pupils. This may resolve spontaneously as theother anaesthetic agents are elim<strong>in</strong>ated and the patientwakes up. If treatment is <strong>in</strong>dicated (respiratory rate lessthan 8 bpm or hypoxia) then first try to rouse the patientand if this fails consider naloxone (400 microgram diluted<strong>in</strong>to 10 ml sal<strong>in</strong>e adm<strong>in</strong>ister<strong>in</strong>g 2 ml boluses <strong>in</strong>travenously).Where available doxapram (1 mg/kg) is a useful respiratorystimulant and will not reverse the analgesic effects ofopioids. Tachypnoea can be associated with certa<strong>in</strong> volatileagents (particularly ether), acidosis, hypovolaemia, pa<strong>in</strong>,hypoxia or other respiratory problem.Circulation can be assessed by palpat<strong>in</strong>g the pulse(thready pulse or tachycardia suggest<strong>in</strong>g volume depletion)and by feel<strong>in</strong>g the peripheries (cold poorly perfused handsalso suggest hypovolaemia or hypothermia follow<strong>in</strong>g longoperations). Heart rate should normally be between 60-90 bpm. Bradycardia is usually associated with deepanaesthesia or vagally stimulat<strong>in</strong>g surgery and may needtreat<strong>in</strong>g if the heart rate is less than 40-50bpm or ifassociated with hypotension (give atrop<strong>in</strong>e 200-400mcg).Tachycardia is likely to be due to poor pa<strong>in</strong> control orhypovolaemia, but may rarely be due to atrial fibrillationor a supraventricular tachycardia. Primary treatmentshould be directed at the cause (morph<strong>in</strong>e or a 250mlfluid challenge). As with respiratory monitor<strong>in</strong>g it is usefulto chart the heart rate and blood pressure so that trendsover time can be more easily seen. A develop<strong>in</strong>gtachycardia is often an early sign of unrecognised bloodFigure 1: The recovery position


44<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>loss. The wound site must also be observed every fewm<strong>in</strong>utes to ensure that any bleed<strong>in</strong>g or haematomaformation is noted early. Dra<strong>in</strong>age from surgical dra<strong>in</strong>sshould also be charted.Conscious level should be monitored by observ<strong>in</strong>g thereturn of reflexes such as the eyelash reflex, swallow<strong>in</strong>gand the start of vocalisation and response to commands.Where the patient has undergone regional anaesthesia(sp<strong>in</strong>al or epidural) the height of the block must be assesseduntil it is seen to be regress<strong>in</strong>g. This is most easily testedby measur<strong>in</strong>g the po<strong>in</strong>t at which cold can no longer beappreciated (us<strong>in</strong>g ethyl chloride or ice). It is safer not tosit these patients up too early as marked posturalhypotension can occur.Once the patient is vocalis<strong>in</strong>g and is reasonably awakepa<strong>in</strong> levels should be assessed. Recovery nurses shouldbe capable of adm<strong>in</strong>ister<strong>in</strong>g <strong>in</strong>travenous analgesia andachiev<strong>in</strong>g adequate analgesia should be a primary goal onceairway reflexes have returned. Pa<strong>in</strong> is most easily treatedby adm<strong>in</strong>ister<strong>in</strong>g morph<strong>in</strong>e 1-2 mg aliquots every 3-5m<strong>in</strong>utes until comfortable. It is very unusual to overdosepatients us<strong>in</strong>g this regime, but <strong>in</strong>travenous naloxone shouldbe available. See also <strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 1997; 7.Supplemental oxygen therapyWhenever possible all patients recover<strong>in</strong>g from anaesthesiashould be given supplemental oxygen (4l/m<strong>in</strong> by face mask).Where facilities are limited, provided the airway andbreath<strong>in</strong>g is monitored closely, young, fit <strong>in</strong>dividuals hav<strong>in</strong>grelatively m<strong>in</strong>or procedures can often recover withoutsupplemental oxygen. However it should be givenwhenever possible <strong>in</strong> the less fit population hav<strong>in</strong>g majorsurgery. <strong>Anaesthesia</strong>, particularly halothane, obtunds, or<strong>in</strong> some cases abolishes, the hypoxic respiratory drive sothat hypoxia no longer stimulates <strong>in</strong>creased ventilation.Coupled with this is a much <strong>in</strong>creased tendency forhypoxaemia to occur due to a variety of reasons <strong>in</strong>clud<strong>in</strong>gairway obstruction due to an obtunded conscious level,hypoventilation secondary to opioids and anaestheticagents, diffusional hypoxia caused by nitrous oxidediffus<strong>in</strong>g <strong>in</strong>to the lungs faster than nitrogen can diffuse <strong>in</strong>the opposite direction and many different causes ofventilation/perfusion mismatch<strong>in</strong>g. These <strong>in</strong>clude atelectasis(absorption collapse, mucus trapp<strong>in</strong>g, prolongedhypoventilation), a decrease <strong>in</strong> functional residual capacitywith anaesthesia and sup<strong>in</strong>e posture, poor mucus clearance(absent/impaired cough reflex and poor ciliary function),and possibly hypovolaemia or pulmonary oedema. Patientsparticularly at risk of postoperative hypoxia <strong>in</strong>clude thosewho have received nitrous oxide or opioids, and thosewith pre-exist<strong>in</strong>g pulmonary disease. Where oxygen canbe adm<strong>in</strong>istered, even 2 litres per m<strong>in</strong>ute via nasalspectacles or face mask may be sufficient to preventdesaturation associated with most of the causes listedabove. It is also important to realise that the tendency forhypoxaemia extends long <strong>in</strong>to the postoperative periodand is particularly likely to occur on the first postoperativenight. If possible, high risk patients undergo<strong>in</strong>g majorsurgery should receive supplemental oxygen for 48-72hours.Monitor<strong>in</strong>g EquipmentThe most useful monitors <strong>in</strong> the recovery area are the pulseoximeter and the sphygmomanometer. The latter isobviously considerably cheaper, more widely available anddoesn’t need electricity to function. It provides valuable<strong>in</strong>formation about a patient’s cardiovascular status.Postoperatively patients are often mildly hypotensive dueto the sedative effects of drugs and the likelihood of bloodloss or <strong>in</strong>traoperative fluid redistribution (coupled withsome degree of dehydration due to preoperative fast<strong>in</strong>g).More marked levels of hypotension (or even moreseriously a downward trend <strong>in</strong> blood pressure) often heraldan unrecognised blood loss, an adverse cardiac event ormay follow sp<strong>in</strong>al anaesthesia. For these reasons it isprudent to monitor blood pressure every five m<strong>in</strong>utes orso until it is stable and with<strong>in</strong> normal limits. This alsodemonstrates why it is important to document the vitalsigns over a period of time, so that these trends can moreeasily be spotted and acted upon.S<strong>in</strong>ce its widespread <strong>in</strong>troduction <strong>in</strong> the 1980’s the pulseoximeter has become one of the ma<strong>in</strong>stays of postanaesthetic monitor<strong>in</strong>g. Where available these mach<strong>in</strong>eswill give a fairly reliable <strong>in</strong>dicator of systemic oxygenation,together with some <strong>in</strong>dication of cardiovascular status.Oxygen saturation levels should rema<strong>in</strong> above 93% anddesaturation below this level <strong>in</strong> recovery is most commonlycaused by airway obstruction and poor or <strong>in</strong>adequateventilation. The presence of a good quality pulsatile signalusually denotes adequate peripheral circulation, althoughvasodilatation and hypotension can still be present, so theblood pressure should still be monitored. See p<strong>11</strong> forfurther read<strong>in</strong>g regard<strong>in</strong>g the use of pulse oximeters.Apart from the above m<strong>in</strong>imal monitor<strong>in</strong>g, furtherassessment must be tailored to a patient’s particular needs.Ur<strong>in</strong>e output should be assessed where an <strong>in</strong>dwell<strong>in</strong>gur<strong>in</strong>ary catheter is sited and ECG monitor<strong>in</strong>g may benecessary where a patient is at risk of arrhythmias.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 45Table 2 Rout<strong>in</strong>e postoperative observations on patients undergo<strong>in</strong>g major surgeryoxygen adm<strong>in</strong>istrationoxygen saturationrespiratory frequencyblood pressure and heart rateconscious levelpa<strong>in</strong> scoreoperation site reviewtemperature and ur<strong>in</strong>e output where necessaryany drugs or fluids adm<strong>in</strong>isteredTemperature should also be checked follow<strong>in</strong>g longoperations (particularly <strong>in</strong> the elderly) where hypothermiais a risk. Lack of attention to temperature ma<strong>in</strong>tenance <strong>in</strong>theatre can lead to major problems <strong>in</strong> recovery. Patientstend to lose heat rapidly under anaesthesia due toobtund<strong>in</strong>g of homeothermic mechanisms and prolongedsurgical exposure. Hypothermia (even a small reductionto 35 degrees centigrade) can have a major impact onpostoperative recovery. As temperature decreases drugmetabolism and excretion also decreases therebyprolong<strong>in</strong>g recovery. Poor metabolism of neuromuscularblock<strong>in</strong>g agents can be a particular problem. Blood clott<strong>in</strong>gis also affected early, with a much <strong>in</strong>creased tendency topostoperative bleed<strong>in</strong>g. Shiver<strong>in</strong>g also causes <strong>in</strong>creasedoxygen utilization, <strong>in</strong>creas<strong>in</strong>g the tendency to hypoxaemia,and is best treated with body surface warm<strong>in</strong>g or<strong>in</strong>travenous pethid<strong>in</strong>e (10-20 mg).Where possible the observations <strong>in</strong> table 2 should berout<strong>in</strong>ely charted on all patients who have undergone majorsurgery:Discharge CriteriaThe patient should cont<strong>in</strong>ue to be observed until fit fordischarge to the ward area. Discharge criteria vary, butshould <strong>in</strong>clude the return of preoperative conscious leveland protective reflexes, ma<strong>in</strong>tenance of a clear airway,satisfactory breath<strong>in</strong>g and oxygenation (oxygen saturation> 93% on air), stable pulse and blood pressure, acceptabletemperature and adequate analgesia (table 3).Table 3 Discharge criteriapatient conscious and ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g a clear airwayreturn of protective airway reflexessatisfactory breath<strong>in</strong>g and oxygenation (oxygen saturation > 93% on air)stable pulse and blood pressuregood peripheral perfusionacceptable temperatureadequate analgesiaReferenceImmediate Postanaesthetic Recovery, 1993. The Association of Anaesthetists of Great Brita<strong>in</strong> and Ireland, 9 BedfordSquare, London WC1B 3RA.


46<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>ANAESTHESIA FOR EMERGENCY EYE SURGERYDr Anna Wilson, Frenchay Hospital, Bristol, UK, Dr Jasmeet Soar, Southmead Hospital, Bristol UKIntroduction<strong>Anaesthesia</strong> for emergency eye surgery can present specialproblems to the anaesthetist. An understand<strong>in</strong>g of somebasic pr<strong>in</strong>ciples and techniques of eye anaesthesia havebeen discussed <strong>in</strong> previous issues of <strong>Update</strong> (Nos. 6 &8).This article discusses the specific problems of emergencyanaesthesia for eye surgery. We try and answer thecommon questions concern<strong>in</strong>g these patients and providea practical guide.Indications for emergency eye surgeryAn emergency is def<strong>in</strong>ed as an event that has to be dealtwith immediately, usually with<strong>in</strong> the first hour afterpresentation. The commonest eye emergencies that fall<strong>in</strong>to this category are chemical burns of the eye and ret<strong>in</strong>alartery occlusion. Neither of these requires surgery as partof the <strong>in</strong>itial management. The majority of cases present<strong>in</strong>gas emergencies can therefore be def<strong>in</strong>ed as urgent cases.Trauma is by far the commonest <strong>in</strong>dication for urgentsurgery. Traumatic <strong>in</strong>juries can be blunt or penetrat<strong>in</strong>g(“open eye”). The <strong>in</strong>cidence is highest <strong>in</strong> young adult malesand children. Trauma is often associated with <strong>in</strong>dustrial ormotor vehicle accidents. Eye protection <strong>in</strong> the work placeand car safety belts have lowered the <strong>in</strong>cidence of eyetrauma <strong>in</strong> many countries. Eye trauma is usually conf<strong>in</strong>edto one eye. Some patients may present with trauma toboth eyes or with multiple <strong>in</strong>juries.Non-traumatic surgical “emergencies” <strong>in</strong>clude spontaneousret<strong>in</strong>al detachment, <strong>in</strong>fections, and complications ofprevious surgery. One of the factors which determ<strong>in</strong>es thedegree of urgency for ret<strong>in</strong>al detachment surgery is thecondition of the macula. The risk of a detachmentprogress<strong>in</strong>g and result<strong>in</strong>g <strong>in</strong> loss of the macula <strong>in</strong>creasesthe sense of urgency. There is usually enough time howeverto allow for fast<strong>in</strong>g prior to surgery.Tim<strong>in</strong>g of surgeryIdeally all patients should be fasted before undergo<strong>in</strong>ggeneral anaesthesia to m<strong>in</strong>imise the risk of aspiration andsubsequent lung <strong>in</strong>jury. This obviously has to be weighedaga<strong>in</strong>st the risk to the eye that delay<strong>in</strong>g surgery may cause.It is essential to liase closely with the surgeon to establishthe degree of urgency. Most cases <strong>in</strong>volv<strong>in</strong>g blunt traumacan usually be delayed to allow for patient fast<strong>in</strong>g.Penetrat<strong>in</strong>g <strong>in</strong>juries may need to be dealt with more urgentlydue to the risk of <strong>in</strong>fection and endophthalmitis. If the patienthas an open eye <strong>in</strong>jury there is also the risk of vitreousloss and ret<strong>in</strong>al detachment. Even with open eye <strong>in</strong>juriesmany ophthalmic surgeons are will<strong>in</strong>g to delay surgery untila patient is adequately fasted prior to anaesthesia. This isespecially the case where there is severe damage to theeye and surgery is not go<strong>in</strong>g to improve sight. This groupof patients are usually admitted for bed rest and have aneye shield cover<strong>in</strong>g the <strong>in</strong>jured eye until they are ready forprimary closure of their eye wounds. Open eye <strong>in</strong>juries <strong>in</strong>which the eye is still largely <strong>in</strong>tact and the visual prognosisis good need to be dealt with more urgently. Decisionmak<strong>in</strong>g needs to be made on a case by case basis. Thedegree of urgency will depend on the size of the lacerationand commensurate risk of loss of ocular contents, howdirty the wound is and the risk of <strong>in</strong>fection.A fast of six hours is normally suggested <strong>in</strong> theuncomplicated patient. It is now common practice to allowpatients to dr<strong>in</strong>k clear fluids (water, non-fizzy fruit dr<strong>in</strong>ks)up to two to four hours prior to the time of surgery. Inpatient’s who have had trauma or received opioids, it cantake up to 24 hours for gastric empty<strong>in</strong>g to take place.The most important time <strong>in</strong>terval is that between the lastmeal and the time of the <strong>in</strong>jury. If trauma occurs soon aftera large meal the patient may still have a full stomach afterthe standard six hour fast. Alcohol also delays gastricempty<strong>in</strong>g. If surgery is necessary <strong>in</strong> a patient with a fullstomach then a rapid sequence <strong>in</strong>duction technique shouldbe used (see below).How long patients should be fasted for prior to surgerywith a local anaesthetic block is controversial. We feelthat <strong>in</strong> the patient undergo<strong>in</strong>g emergency eye anaesthesiathe above pr<strong>in</strong>ciples regard<strong>in</strong>g fast<strong>in</strong>g should be usedirrespective of the anaesthetic technique chosen.Does the patient have other medical problems ?Eye trauma requir<strong>in</strong>g surgery may be associated with other<strong>in</strong>juries that may or may not require surgery. In the multiply<strong>in</strong>jured patient normal trauma pr<strong>in</strong>ciples must always beapplied. Life-threaten<strong>in</strong>g problems should be dealt withbefore sight-threaten<strong>in</strong>g problems. The pr<strong>in</strong>ciples ofmanag<strong>in</strong>g the patient with major trauma have beendiscussed <strong>in</strong> <strong>Update</strong> 1996;6. Patients with other disease


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 47processes such as diabetes or ischaemic heart diseaseshould have these optimised prior to surgery if time allows.Choice of a local or general anaesthetic techniqueThe choice of technique will depend on patient factors aswell as local facilities and surgeon preferences. In manycountries extra-ocular, anterior segment and vitreo-ret<strong>in</strong>aleye surgery is rout<strong>in</strong>ely performed us<strong>in</strong>g local anaesthetictechniques. However there are many practical reasons whya general anaesthetic is often preferable for emergencycases. Firstly, the patient must be able to lie flat, still andprotect his or her own airway safely for the duration of theprocedure. Thus, children, uncooperative or <strong>in</strong>toxicatedpatients are usually better candidates for a generalanaesthetic. An uncooperative patient with an open eye isextremely difficult to manage. Spread of local anaestheticagents is poor <strong>in</strong> patients with eye and orbital <strong>in</strong>fections.Some procedures such as scleral band<strong>in</strong>g (scleral buckl<strong>in</strong>g)for ret<strong>in</strong>al detachment can be extremely uncomfortable evenwith a good local anaesthetic block. In our experienceyounger adults tend to tolerate surgery with a localanaesthetic technique poorly compared with elderlypatients.In open eye <strong>in</strong>juries local anaesthetic techniques are usuallyavoided. Injection of local anaesthetic us<strong>in</strong>g peribulbar andretrobulbar techniques is associated with an <strong>in</strong>crease <strong>in</strong><strong>in</strong>tra-ocular pressure which may lead to vitreous loss.Oculocompression after the block is also not an option ifthe patient has an open eye <strong>in</strong>jury. In some patients it maybe possible to operate on small open eye <strong>in</strong>juries us<strong>in</strong>gtopical anaesthesia, sub-tenon blocks or a carefulperibulbar or retrobulbar block.Is sedation an option ?Sedation should be used cautiously. Oversedation can easilyturn a cooperative patient <strong>in</strong>to a difficult to manage patientdue to airway problems and patient confusion. Sedationshould not be used as an alternative to a general anaesthetic<strong>in</strong> a patient with a full stomach. If a patient develops pa<strong>in</strong>dur<strong>in</strong>g surgery us<strong>in</strong>g a local anaesthetic technique thepatient requires analgesia and not sedation. The surgeonshould supplement the block us<strong>in</strong>g local anaesthesia orsmall doses of <strong>in</strong>travenous analgesia should be given.If sedation is to be used then small doses of a short act<strong>in</strong>gagent such as midazolam should be given. Diazepam <strong>in</strong>small doses may also be an option. Propofol <strong>in</strong> small 10mg<strong>in</strong>crement doses can also be used especially prior toperform<strong>in</strong>g a local anaesthetic eye block. Someanaesthetists use small doses of alfentanil or fentanyl. Thekey to good sedation is to ma<strong>in</strong>ta<strong>in</strong> verbal contact withthe patient.Careful surgical drap<strong>in</strong>g is also important. Patients becomeclaustrophobic if their faces are draped. Use of a bar tohold up the drapes can allow a tent to be made to allowbetter ventilation (figure 1). Oxygen should be given tothe patient, especially if sedation is to be used. Patientsmay f<strong>in</strong>d a face mask or nasal oxygen cannulaeuncomfortable. Oxygen can be <strong>in</strong>sufflated under the drapesus<strong>in</strong>g a breath<strong>in</strong>g circuit. This also improves air circulationunder the drapes.Figure 1Many of the problems associated with local techniquescan be avoided with a clear explanation of the procedureto the patient prior to commenc<strong>in</strong>g surgery, hav<strong>in</strong>g acomfortable operat<strong>in</strong>g table, and somebody to hold thepatient’s hand throughout. Allow<strong>in</strong>g patients to empty theirbladders prior to surgery also helps.Choice of drugs for general anaesthesiaThe choice of <strong>in</strong>travenous <strong>in</strong>duction agent will depend onlocal availability and user familiarity. Most <strong>in</strong>travenous<strong>in</strong>duction agents reduce <strong>in</strong>tra-ocular pressure thereforeprevent<strong>in</strong>g further damage to the <strong>in</strong>jured eye.Ketam<strong>in</strong>e possibly raises <strong>in</strong>tra-ocular pressure althoughthe literature is conflict<strong>in</strong>g. Most textbooks state that itshould be avoided <strong>in</strong> open eye <strong>in</strong>juries. If it is to be used itis best to use it <strong>in</strong> comb<strong>in</strong>ation with small doses of abenzodiazep<strong>in</strong>e (midazolam, diazepam) to blunt itsexcitatory effects. The majority of problems with ketam<strong>in</strong>eand <strong>in</strong>tra-ocular pressure seem to occur when it used as a


48<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>sole agent <strong>in</strong> a patient with an unprotected airway breath<strong>in</strong>gspontaneously. Ideally ketam<strong>in</strong>e should be used with amuscle relaxant and controlled ventilation if <strong>in</strong>tra-ocularpressure control is important.All the non-depolaris<strong>in</strong>g muscle relaxants can be usedwithout adverse effects on the eye so choice will dependon availability. Suxamethonium (scol<strong>in</strong>e) <strong>in</strong>creases <strong>in</strong>traocularpressure. The exact mechanism is unclear but it isnot thought to be solely due to contraction of the extraocularmuscles. Suxamethonium also causes an <strong>in</strong>crease<strong>in</strong> the <strong>in</strong>tra-ocular blood volume and this may contributeto the rise <strong>in</strong> <strong>in</strong>tra-ocular pressure. The rise <strong>in</strong> <strong>in</strong>tra-ocularpressure occurs after one to two m<strong>in</strong>utes and wanes aftersix to ten m<strong>in</strong>utes. The extent of the rise <strong>in</strong> <strong>in</strong>tra-ocularpressure will depend on the other drugs used and theresponse to laryngoscopy and <strong>in</strong>tubation. Its use <strong>in</strong>penetrat<strong>in</strong>g eye <strong>in</strong>jury anaesthesia is controversial. Themajority of eye surgeons prefer if it is not used. Adequatefast<strong>in</strong>g prior to surgery will allow suxamethonium to beavoided for the majority of urgent cases. This obviouslypresents a dilemma <strong>in</strong> the patient with a full stomach assuxamethonium is used as part of a ‘rapid sequence<strong>in</strong>duction’ to enable an airway to be secured quickly. Inthis situation the relative risks need to be weighed, i.e.prevention of aspiration (potentially life threaten<strong>in</strong>g) versesocular damage (potentially sight threaten<strong>in</strong>g).Suxamethonium avoid<strong>in</strong>g techniques <strong>in</strong>clude the use of largedoses of vecuronium or pancuronium to speed up its onsetof action as part of a modifed rapid sequence <strong>in</strong>ductiontechnique. The non-depolaris<strong>in</strong>g neuromuscular blockerrocuronium has a rapid onset of action with a duration of30 to 40 m<strong>in</strong>utes. It can be used for a rapid sequence<strong>in</strong>duction technique but can only be recommended to thosewho have ga<strong>in</strong>ed experience <strong>in</strong> its use and for patients <strong>in</strong>whom airway problems are unlikely to occur.On balance there are no case reports of ocular damagewith suxamethonium use, and no good evidence thatsuxamethonium-avoid<strong>in</strong>g techniques are any better or safer.Airway management and mode of ventilationIt is considered good practice to <strong>in</strong>tubate and ventilate thepatient to ensure a secure airway (the surgical field is <strong>in</strong>close proximity) and to facilitate mild hypocarbia (thisreduces <strong>in</strong>tra-ocular pressure). The laryngeal mask airwayis a popular choice for airway management for electiveeye surgery <strong>in</strong> the UK. Laryngeal mask <strong>in</strong>sertion avoidsthe pressor response to laryngoscopy and <strong>in</strong>tubationcaus<strong>in</strong>g raised <strong>in</strong>tra-ocular pressure. The laryngeal maskAnalgesic DrugsDrug Dose CommentsParacetamol Children: 90 mg/kg total per 24 hours Avoid if liver dysfunction. Decrease(Acetom<strong>in</strong>ophen) orally or rectally <strong>in</strong> 4-6 divided doses dose to total of 60 mg/kg per 24 hoursif treatment for more than 48 hours.Adults: 1g orally or rectally. 4g totalper 24 hoursIbuprofen Children: 10mg/kg orally. 4 doses Ibuprofen has the lowest side effectmaximum <strong>in</strong> 24 hours.profile of the non-steroidal anti<strong>in</strong>flammatorydrugs. Avoid <strong>in</strong> renal andAdults: 400 mg orally.peptic ulcer disease. Use with care <strong>in</strong>4 doses maximum <strong>in</strong> 24 hours. asthma. Not <strong>in</strong> children


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 49Drugs for nausea and vomit<strong>in</strong>gDrug Dose CommentsDroperidol 0.5 to 1 mg <strong>in</strong> adults. Up to 3 times a day Cheap and effective but causesdrows<strong>in</strong>ess, sedation, anxietyand restlessness. Risk ofextrapyramidal effects.Cycliz<strong>in</strong>e Children 1mg/kg iv Up to 3 times a dayAdults 50 mg ivAnti histam<strong>in</strong>e and antichol<strong>in</strong>ergiceffect.Ondansetron Children 0.1 mg/kg iv 3-4 doses per 24 hoursAdults 4 mg ivExpensive but effective withlow side effect profile.does not protect aga<strong>in</strong>st aspiration of gastric contents. Itsuse <strong>in</strong> emergency anaesthesia is therefore limited.Analgesia and control of nausea and vomit<strong>in</strong>gIt is possible to manage pa<strong>in</strong> <strong>in</strong> the majority of patientsafter eye surgery with oral analgesia. Avoid<strong>in</strong>g opioids ifpossible helps prevent nausea and vomit<strong>in</strong>g. Regular dosesof paracetamol (acetom<strong>in</strong>ophen) and a non steroidal anti<strong>in</strong>flammatorydrug (ibuprofen, diclofenac, ketoprofen)should be prescribed. Code<strong>in</strong>e phosphate can also beadded. These drugs are best accepted by children if givenas an elixir (syrup). Some analgesic drugs are listed <strong>in</strong> thetable below. In patients hav<strong>in</strong>g surgery with generalanaesthesia it is a good idea to ask the surgeon to performa local anaesthetic block before wak<strong>in</strong>g up the patient. Ifstronger analgesia is required this is best given as small<strong>in</strong>travenous doses of morph<strong>in</strong>e or pethid<strong>in</strong>e.Nausea and vomit<strong>in</strong>g after emergency eye anaesthesia canbe a major problem <strong>in</strong> some patients. Anti-emeticprophylaxis may help prevent this. Some patients maybenefit from a regular anti-emetic <strong>in</strong> the post-operativeperiod. There is a vast number of anti-emetic drugsavailable. Most have a limited efficacy. Us<strong>in</strong>g a comb<strong>in</strong>ationof small doses of anti-emetic drugs from differentpharmacological classes may enhance efficacy and reduceside effects. Some anti-emetic drugs are listed <strong>in</strong> the tablebelow.A practical approach to emergency eye anaesthesia1) Assess the <strong>in</strong>dication for emergency anaesthesia<strong>in</strong> discussion with the surgeon. Can surgery bedeferred until normal work<strong>in</strong>g hours and toallow adequate fast<strong>in</strong>g?2) Carry out a full preoperative assessment<strong>in</strong>clud<strong>in</strong>g a history and exam<strong>in</strong>ation.3) Are there any medical/trauma issues that needaddress<strong>in</strong>g first?Decide on choice of anaesthetic technique. Providethe patient with a full explanation. Tell the patientwhat to expect if a local anaesthetic technique is tobe used.4) If a general anaesthesia is chosen decide if thepatient has a full stomach and is at risk of aspiration.5) If the patient has a full stomach a rapid sequence<strong>in</strong>duction technique should be used. They shouldbe preoxygenated with 100% oxygen. Pressureon the affected eye from the mask must be avoided.The patient should then be <strong>in</strong>duced with an<strong>in</strong>travenous anaesthetic agent (eg thiopentone 4-7mg/kg) and a rapid onset muscle relaxant(suxamethonium 1-1.5mg/kg is currently the onlyrealistic option). While the patient is be<strong>in</strong>g <strong>in</strong>ducedcricoid pressure should be applied by an assistant(Sellick’s manouvre) thus occlud<strong>in</strong>g the oesophagusbeh<strong>in</strong>d. The patient’s trachea should be <strong>in</strong>tubatedafter which the cricoid pressure can be removed.Note that the endotracheal tube tie should not betight around the neck as this impedes venousdra<strong>in</strong>age and raises <strong>in</strong>tra-ocular pressure.6) Choice of ma<strong>in</strong>tenance depends on local availabilitye.g. 40% O 2, 60% N 2O and an <strong>in</strong>halational agent.Note that all <strong>in</strong>halational agents reduce <strong>in</strong>tra-ocularpressure.


50<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>7) Control ventilation dur<strong>in</strong>g the procedure aim<strong>in</strong>gfor low to normal end-tidal carbon dioxide.This may require the use of a longer act<strong>in</strong>gmuscle relaxant (e.g. vecuronium 0.1mg/kg). Aslight head up tilt helps reduce <strong>in</strong>tra-ocular pressure.8) At the end of the procedure the patient shouldbe extubated on their side and once airway protectivereflexes have returned. In patientsnot deemed at risk of aspiration extubation withthe patient deep and breath<strong>in</strong>g spontaneouslymay prevent cough<strong>in</strong>g. Severe cough<strong>in</strong>g andstra<strong>in</strong><strong>in</strong>g needs to be avoided as this <strong>in</strong>creasesthe risk of ocular haemorrhage.9) If the patient does not have a full stomach and isnot deemed at risk of aspiration, general anaesthesiashould proceed as for an elective patient.Pre-oxygenate the patient for safety and <strong>in</strong>ducewith an <strong>in</strong>travenous agent. Give a long act<strong>in</strong>gmuscle once ability to hand ventilate is established.Laryngoscopy should be performed gently.Consider spray<strong>in</strong>g the vocal cords with lignoca<strong>in</strong>eto m<strong>in</strong>imise the pressor response to<strong>in</strong>tubation. This may also decrease the risk ofcough<strong>in</strong>g on <strong>in</strong>tubation. Intubate, ventilate andma<strong>in</strong>ta<strong>in</strong> anaesthesia as above.10) Post operatively nausea, vomit<strong>in</strong>g and pa<strong>in</strong>should be kept to a m<strong>in</strong>imum as they can causerises <strong>in</strong> <strong>in</strong>tra-ocular pressure. Prescribe regularoral analgesia and an anti-emetic. Some patientsmay need stronger analgesia early after surgery.Titrate small doses of <strong>in</strong>travenous opioid (morph<strong>in</strong>e,pethid<strong>in</strong>e) to control pa<strong>in</strong>.References1. Mcgoldrick KE. The open globe: is an alternative tosucc<strong>in</strong>ylchol<strong>in</strong>e necessary ? J Cl<strong>in</strong> Anaesth 1993, 5: 1-4.This article argues that suxamethonium is probably still the bestmuscle relaxant for the real emergency. It also discusses the useof pretreatment.2. Libonati MM, Leahy JJ, Ellison N: The use ofsucc<strong>in</strong>ylchol<strong>in</strong>e <strong>in</strong> open eye surgery. Anaesthesiology 1985, 62:637-40.This paper studied 100 patients need<strong>in</strong>g “open eye” surgery withsuxamethanium.MANAGEMENT OF A HEAD INJURY - Case ReportDr. Frank J.M. Walters FRCA, Consultant Anaesthetist, Frenchay Hospital, Bristol BS16 1LE, UK,Frank_Walters@Compuserve.com and Dr. Ray Towey FRCA, Consultant Anaesthetist, Bugando MedicalCentre, Mwanza, Tanzania, emach@africaonl<strong>in</strong>e.co.tzThis is a report of a patient who has suffered a head <strong>in</strong>jury.The purpose is to illustrate the practical application of thebasic physiological and pharmacological pr<strong>in</strong>ciplesexpla<strong>in</strong>ed before (Neurophysiology-<strong>in</strong>tracranial pressureand cerebral blood flow, <strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>1998;8:18-23 and Neuropharmacology-Intracranialpressure and cerebral blood flow. <strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>1998;9:29-37). The problem is presented with themanagement and a range of anaesthetic techniques.The CaseCycl<strong>in</strong>g to work <strong>in</strong> the morn<strong>in</strong>g, a fit 30 year old man hasan accident which causes severe damage to his head.Initially he is conscious but confused, and is taken to thelocal Accident Department. When he is admitted it is foundthat he has become unconscious.Initial ManagementAn <strong>in</strong>itial assessment is performed urgently, <strong>in</strong> the sequencedescribed below.ABCDEAirway control <strong>in</strong>clud<strong>in</strong>g cervical sp<strong>in</strong>eimmobilisation with a stiff collar.Breath<strong>in</strong>gCirculationDysfunction or DisabilityExternal Exam<strong>in</strong>ationHis airway is clear. He is breath<strong>in</strong>g adequately. His bloodpressure is 180/90mmHg and he has a regular pulse witha rate of 55 bpm. There was no report of blood loss at thescene. He is warm and well perfused. Thus his circulationis adequate.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 51Neurological dysfunction is assessed by look<strong>in</strong>g atconscious level, pupils and posture. Conscious state isassessed us<strong>in</strong>g the Glasgow Coma Score (GCS scoreTable 1) or the AVPU system. Glasgow Coma scorerange is 3-15, if it is less than 8, the patient has seriousdamage with raised <strong>in</strong>tracranial pressure (ICP) more than20 mmHg (normal 5-13 mmHg).The AVPU is simple to carry out and offers a rapid methodof assessment.AlertVerbal - response toverbal commandPa<strong>in</strong> - response topa<strong>in</strong>ful stimulusUnresponsiveYes/NoYes/NoYes/NoYes/NoPatients who are not alert and are not respond<strong>in</strong>g tocommand (P or worse) are equivalent to a GCS of around8 which <strong>in</strong>dicates a severe <strong>in</strong>jury.On exam<strong>in</strong>ation of the pupils the right pupil is found to befixed and dilated, the left pupil is small and react<strong>in</strong>g. He isunresponsive to pa<strong>in</strong> (GCS less 8, AVPU less than P).This is a neurological emergency where delay may result<strong>in</strong> a fatal outcome or major disability. A rapid secondarysurvey is carried out to exclude other life threaten<strong>in</strong>g<strong>in</strong>juries.Although the risk of neck <strong>in</strong>jury is low, it cannot beexcluded and therefore the neck is kept stabilised with asemi-rigid collar and sand bags or blocks jo<strong>in</strong>ed with tapewith straps across the forehead (figure 1). An IV <strong>in</strong>fusionis started with normal sal<strong>in</strong>e (0.9%).Table 1: The Glasgow Coma ScaleGlasgow Coma Scale for Assessment of Level of ConsciousnessEye Open<strong>in</strong>g:Spontaneous 4To speech (not necessarily a request for eye open<strong>in</strong>g) 3To pa<strong>in</strong> (stimulus should not be applied to face) 2None 1Best Motor Response:Obeys commands 6Localise (purposeful movement towards the stimulus) 5Normal flexion (withdraws from pa<strong>in</strong>ful stimulus) 4Abnormal flexion (decorticate posture) 3Extension (decerebrate posture) 2No movement 1Verbal Response:Oriented (knows name, age) 5Confused (still answers questions) 4Inappropriate words (recognisable words produced) 3Incomprehensible sounds (grunts/groans, no actual words) 2None 1TOTAL SCORE /15


52<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>COMMENTAs soon as the patient is admitted to hospital the basicABCDE sequence described above is rapidly carriedout to detect any problems such as airway obstructionor respiratory arrest which will rapidly cause deathunless treated. With head <strong>in</strong>juries, respiratoryobstruction will cause hypoxia and raised carbondioxide and will lead to <strong>in</strong>creased <strong>in</strong>tracranial pressurecaus<strong>in</strong>g severe secondary damage. An adequate bloodpressure is vital <strong>in</strong> a patient with raised <strong>in</strong>tracranialpressure.The patient has suffered a primary head <strong>in</strong>jury fromtrauma. The signs <strong>in</strong>dicate a rapidly ris<strong>in</strong>g <strong>in</strong>tracranialpressure, with con<strong>in</strong>g of the temporal lobe probablydue, <strong>in</strong> this case to an extradural haematoma. This isa rapidly fatal condition if it is not treated urgently.When treated quickly, a good recovery may result. Itis essential that further bra<strong>in</strong> damage from ischaemia(due to low blood pressure and cerebral swell<strong>in</strong>g)result<strong>in</strong>g from factors such as hypoxia, high carbondioxide levels and venous congestion does not occur.Hypotension and hypoxia will <strong>in</strong>crease mortality ofa patient with a severe head <strong>in</strong>jury by 70-80%.Anaesthetic ManagementWhenever possible the patient should be reviewed by ananaesthetist <strong>in</strong> the receiv<strong>in</strong>g room or accident department.As the patient has low AVPU and GCS scores, he needsto be <strong>in</strong>tubated and ventilated to ensure a clear airway, fulloxygenation and low normal carbon dioxide levels beforego<strong>in</strong>g to the CT scanner. S<strong>in</strong>ce there is still concernregard<strong>in</strong>g a possible neck <strong>in</strong>jury, further movement of theneck dur<strong>in</strong>g <strong>in</strong>tubation could cause <strong>in</strong>jury to the cervicalcord. Therefore <strong>in</strong>tubation is carried out with the head <strong>in</strong>the neutral position and manual <strong>in</strong>-l<strong>in</strong>e traction to preventneck movement (figure 2). To perform this manoeuvre, anassistant grasps the mastoid processes and the front partof the collar is removed to allow adequate mouth open<strong>in</strong>g.Do not apply excessive traction as this can cause furtherdamage to the cervical sp<strong>in</strong>e.The mouth is clear, but as he may have eaten breakfastrecently, a rapid sequence <strong>in</strong>duction is necessary. He ispre-oxygenated and given an <strong>in</strong>travenous narcotic fentanyl150 mcg, (pethid<strong>in</strong>e 50 mg or morph<strong>in</strong>e 5 mg would bereasonable alternatives) followed by a slightly reduceddose of thiopentone 150-200 mg to ensure anaesthesia,Figure 2: Rapid sequence <strong>in</strong>duction of anaesthesia andmanual <strong>in</strong>-l<strong>in</strong>e cervical traction <strong>in</strong> an acute trauma patientFigure 1: Cervical sp<strong>in</strong>e immobilisation with a long sp<strong>in</strong>eboard, rigid collar, lateral blocks and straps.without caus<strong>in</strong>g hypotension. Many places today are nowus<strong>in</strong>g a reduced dose of propofol 90 - 100 mg, for<strong>in</strong>duction and cont<strong>in</strong>u<strong>in</strong>g anaesthesia with a propofol<strong>in</strong>fusion. Cricoid pressure is applied, he is paralysed with100mg of suxamethonium, and <strong>in</strong>tubated once fasciculationhas stopped.It is important to ma<strong>in</strong>ta<strong>in</strong> <strong>in</strong>termittent positivepressure ventilation for neurosurgical patients toproduce a moderately low normal arterial CO 2(PaCO 235 mmHg - 4.7 kPa) which will help to reducecerebral swell<strong>in</strong>g and hence <strong>in</strong>tracranial pressure.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 53After ty<strong>in</strong>g <strong>in</strong> the endotracheal tube the blood pressure ismeasured aga<strong>in</strong>. It has fallen to 80/55 mmHg. 500mls ofnormal sal<strong>in</strong>e (0.9%) is rapidly given, and a 6mg dose ofephedr<strong>in</strong>e is adm<strong>in</strong>istered IV which restores the bloodpressure to 180/90 mmHg.IV fluid therapyWhen anaesthesia is started, the cardiovascular system isdepressed, particularly the ability to compensate for areduction <strong>in</strong> blood volume (Cardiovascular Physiology<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 1999;10:2-8). Therefore part ofthe treatment of a fall <strong>in</strong> blood pressure is a rapid <strong>in</strong>fusionof fluid <strong>in</strong>travenously.<strong>Anaesthesia</strong> is now ma<strong>in</strong>ta<strong>in</strong>ed us<strong>in</strong>g a further dose offentanyl 150 mcg or iv morph<strong>in</strong>e 10mg slowly, vecuronium10mg and the patient ventilated with oxygen enriched air.He is monitored with a pulse oximeter, an ECG and BP.An <strong>in</strong>fusion of 150mls 20% mannitol (0.25 - 0.5 g/kg) iscommenced, followed by a litre of 0.9% sal<strong>in</strong>e, and aur<strong>in</strong>ary catheter <strong>in</strong>serted.He is transported to the CT scanner which shows a largeextradural haematoma (figure 3) and therefore isimmediately taken to the operat<strong>in</strong>g theatre for craniotomy.Figure 3: CT scan of a patient with an acute extraduralhaematomaTeach<strong>in</strong>g Po<strong>in</strong>tHypotension follow<strong>in</strong>g <strong>in</strong>ductionReasons for concern - hypotension will reduceperfusion pressure <strong>in</strong> the bra<strong>in</strong>. This has two adverseeffects:1 Blood flow through the bra<strong>in</strong> will falldramatically, reduc<strong>in</strong>g oxygenation of the bra<strong>in</strong>and cause ischaemia. The bra<strong>in</strong> tolerates thisbadly and will suffer major neurological damage(stroke, paralysis, death).2 The arteries <strong>in</strong> the bra<strong>in</strong> will sense a reduction<strong>in</strong> flow and will try to compensate(autoregulation). They will dilate <strong>in</strong> an attemptto reduce their resistance and thus <strong>in</strong>crease flow.Dilatation will <strong>in</strong>crease their volume and causea further <strong>in</strong>crease <strong>in</strong> bra<strong>in</strong> volume and <strong>in</strong>tracranialpressure, mak<strong>in</strong>g the situation worse.Sal<strong>in</strong>e vs Colloid vs DextroseThe bra<strong>in</strong> is surrounded by a membrane separat<strong>in</strong>g itfrom the vascular space - the blood-bra<strong>in</strong> barrier.This membrane will only allow water to pass throughit. Therefore only fluid with the sameconcentration of sodium as plasma should begiven <strong>in</strong>travenously. Otherwise, the plasma willbecome more dilute and water will pass from it <strong>in</strong>tothe bra<strong>in</strong>, mak<strong>in</strong>g the bra<strong>in</strong> swell, and thus <strong>in</strong>creasepressure further.Normal Sal<strong>in</strong>e (0.9%) has a similar concentration ofsodium and therefore is the fluid of choice for the bra<strong>in</strong>.Colloid can be given if required to treat hypovolaemiadue by major blood loss.When Dextrose solutions <strong>in</strong> water (5% Dextrose,Dextrose 4%-Sal<strong>in</strong>e 0.18%) are given, the dextroseis metabolised leav<strong>in</strong>g just the water or a very dilutesal<strong>in</strong>e solution. This “dilutes” the blood, reduc<strong>in</strong>g theconcentration of sodium <strong>in</strong> the plasma. The water thenpasses <strong>in</strong>to the bra<strong>in</strong> where the concentration ofsodium is higher. The bra<strong>in</strong> then swells, and <strong>in</strong>tracranialpressure will rise.Vasopressors As expla<strong>in</strong>ed, the blood pressuremust be raised quickly. Therefore a small dose ofcardiovascular stimulant drug can also be given<strong>in</strong>travenously to raise the blood pressure while the fluidis be<strong>in</strong>g run <strong>in</strong>. Suitable drugs <strong>in</strong>clude ephedr<strong>in</strong>e, 3-6mg, methoxam<strong>in</strong>e 1-2 mg, or adrenal<strong>in</strong>e 25-100 mcg.


54<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Teach<strong>in</strong>g po<strong>in</strong>tDifferent anaesthetic options dur<strong>in</strong>g transfer to theatreand <strong>in</strong> the CT scannerThe aim of the anaesthetist is the ma<strong>in</strong>tenance of thepatient <strong>in</strong> a physiologically stable state so that no furtherharm to the damaged bra<strong>in</strong> occurs. This means fulloxygenation with slight hypocapnia and withoutcough<strong>in</strong>g or stra<strong>in</strong><strong>in</strong>g (avoid<strong>in</strong>g cerebral venouscongestion). As an alternative to the techniquedescribed, many centres now use a propofol <strong>in</strong>fusion,2-6 mg/kg/h, by syr<strong>in</strong>ge pump which can be started <strong>in</strong>the accident department and cont<strong>in</strong>ued <strong>in</strong>to theatre. Athiopentone <strong>in</strong>fusion can be used, but is much moredifficult to manage because thiopentone is not rapidlymetabolised. Therefore it accumulates and can takedays to reverse.Importance of monitor<strong>in</strong>gIt is easy for the bra<strong>in</strong> to be damaged dur<strong>in</strong>g this period.Unnoticed hypotension, hypoxia or cough<strong>in</strong>g, whichcan occur unexpectedly and suddenly, can causeirreversible damage. Therefore close cl<strong>in</strong>ical monitor<strong>in</strong>gof the patient is crucial.CT scannerThe CT scanner is used to confirm the diagnosis andto guide the surgeon to where the bone flap should beraised. A short emergency scan is carried out caus<strong>in</strong>gthe m<strong>in</strong>imum of delay to the start of surgery (figure 3).CT scann<strong>in</strong>g is not available <strong>in</strong> many centres, andtherefore the patient would be transferred directly totheatre by the anaesthetist for <strong>in</strong>itial burr holes to becarried out <strong>in</strong> the temporal region on the side of thedilated pupil.TheatreThere is a wide range of anaesthetic drugs and hencetechniques available. <strong>Anaesthesia</strong> may be ma<strong>in</strong>ta<strong>in</strong>ed withan <strong>in</strong>halational agent - isoflurane would be the first choiceand halothane the second choice. If only ether is availablethen use ether. If available, <strong>in</strong>crements of morph<strong>in</strong>e,pethid<strong>in</strong>e or preferably fentanyl should be used as narcoticsreduce the risk of cough<strong>in</strong>g and the concentration of<strong>in</strong>halational agent required. Neuromuscular blockade isma<strong>in</strong>ta<strong>in</strong>ed with non-depolaris<strong>in</strong>g muscle relaxants, to avoidcough<strong>in</strong>g and stra<strong>in</strong><strong>in</strong>g with the m<strong>in</strong>imum concentration ofthe <strong>in</strong>halational agent required. However, if no long act<strong>in</strong>gmuscle relaxant is available then cont<strong>in</strong>ue with <strong>in</strong>termittentpositive pressure ventilation us<strong>in</strong>g the <strong>in</strong>halational agent tosuppress normal ventilation. In some units where propofolis available, anaesthesia can be ma<strong>in</strong>ta<strong>in</strong>ed with a propofol<strong>in</strong>fusion (2-6 mg/kg/hour), oxygen enriched air, and small<strong>in</strong>crements of narcotics. The <strong>in</strong>fusion rate is adjusted toensure that the blood pressure does not fall.The circulation is monitored by observ<strong>in</strong>g the peripheralcirculation, pulse rate, blood pressure and ur<strong>in</strong>e output.Blood pressure should be monitored either <strong>in</strong>vasively orfrequently with a cuff. Cont<strong>in</strong>uous measurement of thepatient’s blood pressure is very helpful as it allows bloodpressure changes to be treated accurately and efficiently.Do not delay surgery to <strong>in</strong>sert an arterial l<strong>in</strong>e. Howeverthere is usually time dur<strong>in</strong>g preparation of the patient toattempt radial artery cannulation. If this proves difficultthen a cannula can be put <strong>in</strong>to the femoral artery to providemonitor<strong>in</strong>g for the duration of surgery.Teach<strong>in</strong>g po<strong>in</strong>tHypertension <strong>in</strong> theatreA systolic blood pressure of 180 mmHg, may appearto be high for a 30 year old man, but it is vital until theclot has been removed. This is because the body hasraised the blood pressure to overcome the high<strong>in</strong>tracranial pressure. Therefore do not allow the bloodpressure to fall below this level.In contrast, if the blood pressure rises to more than200 mmHg systolic, this <strong>in</strong>dicates <strong>in</strong>sufficient depth ofanaesthesia. Treat this with a small <strong>in</strong>crease <strong>in</strong>concentration of <strong>in</strong>halational agent or propofol <strong>in</strong>fusionrate and a further dose of narcotic until the mean arterialblood pressure falls to 140 mmHg (correspond<strong>in</strong>gapproximately to a systolic arterial pressure 180mmHg).Hypotension <strong>in</strong> theatreNote that high concentrations of <strong>in</strong>halational agentscause cerebral vasodilatation, <strong>in</strong>creas<strong>in</strong>g cerebral bloodvolume and thus cerebral swell<strong>in</strong>g. This worsens thesituation by caus<strong>in</strong>g a further rise <strong>in</strong> <strong>in</strong>tracranialpressure. In addition higher concentrations may causea fall <strong>in</strong> blood pressure. The comb<strong>in</strong>ation of high ICPand low BP would severely reduce cerebral perfusionand should be treated quickly with <strong>in</strong>travenous fluids,vasopressors and a reduction <strong>in</strong> the concentration ofvolatile agent.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 55OperationAt operation, a large clot is found under high pressure.Once released, the blood pressure falls to normal levels.The bleed<strong>in</strong>g po<strong>in</strong>t is identified and secured. The bra<strong>in</strong>which was compressed, is pulsat<strong>in</strong>g with each heart beatand respiration. If an Intensive Care (ICU) bed is availableand it is decided to ventilate the patient for a periodpostoperatively, an ICP monitor is <strong>in</strong>serted. As describedbelow, a catheter is <strong>in</strong>serted subdurally and connected toan arterial transducer.Postoperative careThe patient is now taken to ICU to allow the anaestheticdrugs to wear off with an <strong>in</strong>tracranial pressure monitor <strong>in</strong>situ. After some hours he is open<strong>in</strong>g his eyes, cough<strong>in</strong>g onthe ET tube and breath<strong>in</strong>g well. His ICP is 12 mmHg andhe is allowed to wake up and is extubated.An <strong>in</strong>expensive ICP monitorIf an arterial pressure transducer is available this can bedone simply with a neonatal umbilical catheter. The catheteris <strong>in</strong>serted either subdurally or <strong>in</strong>traventricularly and filledwith sal<strong>in</strong>e by the surgeon. A 1-2 cm subcutaneous tunnelis formed to reduce the risk of the catheter be<strong>in</strong>g pulledout. Care must be taken to avoid k<strong>in</strong>k<strong>in</strong>g the catheter.Under aseptic conditions it is connected to a transducerwithout the usual pressure hepar<strong>in</strong> flush system. Adampened look<strong>in</strong>g pressure trace is seen with pressurefluctuations with each cardiac cycle. It will rise withcough<strong>in</strong>g and will be flat if it is blocked or ICP is veryhigh. It does not often block, but if this happens only thesurgical team should attempt to unblock it. Intraventricularcatheters are less likely to block but have greater risk of<strong>in</strong>fection, their use be<strong>in</strong>g limited to 5 daysConclusion1 The <strong>in</strong>itial assessment and resuscitation is vital andmust be carried out: a scheme is described.2 A method of anaesthesia is described based onsimple physiological and pharmacological pr<strong>in</strong>cipleswhich, when used, will reduce the risk of addeddamage.An unconscious patient with an extraduralhaematoma will die or be permanently severelydamaged unless treated quickly and correctly.Urgent surgical decompression is required. ItALONE is not enough. Attention to basic simplecl<strong>in</strong>ical details will prevent additional irreversibledamage occurr<strong>in</strong>g before the <strong>in</strong>tracranial pressurecan be reduced by releas<strong>in</strong>g the haematoma.Teach<strong>in</strong>g Po<strong>in</strong>tAt the end of surgery the anaesthetist should achievethe follow<strong>in</strong>g aims1 Prevent further damage from physiologicalfactors which will cause bra<strong>in</strong> swell<strong>in</strong>g.2 Observe the patient to detect anydeterioration.3 Provide adequate analgesia.Deterioration postoperatively may occur from bra<strong>in</strong>swell<strong>in</strong>g or accumulation of a further haematoma. Thebest method of detect<strong>in</strong>g any deterioration <strong>in</strong>neurological status postoperatively is observation ofthe conscious patient, look<strong>in</strong>g for a change <strong>in</strong> consciouslevel and new or changed neurological signs. Thereforewhen a simple haematoma without bruis<strong>in</strong>g or contusionto the bra<strong>in</strong> is removed early from an otherwise fitpatient who has no other trauma, as <strong>in</strong> this case, it isbetter to wake the patient up immediately after surgery.<strong>Anaesthesia</strong> is stopped and the patient extubated. Incontrast, when there is significant bra<strong>in</strong> contusion orother systems are damaged by the accident, wak<strong>in</strong>gand extubation are delayed if an ICU bed is available.ICU availableThe patient is taken to the ITU where ventilation andsedation are cont<strong>in</strong>ued. BP, pulse and ICP aremonitored. When the ICP rema<strong>in</strong>s normal, the patientis allowed to wake up and be extubated.ICU not available<strong>Anaesthesia</strong> is stopped <strong>in</strong> theatre and the patientallowed to wake up. Neuromuscular block is reversedand spontaneous respiration allowed to start.Extubation should be carried out when theendotracheal tube is seen to be irritat<strong>in</strong>g the trachea.Initially the patient lies <strong>in</strong> the recovery (lateral) positionuntil airway reflexes have returned. The patient is thensat up at about 30° to reduce cerebral venouscongestion. The patient should be given the best nurs<strong>in</strong>gcare that the hospital can provide with Glasgow ComaScore or AVPU record<strong>in</strong>gs started, recorded andrepeated at 15 m<strong>in</strong>ute <strong>in</strong>tervals. Any deterioration <strong>in</strong>conscious level or appearance of new neurologicalsigns is reported to the surgical team immediately.


56<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>NERVE BLOCKS FOR ANAESTHESIA AND ANALGESIA OF THE LOWERLIMB - A PRACTICAL GUIDE: Femoral, Lumbar plexus, SciaticDr Simon Morphett, Specialist Registrar <strong>in</strong> Anaesthetics, Derriford Hospital, Plymouth, UK.IntroductionThe purpose of this guide is to provide a detailed, step bystep description of how to safely and reliably perform nerveblocks for surgery and pa<strong>in</strong> relief on the lower limb, forthe non-specialist anaesthetic practitioner. It covers femoralnerve blockade, lumbar plexus blockade us<strong>in</strong>g the <strong>in</strong>gu<strong>in</strong>alparavascular approach and sciatic nerve blockade. Nodescription is given of more distal blocks, s<strong>in</strong>ce the majorityof the limb is readily anaesthetised with the techniquesdescribed and as a group they are relatively simple, reliableand commonly used.Conduct of nerve blocksIt is recommended that all blocks on major nerves becarried out on patients that are awake or only lightlysedated, as it is believed that this decreased the risk ofserious nerve damage, and will not hide the signs ofunexpected local anaesthetic toxicity. Sedated patients muststill be able to communicate with the operator dur<strong>in</strong>g thenerve block procedure. It is also recommended that a nervestimulator be used if one is available as this <strong>in</strong>creases thesuccess rate of the blocks especially <strong>in</strong> <strong>in</strong>experiencedhands.Local anaesthetic drugs and dosagesFor fast onset and short duration blocks, lignoca<strong>in</strong>e(maximum 4mg/kg) or lignoca<strong>in</strong>e with adrenal<strong>in</strong>e1:200,000 (6mg/kg) can be used. When <strong>in</strong>jected <strong>in</strong>to aplexus or near a large nerve such as the sciatic nerve theblock will come on at about 10-20 m<strong>in</strong>s and last for 4-8hours. The adrenal<strong>in</strong>e will prolong the block but maypossibly <strong>in</strong>crease the risk of nerve damage throughischaemia. Bupivaca<strong>in</strong>e <strong>in</strong> a maximum dose of 3mg/kg willgive a block of a major nerve that will start at 20-30 m<strong>in</strong>utesand last as long as 18 hours. There is no value <strong>in</strong> add<strong>in</strong>gadrenal<strong>in</strong>e to bupivaca<strong>in</strong>e except for local sk<strong>in</strong> <strong>in</strong>filtration.AnatomyThe nerve supply of the lower limb is derived from thelumbar and sacral plexuses, a network of nervescomposed of the anterior primary rami of all the lumbarand the first three sacral nerve roots (and sometimes witha contribution from the twelfth thoracic nerve root). Aris<strong>in</strong>gfrom these plexuses are the five ma<strong>in</strong> nerves that <strong>in</strong>nervatethe lower limb.The lumbar plexus: This gives rise to the femoral nerve,obturator nerve and lateral cutaneous nerve of the thigh.The femoral nerve runs <strong>in</strong> the groove between the psoasmajor and iliacus muscles, with a cover<strong>in</strong>g of these muscles’fascia. It enters the thigh pass<strong>in</strong>g under the <strong>in</strong>gu<strong>in</strong>alligament, where it is lateral to the femoral artery, whosepulsations are used to help locate the nerve. The femoralnerve block is performed at this po<strong>in</strong>t and there are twoimportant features of the anatomy. Firstly, below the <strong>in</strong>gu<strong>in</strong>alligament, the femoral nerve divides <strong>in</strong>to anterior andposterior branches, the anterior (superficial) branchsupply<strong>in</strong>g sensation to the sk<strong>in</strong> of the anterior and medialthigh and a posterior (deep) branch that supplies thequadriceps muscles, the medial knee jo<strong>in</strong>t, and the sk<strong>in</strong>on the medial side of the calf and foot (via the saphenousnerve). Therefore, the block should not be performedlower than just distal to the <strong>in</strong>gu<strong>in</strong>al ligament, <strong>in</strong> order notto miss one of the branches. Secondly, as it enters thethigh, the femoral nerve has two fascial layers cover<strong>in</strong>g it,the fascia lata and the fascia iliaca. This is <strong>in</strong> contrast tothe femoral artery, which is only covered by the fascia lataalone. This means that the nerve will lie <strong>in</strong> a different tissueplane than the artery and usually a little deeper. Thesecover<strong>in</strong>gs can be used <strong>in</strong> block<strong>in</strong>g the nerve. (Seetechniques).The lateral cutaneous nerve of the thigh and the obturatornerve both have important sensory distributions (to thethigh and knee). This article does not cover blocks of thesenerves as s<strong>in</strong>gle entities. However, they can readily beblocked <strong>in</strong> conjunction with the femoral nerve, us<strong>in</strong>g thesame technique, to produce a “3-<strong>in</strong>-1” block and this isdescribed later. (see Blockade of the lumbar plexus us<strong>in</strong>gthe <strong>in</strong>gu<strong>in</strong>al paravascular approach).The sacral plexus: This gives rise to the sciatic nerveand the posterior cutaneous nerve of the thigh. Althoughthese nerves are formed separately with<strong>in</strong> the plexus, theypass through the pelvis and buttock together and with thetechniques described here are blocked with the same<strong>in</strong>jection. Hence they are considered here as a s<strong>in</strong>gle nervetrunk, and unless specifically stated, “sciatic nerve” willrefer to both the sciatic nerve and the posterior cutaneousnerve of the thigh.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 57The sciatic nerve leaves the pelvis and enters the buttockthrough the greater sciatic foramen, and then passes slightlymedial to the midpo<strong>in</strong>t between the greater trochanter andthe ischial tuberosity, ly<strong>in</strong>g just posterior to the hip jo<strong>in</strong>t. Itcan be blocked at several po<strong>in</strong>ts along this course (seetechniques). The sciatic nerve leaves the buttock, pass<strong>in</strong>gout from under the lower border of gluteus maximus muscleand runs distally down the thigh to the popliteal fossa.Areas supplied by the <strong>in</strong>dividual nerves:A pictorial illustration of the sk<strong>in</strong> areas supplied is given <strong>in</strong>figure 1.Femoral nerve: supplies sk<strong>in</strong> over the anterior (front) ofthe thigh, the anterior knee, some of the medial (<strong>in</strong>ner)thigh, via the saphenous nerve it also supplies the anteromedialaspect of the calf down to and <strong>in</strong>clud<strong>in</strong>g the medialmalleolus. It has branches to the hip jo<strong>in</strong>t and knee jo<strong>in</strong>tand supplies much of the shaft of the femur. Sensation tothe medial aspect of the big toe may come from thesaphenous (femoral nerve).Lateral cutaneous nerve of the thigh: supplies sensationto the sk<strong>in</strong> over the lateral (outside) thigh, from the greatertrochanter to the knee, and on to the anterior thigh.Figure 1: Cutaneous nerve distribution of the lower limb.


58<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Obturator nerve: supplies a small, variable amount ofsk<strong>in</strong> on the medial aspect of the knee and lower thigh.More importantly, it has a branch to the knee jo<strong>in</strong>t. Thereis also a small branch to the hip jo<strong>in</strong>t.Posterior cutaneous nerve of the thigh: supplies sk<strong>in</strong>over the posterior (back) thigh, the popliteal fossa, thelower buttock and some of the genital area. Note that thisnerve is blocked with the posterior approaches and is oftenmissed with the anterior approach to the sciatic nerve.Sciatic nerve: via its branches supplies all the sk<strong>in</strong> of theleg below the knee and all the foot, except for the medialcalf and ankle, which is supplied by the saphenous (femoral)nerve. The sciatic nerve also has a small branch to the hipjo<strong>in</strong>t, a branch to the knee jo<strong>in</strong>t and fully <strong>in</strong>nervates theankle jo<strong>in</strong>t.Surface anatomy mark<strong>in</strong>gsWhen it comes to perform<strong>in</strong>g the nerve blocks, it is crucialto be able to palpate and accurately locate bony landmarks,s<strong>in</strong>ce these are the reference po<strong>in</strong>ts we use for determ<strong>in</strong><strong>in</strong>gthe correct site for needle <strong>in</strong>sertion. The follow<strong>in</strong>g is adescription of the bony landmarks used for femoral andsciatic nerve blocks. They are shown <strong>in</strong> the diagrams ofthe nerve block techniques.Anterior superior iliac sp<strong>in</strong>e follow<strong>in</strong>g the iliac crest (ridgeof the pelvic bones) from the flanks forwards, it ends <strong>in</strong> anobvious bony prom<strong>in</strong>ence, at the side of the lowerabdomen. This is the anterior superior iliac sp<strong>in</strong>e.Pubic tubercle is the bony prom<strong>in</strong>ence that can be felt atthe <strong>in</strong>ner (medial) end of the gro<strong>in</strong> crease. It is about 2 - 4cm from the midl<strong>in</strong>e, at the top of the genital area.Posterior superior iliac sp<strong>in</strong>e is the bony prom<strong>in</strong>ence atthe posterior end of the iliac crest. It is directly caudal tothe “sacral dimple”- that depression <strong>in</strong> the sk<strong>in</strong> visible cranialto (above) the buttocks, on each side, close to the midl<strong>in</strong>e.Greater trochanter this bony landmark is part of thelateral femur, just below the hip jo<strong>in</strong>t. It is easy to f<strong>in</strong>d atthe top of the thigh, protrud<strong>in</strong>g directly laterally. With thepatient on their side, it represents the highest po<strong>in</strong>t on theupper thigh. In obese patients try <strong>in</strong>ternally and externallyrotat<strong>in</strong>g the hip, as this makes the greater trochanter morevisible.The sacral cornu are two bony prom<strong>in</strong>ences either sideof the midl<strong>in</strong>e just at the top end of the natal cleft. One canreadily palpate a narrow depression between them - thesacral hiatus. (see figure 3)The ischial tuberosity is that part of the pelvic bonestructure that can be felt posteriorly, on the medial side ofthe base of the buttock. It is the bony structure that we“sit on.”Indications for specific nerve blocksFrom the outl<strong>in</strong>e of the areas covered by each nerve, thereader should know which blocks would be useful <strong>in</strong> agiven situation. Two po<strong>in</strong>ts are worth emphasis<strong>in</strong>g. Theknee jo<strong>in</strong>t has significant contributions from femoral,obturator and sciatic nerves and significant <strong>in</strong>jury or surgeryto this jo<strong>in</strong>t will require that all these be blocked. (For thehip, it is nearly always sufficient to perform a 3-<strong>in</strong>-1 lumbarplexus block even though there is a small contribution fromthe sciatic nerve.) Secondly, the area covered by thedifferent nerves may vary considerably and if <strong>in</strong> doubt, itis best to block both ma<strong>in</strong> nerve trunks.The follow<strong>in</strong>g are some examples of the possible uses.Femoral nerve blocks: operations on the anterior thigh, such as repairof large lacerations. pa<strong>in</strong> relief for fractures of the shaft of thefemur, particularly more proximal fractures.Lumbar plexus (3-<strong>in</strong>-1) block: all the uses of a femoral nerve block, plus thefollow<strong>in</strong>g:pa<strong>in</strong> relief and anaesthesia for hip <strong>in</strong>juries suchas dislocations and fractures of the neck ofthe femur. (Major hip surgery will also requirea sciatic nerve block.)anaesthesia for operations on the lateral thighsuch as harvest<strong>in</strong>g of sk<strong>in</strong> grafts, or musclebiopsies.pa<strong>in</strong> relief for <strong>in</strong>juries and operations on theknee; extensive <strong>in</strong>juries and full kneeanaesthesia require a sciatic nerve block also this block extends the field of a simple femoralnerve block considerably and is no moredifficult to perform.Sciatic nerve block:pa<strong>in</strong> relief or anaesthesia for <strong>in</strong>juries oroperations on the sole of the foot or any ofthe toes, such as toe amputation (amputationof the big toe may require supplementationat the medial maleolus as well, because the


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 59distribution of the saphenous nerveoccasionally extends down the medial sideof the big toe). the distribution of the sciatic nerve means thatit has fairly limited application as a block onits own and is most often comb<strong>in</strong>ed with afemoral or 3-<strong>in</strong>-1 block.Comb<strong>in</strong>ed sciatic and femoral or 3-<strong>in</strong>-1 block: with this comb<strong>in</strong>ation pa<strong>in</strong> relief andanaesthesia can be provided for almost any<strong>in</strong>jury or operation from the upper thighdownwards.one area sometimes not covered is the upper,<strong>in</strong>ner thigh, and possibly the posterior thigh.This may be a problem with tourniquetsapplied high on the leg and <strong>in</strong> this situationsome supplementary parenteral analgesia orsedation can be useful. it may be difficult to provide adequateanaesthesia for major hip surgery, althoughthe blocks described will provide goodpostoperative analgesia.Plann<strong>in</strong>g the dose of local anaesthetic and deal<strong>in</strong>g withpossible side effectsThe above discussion will <strong>in</strong>dicate that there are oftensituations <strong>in</strong> which one wishes to perform a comb<strong>in</strong>ed sciaticand 3-<strong>in</strong>-1 block at the same time. This will necessitateus<strong>in</strong>g large volumes of local anaesthetic and the total doseadm<strong>in</strong>istered may often be at the limit of recommendedsafe doses. It is important to be able to adjust theconcentration of the solution <strong>in</strong>jected when us<strong>in</strong>g largevolumes, <strong>in</strong> order to keep the total dose at an acceptablelevel. See local anaesthetic, drugs and dosage page 56.Local complications of local anaesthetic blocks:The most important is damage to the nerve. Permanentnerve damage is very rare. It may be caused by accidentally<strong>in</strong>ject<strong>in</strong>g local anaesthetic with<strong>in</strong> the nerve itself (<strong>in</strong>traneural)or by traumatis<strong>in</strong>g the nerve with the needle po<strong>in</strong>t. Twosigns of <strong>in</strong>traneural <strong>in</strong>jection are severe pa<strong>in</strong> on attempted<strong>in</strong>jection and marked resistance to <strong>in</strong>jection. (For thepatient to respond to the pa<strong>in</strong> of <strong>in</strong>traneural <strong>in</strong>jection he orshe must be awake, or only slightly sedated.) Either ofthese warn<strong>in</strong>g signs should prompt the operator to stop<strong>in</strong>ject<strong>in</strong>g and reposition the needle. Intraneural <strong>in</strong>jectionmay also be less likely if a short-bevel needle is used 1 .Paraesthesia is the “electric shock-like” feel<strong>in</strong>g felt as thenerve is touched by the needle. It should be a warn<strong>in</strong>gsign that nerve damage may occur if the needle is <strong>in</strong>sertedfurther.It is also possible to cause a haematoma by punctur<strong>in</strong>g anartery with the needle - most commonly this will be thefemoral artery. This is rarely of any significance. If thefemoral artery is punctured then firm pressure applied tothe site for 5 m<strong>in</strong>utes will m<strong>in</strong>imise the haematoma.Perform<strong>in</strong>g the nerve blocks - patient preparationand techniquesWhen perform<strong>in</strong>g any of the blocks that are describedhere, the steps taken to safely prepare the patient shouldbe carefully followed.Prepar<strong>in</strong>g the patient Consent - expla<strong>in</strong> the entire procedure to thepatient. This will help to relieve any anxiety and<strong>in</strong>crease co-operation.Fast<strong>in</strong>g - if an elective procedure is planned, thenthe patient should be fasted similar to hav<strong>in</strong>g a generalanaesthetic. This <strong>in</strong>creases safety <strong>in</strong> the event that ageneral anaesthetic or resuscitation is required.Monitor<strong>in</strong>g - the potential complications described<strong>in</strong> the preced<strong>in</strong>g section mean that monitor<strong>in</strong>g isessential. If available, ECG and blood pressuremonitor<strong>in</strong>g should be used. If sedation is plannedthen a pulse oximeter should also be used. In everycase, the most useful monitor is to ma<strong>in</strong>ta<strong>in</strong> careful,cont<strong>in</strong>uous observation of the patient throughout.An assistant can be <strong>in</strong>valuable <strong>in</strong> help<strong>in</strong>g with this.Intravenous access - because of the possiblecomplications, should be <strong>in</strong>travenous accesssecured before any block is performed. This alsoallows adm<strong>in</strong>istration of <strong>in</strong>travenous fluids, sedativeagents and resuscitation drugs if required.Position<strong>in</strong>g - take care with position<strong>in</strong>g the patientfor the block and make sure they are ascomfortable as possible as this will make the blockeasier to perform.Identify the bony landmarks - these aredescribed <strong>in</strong> the anatomy section.Clean the site - the sk<strong>in</strong> over the block site shouldbe cleaned with an antiseptic agent and surroundedwith sterile drapes. The operator should wash theirhands and wear sterile gloves.Perform the block!


60<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> Allow time for the local anaesthetic to takeeffect - at least 15 - 20 m<strong>in</strong>utes will be required forsurgical anaesthesia.With the weaker concentrationsof bupivaca<strong>in</strong>e, 30 - 45 m<strong>in</strong>utes may be required.TechniquesThe femoral nerve and lumbar plexusAnatomy The femoral nerve has contributions from thesecond, third and fourth lumbar nerves. It is derived fromthe lumbar plexus and <strong>in</strong> fact lies with<strong>in</strong> the same fascialenvelope as the lumbar plexus. This important fact maybe utilised to block most of the nerves orig<strong>in</strong>at<strong>in</strong>g <strong>in</strong> thelumbar plexus with a s<strong>in</strong>gle <strong>in</strong>jection distally, as localanaesthetic can be made to spread proximally with<strong>in</strong> thisplane. (See anatomy)Technique (figure 2) The patient lies sup<strong>in</strong>e with the legextended, ly<strong>in</strong>g flat on the bed. The operator stands onthe side of the patient that is to be blocked. Firstly, identifythe po<strong>in</strong>t of <strong>in</strong>jection, us<strong>in</strong>g the surface landmarks. For thefemoral nerve, this is just below (distal to) the <strong>in</strong>gu<strong>in</strong>alligament. Palpate both the anterior superior iliac sp<strong>in</strong>e andthe pubic tubercle. The l<strong>in</strong>e between these two overliesthe <strong>in</strong>gu<strong>in</strong>al ligament. It is often helpful to draw the l<strong>in</strong>esthat are described on the sk<strong>in</strong>. The femoral artery shouldlie at the midpo<strong>in</strong>t of the <strong>in</strong>gu<strong>in</strong>al ligament and it is necessaryto locate this by feel<strong>in</strong>g for the pulse at this po<strong>in</strong>t. The sitefor <strong>in</strong>jection is 1cm lateral to (outside of) the pulsations ofthe femoral artery and 1 - 2cm below (distal to) the l<strong>in</strong>e ofthe <strong>in</strong>gu<strong>in</strong>al ligament. Hav<strong>in</strong>g identified the site, it will bemore comfortable for the patient if a small amount of localanaesthetic is used to create a sk<strong>in</strong> wheal (“bleb”) at the<strong>in</strong>jection po<strong>in</strong>t.An ord<strong>in</strong>ary needle of length 3 - 4 cm and 21 - 23g <strong>in</strong>width is suitable for perform<strong>in</strong>g this block. It should be<strong>in</strong>serted perpendicular to the sk<strong>in</strong>, but aim<strong>in</strong>g slightlytowards the head of the patient.The follow<strong>in</strong>g are two ways of carry<strong>in</strong>g out the block. Inthe first technique, the operator attempts to locate the nerveby elicit<strong>in</strong>g paraesthesiae, or fail<strong>in</strong>g this by deposit<strong>in</strong>g thelocal anaesthetic over a range of areas (the classicaltechnique of Labat 5 ). In the second technique, use is madeof the fascial layers overly<strong>in</strong>g the nerve and a s<strong>in</strong>gle <strong>in</strong>jectiononly is employed (Khoo and Brown 2 ). In both cases, it isvery important to remember the anatomy. The femoralnerve lies adjacent to but slightly deeper than the structuresconta<strong>in</strong>ed with<strong>in</strong> the femoral sheath (the artery, ve<strong>in</strong> andfemoral canal). This is because the nerve lies deep to thefascia iliaca, while the contents of the femoral sheath lie ontop of it.Figure 2: Left - Site of <strong>in</strong>jection for femoral nerve block. Right - Transverse section.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 61The classical approach The needle is advancedthrough the sk<strong>in</strong>, as described above, until the patientfeels paraesthesiae <strong>in</strong> the distribution of the femoralnerve. If a depth of 4 - 5cm is reached and noparaesthesiae are found, then it should be withdrawnto just below the sk<strong>in</strong> and advanced aga<strong>in</strong> <strong>in</strong> a slightlymedial or lateral direction, repeat<strong>in</strong>g this until thepatient feels paraesthesiae. Once this occurs, the needleshould be fixed <strong>in</strong> position with one hand, rest<strong>in</strong>g thishand on the patient to try and m<strong>in</strong>imise movement.With the other hand, the syr<strong>in</strong>ge conta<strong>in</strong><strong>in</strong>g localanaesthetic is then connected to the needle and gentleaspiration performed. If no blood is seen then 15 - 20mls of local anaesthetic is <strong>in</strong>jected (aspirat<strong>in</strong>g aga<strong>in</strong>regularly to check for the presence of blood).The presence of paraesthesiae is the best <strong>in</strong>dicator forcorrect position<strong>in</strong>g of the tip of the needle, but it is oftennot easy or even possible to locate the femoral nerve <strong>in</strong>this manner.Alternatively as the needle is advanced alongside theartery, its pulsations may cause lateral (side to side)movement of the hub of the needle. If this is the case,the needle is slowly advanced and frequentobservations made until the po<strong>in</strong>t is reached when thelateral movements are at their greatest. This generallyrepresents a depth where the tip of the needle is justdeep to the artery and should be <strong>in</strong> the correct plane.The needle is then fixed, the syr<strong>in</strong>ge connected andaspiration performed as before. However, only 10 mlof local anaesthetic is <strong>in</strong>jected at this site. This <strong>in</strong>jectionis then supplemented by withdraw<strong>in</strong>g the needleslightly redirect<strong>in</strong>g the tip outwards (laterally),<strong>in</strong>sert<strong>in</strong>g to the same depth as before and <strong>in</strong>ject<strong>in</strong>g 3 -4 mls of local anaesthetic (after aspiration). Thisprocess is repeated 2 or 3 times, mov<strong>in</strong>g progressivelyfurther laterally, such that a total of 20 - 25mls of localanaesthetic is deposited <strong>in</strong> a “fan-shaped” area lateraland deep to the femoral artery.The s<strong>in</strong>gle <strong>in</strong>jection technique 2 This method has thevirtue of simplicity and generally <strong>in</strong>volves less prob<strong>in</strong>g withthe needle. For this reason it is popular but requires somepractice for a high success rate.The site for <strong>in</strong>jection is the same as already described.However, the needle is <strong>in</strong>serted directly perpendicular tothe sk<strong>in</strong>. If the needle is held gently between thumb andforef<strong>in</strong>ger, then a slight resistance is encountered at thefascia lata, followed by a def<strong>in</strong>ite loss of resistance, or“pop” as the needle penetrates this layer. The same th<strong>in</strong>gis felt as the needle penetrates the fascia iliaca and comes<strong>in</strong>to the proximity of the femoral nerve. Therefore,immediately on feel<strong>in</strong>g this second loss of resistance, or“pop”, the tip of the needle should be <strong>in</strong> the correct position.The needle is then fixed <strong>in</strong> position with one hand, theother hand aga<strong>in</strong> be<strong>in</strong>g used to connect a syr<strong>in</strong>ge, aspirateto check for blood and <strong>in</strong>ject 20 ml of local anaesthetic.This technique is entirely dependent on be<strong>in</strong>g able to detectthe two po<strong>in</strong>ts of loss of resistance as each of the fasciallayers is penetrated. This is much easier if a short-bevelneedle is available to use, as it does not pierce the fasciaquite as easily as an ord<strong>in</strong>ary needle, mak<strong>in</strong>g the feel ofthe layers more obvious. If a short-bevel needle is notavailable, then the same effect can be achieved us<strong>in</strong>g anord<strong>in</strong>ary needle but blunt<strong>in</strong>g it prior to <strong>in</strong>sertion. The“blunt<strong>in</strong>g” may be cleanly achieved by pierc<strong>in</strong>g the side ofthe protective plastic sheath (that comes with the needle)several times with the needle tip before perform<strong>in</strong>g theblock. The detection of paraesthesiae is not to berecommended when us<strong>in</strong>g this technique as the “blunted”needle is more likely to cause nerve damage.Use of a nerve stimulator If an <strong>in</strong>sulated stimulat<strong>in</strong>gneedle is available for use, then it is necessary to obta<strong>in</strong>contraction of the quadriceps muscle group. This is mostreliably seen by movement of the patella and extension ofthe knee jo<strong>in</strong>t. (The movement of the knee is not normallyobvious, as the patient’s leg is usually flat on the bed andfully extended anyway.) The contractions should still bevisible at a stimulat<strong>in</strong>g current of 0.3 - 0.5 mA <strong>in</strong>dicat<strong>in</strong>gadequate proximity to the nerve. Exactly the sametechnique will be used if one wishes to perform a lumbarplexus block us<strong>in</strong>g this approach.Blockade of the lumbar plexus us<strong>in</strong>g the <strong>in</strong>gu<strong>in</strong>alparavascular approachThis technique is also referred to as the “W<strong>in</strong>nie 3-<strong>in</strong>-1block” after the author who first described it 3 . It is so called,because it aims to block three nerves with the one <strong>in</strong>jection:the femoral nerve, the lateral cutaneous nerve of the thighand the obturator nerve.Anatomy For most operations on the thigh and knee it isnot sufficient to block the femoral nerve alone. The lateralcutaneous nerve of the thigh supplies all the outside of thethigh and the obturator nerve supplies a variable amountof sk<strong>in</strong> on the <strong>in</strong>ner thigh just above the knee andcontributes to the <strong>in</strong>nervation of the knee jo<strong>in</strong>t.All three nerves are derived from the lumbar plexus. Theplexus lies on the quadratus lumborum muscle and beh<strong>in</strong>d


62<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>the psoas major muscle and is <strong>in</strong>vested <strong>in</strong> a fascialsheath derived from these two muscles. This sheathforms a cont<strong>in</strong>uous cover<strong>in</strong>g around the plexus,extend<strong>in</strong>g down to the femoral nerve just below the<strong>in</strong>gu<strong>in</strong>al ligament. Therefore if local anaesthetic<strong>in</strong>jected around the femoral nerve at the <strong>in</strong>gu<strong>in</strong>alligament can be made to spread proximally, then theother two nerves can be simultaneously blocked at theirorig<strong>in</strong>s from the lumbar plexus.Technique The <strong>in</strong>jection po<strong>in</strong>t and method for correctneedle placement are exactly as described for the femoralnerve. It is most practical to use the s<strong>in</strong>gle <strong>in</strong>jectiontechnique, as this will enable placement of the large volumesrequired.There are two differences; the ma<strong>in</strong> difference comes withthe actual <strong>in</strong>jection of the local anaesthetic. Hav<strong>in</strong>g aspiratedon the needle to check that the tip is not <strong>in</strong>travascular, thehand is then moved to apply firm pressure on the thigh(with the thumb) about 2 - 4 cm. below the <strong>in</strong>sertion po<strong>in</strong>tof the needle. The <strong>in</strong>jection is then performed, all the whilema<strong>in</strong>ta<strong>in</strong><strong>in</strong>g the pressure. The pressure can be releasedabout thirty seconds after the <strong>in</strong>jection has been completed.(The <strong>in</strong>jection will require an assistant, as the operator willhave one hand immobilis<strong>in</strong>g the needle and the otherapply<strong>in</strong>g pressure.) This procedure encourages spread ofthe local anaesthetic upwards, towards the lumbar nerveroots.The second difference is that larger volumes of localanaesthetic are used to achieve the necessary spread. Them<strong>in</strong>imum volume to block all three nerves is 20 mls.However, many texts suggest larger volumes such as 25 -30 mls. When us<strong>in</strong>g these volumes, particularly <strong>in</strong>comb<strong>in</strong>ation with a sciatic nerve block, it may be necessaryto dilute the concentration of local anaesthetic solution used<strong>in</strong> order to limit the total dose given.Use of a nerve stimulator: as for the femoral nerve.The Sciatic NerveAnatomy The sciatic nerve is the largest nerve <strong>in</strong> the body,measur<strong>in</strong>g about 2 centimetres <strong>in</strong> thickness <strong>in</strong> its proximalportion. In this portion it is actually made up of the sciaticnerve and the posterior cutaneous nerve of the thigh. This“double nerve” conta<strong>in</strong>s contributions from lumbar nerveroots 4 and 5 and sacral nerve roots 1,2 and 3. In thetechniques that are described here, this large “doublenerve” is considered effectively as a s<strong>in</strong>gle nerve andblocked with the one <strong>in</strong>jection. For simplicity, it is referredto just as the sciatic nerve.The important bony landmarks that one needs to be ableto identify for block<strong>in</strong>g the sciatic nerve via the twoposterior approaches described are the greater trochanter,posterior superior iliac sp<strong>in</strong>e, the ischial tuberosity andthe sacral hiatus. For the anterior approach, thelandmarks are the anterior superior iliac sp<strong>in</strong>e and thepubic symphysis on the pelvis and the greatertrochanter on the femur.Technique It will be appreciated from the descriptionof these landmarks that there are several possible routesto block the sciatic nerve. Three of the most commonapproaches are described here. The first is the classicalposterior approach of Labat 5 performed with the patient<strong>in</strong> the lateral position. The second is another posteriorapproach, but the patient is sup<strong>in</strong>e and the leg is flexed atthe hip and at the knee. F<strong>in</strong>ally, the anterior approach isdescribed where the patient is sup<strong>in</strong>e with the legs ly<strong>in</strong>gnaturally extended. The choice of technique will to someextent be <strong>in</strong>fluenced by the position that is easiest for thepatient to assume. However, the success rate is higherwith the posterior approaches unless a nerve stimulator isused 4 . Furthermore, the anterior technique tends to betechnically more difficult 4 and therefore it is suggested thatevery effort should be made to position the patient for oneof the posterior approaches.Posterior approach of Labat 5 (figure 3) The patient isfirst placed <strong>in</strong> the lateral position with the side to be blockeduppermost. While the lower leg is kept straight, the upperleg is flexed at the knee so that the ankle is brought overthe knee of the lower leg. Another way of achiev<strong>in</strong>g thecorrect degree of hip and knee flexion is to have theposterior superior iliac sp<strong>in</strong>e, the greater trochanter andthe knee <strong>in</strong> a straight l<strong>in</strong>e.The po<strong>in</strong>t of <strong>in</strong>jection is identified as follows:A l<strong>in</strong>e is drawn between the greater trochanter and theposterior superior iliac sp<strong>in</strong>e (the l<strong>in</strong>e lies approximatelyover the upper border of the piriformis muscle). From themidpo<strong>in</strong>t of this l<strong>in</strong>e, at right angles to it, draw a secondl<strong>in</strong>e pass<strong>in</strong>g down over the buttock. The po<strong>in</strong>t of <strong>in</strong>jectionis 3 - 5 centimetres along this perpendicular l<strong>in</strong>e. It can bemore precisely identified by draw<strong>in</strong>g a third l<strong>in</strong>e betweenthe greater trochanter and sacral hiatus, the po<strong>in</strong>t of<strong>in</strong>jection be<strong>in</strong>g where this third l<strong>in</strong>e <strong>in</strong>tersects with thesecond, perpendicular l<strong>in</strong>e. Hav<strong>in</strong>g identified this po<strong>in</strong>t,place a small wheal of local anaesthetic at the site.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 63Figure 3: Anatomical landmarks for Labat’s technique for sciatic nerve blockThe needle that is required for this block needs to bequite long. A standard adult lumbar puncture needle isusually sufficient (9cm, 22G). In a very large person,an extra long needle, (10 - 12cm) may make thelocation of the nerve an easier task.The needle is <strong>in</strong>serted perpendicular to the sk<strong>in</strong> andslowly advanced until either bone is encountered, orparaesthesiae are elicited. (For the block to besuccessful, paraesthesiae below the knee should befelt.) If bone is encountered, the needle is withdrawnapproximately 1-3cm and redirected slightly, eithermedially or laterally. Gentle prob<strong>in</strong>g with<strong>in</strong> this s<strong>in</strong>gle(transverse) plane should enable the nerve to be locatedby produc<strong>in</strong>g paraesthesiae as described. If the needlehas been <strong>in</strong>serted as far as possible and neitherparaesthesiae elicited nor bone encountered then thetip may have entered the greater sciatic notch. Shouldthis occur, then the needle should be withdrawn almostfully, until the tip is just beneath the sk<strong>in</strong> and thenredirected <strong>in</strong> a slightly medial or lateral plane as describedabove.Hav<strong>in</strong>g located the nerve by paraesthesiae, the needleshould be fixed <strong>in</strong> position and a syr<strong>in</strong>ge conta<strong>in</strong><strong>in</strong>gapproximately 20ml of local anaesthetic connected.Aspiration is performed to exclude <strong>in</strong>travascular placementof the needle and the local anaesthetic is then <strong>in</strong>jected.Repeat aspiration half way through the <strong>in</strong>jection, <strong>in</strong> casethe tip of the needle has moved). It is important that ifsevere pa<strong>in</strong> occurs or if there is significant resistance to<strong>in</strong>jection then the operator should stop immediatelyand reposition the needle, as these may be signs of<strong>in</strong>traneural <strong>in</strong>jection.Alternative posterior approach (of Raj) If it is notpossible to have the patient ly<strong>in</strong>g on their side, then avariation of the posterior approach may be performed withthe patient sup<strong>in</strong>e, although the hip is still manipulated.To perform this block, the operator stands by the patient’sbed, on the side to be blocked. The hip is then flexed asmuch as possible with knee bent. This position can beheld stable by brac<strong>in</strong>g the foot aga<strong>in</strong>st the front of theoperator’s shoulder as they face towards the head of thebed. Alternatively, an assistant can hold the leg steady.The greater trochanter is palpated on the outside of theleg and the ischial tuberosity is also located, be<strong>in</strong>g the ma<strong>in</strong>prom<strong>in</strong>ence at the base of the buttock. It is often possible


64<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>to palpate these two bony protuberances at the sametime us<strong>in</strong>g the thumb and middle f<strong>in</strong>ger of the samehand. The midpo<strong>in</strong>t between these two landmarks isthe <strong>in</strong>jection po<strong>in</strong>t. It is sometimes possible to identifythis l<strong>in</strong>e jo<strong>in</strong><strong>in</strong>g the greater trochanter and ischialtuberosity as a depression between two muscle bellies- semitend<strong>in</strong>osus and biceps femoris.Hav<strong>in</strong>g located the <strong>in</strong>jection po<strong>in</strong>t a small sk<strong>in</strong> wheal israised and the same needle as above is <strong>in</strong>serted at rightangles to the sk<strong>in</strong>. Once aga<strong>in</strong> the aim is to elicitparaesthesiae below the knee and this is achieved exactlyas described above - by gentle prob<strong>in</strong>g <strong>in</strong> the transverse(“side to side”) plane. The sciatic nerve is most likely to lieslightly medial to the path of the needle if these landmarksare used. The <strong>in</strong>jection of local anaesthetic is then alsoperformed <strong>in</strong> exactly the same manner as for the classicaltechnique of Labat.It should be noted that this alternative approach wouldblock the sciatic nerve several centimetres more distallythan the first approach described. However, it is rare tomiss the posterior cutaneous nerve of the thigh, even withthe alternative approach.Anterior approach to the sciatic nerve Occasionally,it will be not be possible to move the patient’s leg fromthe neutral position with them ly<strong>in</strong>g sup<strong>in</strong>e. In thiscase a sciatic nerve block can be performed us<strong>in</strong>g ananterior approach although as already stated, this tendsto be more of a technical challenge! This techniquewill also result <strong>in</strong> the sciatic nerve be<strong>in</strong>g blocked at arelatively distal po<strong>in</strong>t (just beyond the hip jo<strong>in</strong>t) andhence it is possible to miss the posterior cutaneousnerve of the thigh, which becomes separated from thesciatic nerve by the hamstr<strong>in</strong>g muscles just below thebuttock.The landmarks for the po<strong>in</strong>t of <strong>in</strong>jection are as follows:(see figure 4) firstly, trace a l<strong>in</strong>e over the <strong>in</strong>gu<strong>in</strong>al ligament(from the anterior superior iliac sp<strong>in</strong>e to the pubic tubercle)and divide it <strong>in</strong>to thirds. From the junction of the <strong>in</strong>ner andmiddle thirds draw another l<strong>in</strong>e at right angles to the first,go<strong>in</strong>g down the leg. The next step is to f<strong>in</strong>d the greatertrochanter and from this draw another l<strong>in</strong>e parallel to thel<strong>in</strong>e over the <strong>in</strong>gu<strong>in</strong>al ligament (the first l<strong>in</strong>e drawn). Wherethis last l<strong>in</strong>e crosses the perpendicular l<strong>in</strong>e (the secondl<strong>in</strong>e) is the po<strong>in</strong>t of <strong>in</strong>jection. A small sk<strong>in</strong> wheal of localanaesthetic is then <strong>in</strong>jected at this site.The needle used for this block is a standard adult lumbarFigure 4: Landmarks for the anterior approach to the sciatic nerve.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 65puncture needle (9 cm long). However, the depth of<strong>in</strong>sertion required for this block is commonly greater thanfor the posterior approaches and a longer needle is oftenrequired.The needle is then <strong>in</strong>serted perpendicular to the sk<strong>in</strong>, whichmeans aim<strong>in</strong>g <strong>in</strong> a slightly lateral direction. The operatorshould aim to strike bone, close to the medial edge of thefemur. This will be at about the level of the lesser trochanter.The needle is then withdrawn slightly, redirected moremedially (it should be more towards the vertical) andadvanced, this be<strong>in</strong>g repeated until the needle is “walkedoff” the bone, the aim be<strong>in</strong>g to just slip past the medialedge of the femur. The operator should note the depth atwhich the needle <strong>in</strong>itially strikes the femur. Normally this isdone by carefully observ<strong>in</strong>g the portion of needle shaftrema<strong>in</strong><strong>in</strong>g at the sk<strong>in</strong>. Once the needle has been directedoff the bone, as described above, it should be <strong>in</strong>serted afurther 5 cm (2 <strong>in</strong>ches). The tip of the needle should nowbe <strong>in</strong> the region of the neuromuscular bundle. (Seefigure 5)Aspiration to check for <strong>in</strong>travascular needle placement isparticularly important if this approach is used, as there is ahigher likelihood of vascular puncture. Hav<strong>in</strong>g aspirated,the needle is immobilised <strong>in</strong> the usual fashion andapproximately 20 ml of local anaesthetic <strong>in</strong>jected.If there is resistance to <strong>in</strong>jection, then the tip of the needlemay still be with<strong>in</strong> muscle substance. If this occurs thenthe needle should be slowly advanced until <strong>in</strong>jectionis easily accomplished.This technique does not require that paraesthesiae arefound, but if they are elicited this is a positive sign of correctneedle placement.If one wishes to be positive about the needle placementand it is not possible to elicit paraesthesiae us<strong>in</strong>g the anteriorapproach as just described, then it is sometimes helpful touse a more medial <strong>in</strong>jection po<strong>in</strong>t (about 1 - 2cm <strong>in</strong>side ofthe one described). This means that the needle will passthe medial edge of the femur at more of an angle thanFigure 5: Anterior approach to the sciatic nerve.


66<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>before and the tip will end posterior to the femur. This I would like to acknowledge the k<strong>in</strong>d assistance of Drmay help f<strong>in</strong>d the nerve, which tends to lie slightly beh<strong>in</strong>d Barry Nicholls for advice, particularly with regard to thethe femur at this level. (When us<strong>in</strong>g this more medial block techniques and Dr Krist<strong>in</strong>e Barnden for proof<strong>in</strong>jection po<strong>in</strong>t, it may help to place the free hand under read<strong>in</strong>g the manuscript.the buttock and palpate the ischial tuberosity. The needleReferencesis then aimed at a po<strong>in</strong>t estimated to be 1 - 2cm lateral to1. Selander D., Dhuner K.E. and Lundberg E. Peripheral nervethe ischial tuberosity.)<strong>in</strong>juries due to <strong>in</strong>jection needles used for regional anaesthesia.Perform<strong>in</strong>g a sciatic nerve block us<strong>in</strong>g a nerve Acta Anaesthesiologica Scand<strong>in</strong>avica 1977; 21: 182.stimulator A nerve stimulator may be used <strong>in</strong> 2. Khoo S.T. and Brown T.C.K. Femoral nerve block - theconjunction with any of the approaches to the sciatic anatomical basis for a s<strong>in</strong>gle <strong>in</strong>jection technique. <strong>Anaesthesia</strong>nerve that have been described above. The techniques and Intensive Care 1983; <strong>11</strong>: 40-2.for determ<strong>in</strong><strong>in</strong>g the po<strong>in</strong>t of <strong>in</strong>jection and locat<strong>in</strong>g the 3. W<strong>in</strong>nie A.P., Ramamurthy S. and Durrani Z. The <strong>in</strong>gu<strong>in</strong>alnerve are no different, except that one will look for paravascular technic of lumbar plexus anaesthesia. The “3-<strong>in</strong>-1muscle contraction. The best <strong>in</strong>dicator of proximity Block.” Anesthesia and Analgesia 1973; 52: 989-96.to the nerve is dorsiflexion of the foot at the ankle and 4. Dalens B., Tanguy A. and Vanneuville G. Sciatic nerve blocksone should aim to achieve this at a stimulat<strong>in</strong>g current <strong>in</strong> children: Comparison of the posterior, anterior and lateralapproaches <strong>in</strong> 180 paediatric patients. <strong>Anaesthesia</strong> and Analgesiaof 0.3 - 0.5 mA. However, when us<strong>in</strong>g the posterior1990; 70: 131-7.approaches, one may also see contraction of the5. Labat G. Regional <strong>Anaesthesia</strong>, Its Technique and Cl<strong>in</strong>ical“hamstr<strong>in</strong>g” muscles down the back of the thigh, whichApplication. Philadelphia. W.J. Saunders. 1924may be taken as a sign of proximity to the sciatic nerve.Hav<strong>in</strong>g achieved muscle contraction at the required Further read<strong>in</strong>g:stimulat<strong>in</strong>g current, <strong>in</strong>jection of local anaesthetic is 1. Macrae W.A. Lower Limb Blocks <strong>in</strong> Wildsmith J.A.W. andperformed <strong>in</strong> the usual manner.Armitage E.N. (eds)2. Bridenbaugh P.O. and Wedel D.J. The lower extremity - somaticAcknowledgementsblockade. In Cous<strong>in</strong>s M.J. and Bridenbaugh P.O. (eds) NeuralBlockade <strong>in</strong> Cl<strong>in</strong>ical <strong>Anaesthesia</strong> and Management of Pa<strong>in</strong> 3rded. pp 373 - 94 Lipp<strong>in</strong>cott-Raven 1998.CLINICAL MANAGEMENT OF DIABETES MELLITUS DURING3. Cov<strong>in</strong>o B.G. and Wildsmith J.A.W. Cl<strong>in</strong>ical pharmacology ofANAESTHESIA AND SURGERYlocal anaesthetic agents. In Cous<strong>in</strong>s M.J. and Bridenbaugh P.O.(eds) Neural Blockade <strong>in</strong> Cl<strong>in</strong>ical <strong>Anaesthesia</strong> and ManagementDr Gordon French FRCA, Northampton General Hospital, of Northampton, Pa<strong>in</strong> 3rd ed. pp UK. 97 - 128 Lipp<strong>in</strong>cott-Raven 1998.INTRODUCTIONDiabetes is a condition where the cells of the body cannotmetabolise sugar properly, due to a total or relative lackof <strong>in</strong>sul<strong>in</strong>. The body then breaks down its own fat, prote<strong>in</strong>sand glycogen to produce sugar, result<strong>in</strong>g <strong>in</strong> high sugar levels<strong>in</strong> the blood (hyperglycaemia) with excess by-productscalled ketones be<strong>in</strong>g produced by the liver.There are two ma<strong>in</strong> types of diabetes (table 1) whichclassically affect different age groups. In reality there is ahuge overlap between age groups.Diabetes causes disease <strong>in</strong> many organ systems, theseverity of which may be related to how long the diseasehas been present and how well it has been controlled.Damage to small blood vessels (diabetic microangiopathy)and nerves (neuropathy) throughout the body results <strong>in</strong>many pitfalls for the unwary anaesthetist. The follow<strong>in</strong>gguidel<strong>in</strong>es should help to identify these problems and copewith them.Preoperative assessment. The general preoperativeassessment has been reviewed <strong>in</strong> a previous article. <strong>Update</strong><strong>in</strong> <strong>Anaesthesia</strong> <strong>in</strong> 1997;7.Specific problems arise:Cardiovascular- diabetics are more prone tohypertension, ischaemic heart disease, cerebrovasculardisease, myocardial <strong>in</strong>farction which may be silent andcardiomyopathy. Damage to the nerves controll<strong>in</strong>g theheart and blood vessels (autonomic neuropathy) may result<strong>in</strong> sudden tachycardia, bradycardia or a tendency topostural hypotension. A history of shortness of breath,palpitations, ankle swell<strong>in</strong>g, tiredness and of course chestpa<strong>in</strong> should therefore be sought and a careful exam<strong>in</strong>ation


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 67Table 1. Classification of diabetes mellitus *Insul<strong>in</strong> Dependent (Type I)Non Insul<strong>in</strong> Dependent (Type II)Age of onset Infancy to twenties Sixties onwards, occasionally youngerPathology Pancreas unable to produce Body unable to use <strong>in</strong>sul<strong>in</strong> properly<strong>in</strong>sul<strong>in</strong> (autoimmune disorder)Treatment Insul<strong>in</strong> Diet and oral hypoglycaemics.* Note. This is a general classification and there is considerable overlap. Obesity is a common cause of Type II- the pancreas cannotmake enough <strong>in</strong>sul<strong>in</strong> for the body size. Diet /oral hypoglycaemics may <strong>in</strong>itially be enough but eventually <strong>in</strong>sul<strong>in</strong> may be required.for heart failure (distended neck ve<strong>in</strong>s, ankle swell<strong>in</strong>g,tender swollen liver, crackles heard on listen<strong>in</strong>g to the chest)made. A preoperative ECG should be performed. Heartfailure is a very serious risk factor and must be improvedbefore surgery with diuretics. Table 2 describes how totest cl<strong>in</strong>ically for autonomic neuropathy.Renal - kidney damage may already be present, often<strong>in</strong>dicated by the presence of prote<strong>in</strong> (album<strong>in</strong>) <strong>in</strong> the ur<strong>in</strong>e.Ur<strong>in</strong>e <strong>in</strong>fections are common and should be treatedaggressively with antibiotics. The diabetic is at risk of acuterenal failure and retention postoperatively. Bloodelectrolyte measurement (if possible) may reveal a raisedurea and creat<strong>in</strong><strong>in</strong>e. If the potassium is high (> 5 mmol/l)then specific measures should be taken to lower it beforesurgery.Respiratory - diabetics, especially if obese and smokers,are particularly prone to chest <strong>in</strong>fections. Chestphysiotherapy pre and postoperatively are <strong>in</strong>dicated, withnebulised oxygen and regular bronchodilators (salbutamol2.5-5mg <strong>in</strong> 5ml sal<strong>in</strong>e) if wheeze is heard. A chest X-ray,blood gases and spirometry are the gold standard<strong>in</strong>vestigations, but careful repeated cl<strong>in</strong>ical assessment willusually reveal when a patient is as good as they are go<strong>in</strong>gto get. Non-emergency surgery should be delayed untilthis po<strong>in</strong>t.Airway - thicken<strong>in</strong>g of soft tissues occurs eg ligamentsaround jo<strong>in</strong>ts. If the neck is affected there may be difficultyextend<strong>in</strong>g the neck, mak<strong>in</strong>g <strong>in</strong>tubation difficult. To test ifthe patient is at risk, ask them to br<strong>in</strong>g their hands togetheras <strong>in</strong> pray<strong>in</strong>g. If they cannot have the f<strong>in</strong>gers of each handflat aga<strong>in</strong>st the other hand, then they probably have ligamentthicken<strong>in</strong>g of the f<strong>in</strong>ger jo<strong>in</strong>ts, and difficult <strong>in</strong>tubation shouldalso be anticipated.Gastro<strong>in</strong>test<strong>in</strong>al - the nerves to the gut wall and sph<strong>in</strong>cterscan be damaged. Delayed gastric empty<strong>in</strong>g and <strong>in</strong>creasedreflux of acid make them more prone to regurgitation andat risk of aspiration on <strong>in</strong>duction of anaesthesia. A historyshould be sought of heartburn and acid reflux when ly<strong>in</strong>gflat; if present they should have a rapid sequence <strong>in</strong>ductionwith cricoid pressure, even for elective procedures. Ifavailable, prescribe an H 2antagonist and metoclopramideas a premedication. Ranitid<strong>in</strong>e 150mg or cimetid<strong>in</strong>e 400mgplus metoclopramide 10mg orally 2 hours preoperativelyto reduce the volume of stomach acid.Table 2: Detect<strong>in</strong>g autonomic neuropathyTests for autonomicNormal response Abnormal responseneuropathySympathetic System Measure systolic blood Decrease < 10 mm Hg Decrease > 30 mm Hgpressure ly<strong>in</strong>g down thenstand<strong>in</strong>g.Parasympathetic Measure heart rate response Increase rate > 15 beats /m<strong>in</strong> Increase < 10 beats /m<strong>in</strong>systemto deep breath<strong>in</strong>gNote: if above detected, patient at risk of unstable BP, myocardial ischaemia, arrhythmias, gastric reflux and aspiration, <strong>in</strong>abilityto ma<strong>in</strong>ta<strong>in</strong> body temperature under anaesthesia.


68<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Eyes - cataracts are common, as is an abnormal growthof blood vessels <strong>in</strong>side the eye (ret<strong>in</strong>opathy). Theanaesthetist should try to prevent sudden rises <strong>in</strong> bloodpressure that might rupture them, further damag<strong>in</strong>g theeyesight. Ensure an adequate depth of anaesthesia,especially at <strong>in</strong>duction.Infection - diabetics are prone to gett<strong>in</strong>g <strong>in</strong>fections thatcan upset their sugar control. If possible, delay surgeryuntil these are treated. Wound <strong>in</strong>fections are common.Great care should be paid to aseptic techniques when anyprocedure is undertaken.Miscellaneous - diabetes may be caused or worsenedby treatment with corticosteroids, thiazide diuretics andthe contraceptive pill. Thyroid disease, obesity, pregnancyand even stress can affect diabetic control.Blood and ur<strong>in</strong>e glucose monitor<strong>in</strong>g - meter analysis(most accurate) or reagent strips (which employ a visualcolour comparison with a pre-pr<strong>in</strong>ted chart) are commonlyavailable. It is vital that the <strong>in</strong>structions are properlyfollowed for whatever method is used. Out-of-date stripswill give an <strong>in</strong>accurate read<strong>in</strong>g. If strips are cut <strong>in</strong> half foreconomy (not recommended), then the unused portionmust be carefully stored <strong>in</strong> a dry place. When us<strong>in</strong>g meters,ensure that the test<strong>in</strong>g strips are properly matched for themeter. Remember, false read<strong>in</strong>gs could lead to the wrong,even life threaten<strong>in</strong>g treatment be<strong>in</strong>g given. Strips or tabletscan also be used to test the ur<strong>in</strong>e for glucose or ketones.The same precautions apply.Anaesthetic management:Many of the operations diabetic patients face are a directresult of their disease. Sk<strong>in</strong> ulcers, amputations andabscesses are amongst the commonest.Preoperative assessment-Tim<strong>in</strong>g - diabetic patients should be placed first on theoperat<strong>in</strong>g list. This shortens their preoperative fast. Badlycontrolled diabetics need to be admitted to hospital oneor two days before surgery if possible to allow theirtreatment to be stabilised.Hydration - Glucose <strong>in</strong> the ur<strong>in</strong>e (glycosuria) causes adiuresis which makes the patient dehydrated and evenmore susceptible to hypotension. Check for dehydration(Table 3) and start an <strong>in</strong>travenous <strong>in</strong>fusion.Medication - all medications should be cont<strong>in</strong>ued up untilsurgery. Surgery causes a stress response which willchange the patient’s <strong>in</strong>sul<strong>in</strong> requirements. Treatment willneed to be adjusted accord<strong>in</strong>g to:- the extent of the anticipated surgery- whether the patient is <strong>in</strong>sul<strong>in</strong> dependant(IDDM) or non-<strong>in</strong>sul<strong>in</strong> dependant (NIDDM)- the quality of their blood sugar control.In general, if the patient can be expected to eat and dr<strong>in</strong>kwith<strong>in</strong> 4 hours of surgery, then it is classified as MINOR.All surgery other than m<strong>in</strong>or is classified as MAJOR.Figures 1-4 give regimes for major and m<strong>in</strong>or surgery andfor NIDDM and IDDM.The aim is to keep the blood glucose level with<strong>in</strong> therange 6 -10 mmol/l at all times.Special problems.Low Blood Sugar (hypoglycaemia)-The ma<strong>in</strong> danger to diabetics is low blood sugar levels(blood glucose < 4mmol/l). Fast<strong>in</strong>g, alcohol, liver failure,septicaemia and malaria can cause this. The characteristicsigns and symptoms of early hypoglycaemia aretachycardia, light-headedness, sweat<strong>in</strong>g and pallor. Ifhypoglycaemia persists or gets worse then confusion,restlessness, <strong>in</strong>comprehensible speech, double vision,convulsions and coma will ensue. If untreated, permanentbra<strong>in</strong> damage will occur, made worse by hypotension andhypoxia.Anaesthetised patients may not show any of these signs.The anaesthetist must therefore monitor the blood sugarregularly if possible, and be very suspicious of anyunexpla<strong>in</strong>ed changes <strong>in</strong> the patient’s condition. If <strong>in</strong> doubt,regard them as <strong>in</strong>dicat<strong>in</strong>g hypoglycaemia and treat.Treatment - diabetic patients learn to recognise the earlysigns and often carry glucose with them to take orally. Ifunconscious, 50ml of 50% glucose (or any glucose solutionavailable) given <strong>in</strong>travenously and repeated as necessaryis the treatment of choice. If no sugar is available, 1mg ofglucagon <strong>in</strong>tramuscularly will help.High Blood Sugar (hyperglycaemia)-This is def<strong>in</strong>ed as a fast<strong>in</strong>g blood sugar level > 6 mmol/l. Itis a common problem found <strong>in</strong> many conditions other thandiabetes eg - pancreatitis, sepsis, thiazide diuretic therapy,ether adm<strong>in</strong>istration, glucose <strong>in</strong>fusions, parenteral nutritionadm<strong>in</strong>istration and most importantly, any cause of stresssuch as surgery, burns or trauma. Slightly elevated levelsare thus commonly found after rout<strong>in</strong>e major surgery. It isusual to treat this only if the level is above 10 mmol/l. Atthis level, sugar is present <strong>in</strong> the ur<strong>in</strong>e and causes a diuresiswhich may result <strong>in</strong> dehydration, loss of potassium


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 69(hypokalaemia) and sodium (hyponatraemia) ions. Theblood thickens and this may cause clott<strong>in</strong>g problems suchas thrombosis, and could precipitate a crisis <strong>in</strong> a patientwith sickle cell disease.Assess the patient, rehydrate them and delay surgery ifnecessary. Remember the aim is a sugar level of 6-10mmol/l. If the sugar is below 10 mmol/l, observe andrecheck it hourly throughout the operation. Should it beabove 10 mmol/l, then follow the regimes <strong>in</strong> figures 1 - 4,accord<strong>in</strong>g to the extent of the surgery planned.After surgery, the <strong>in</strong>sul<strong>in</strong> requirements fall as the stressresponse subsides. Newly diagnosed diabetics need further<strong>in</strong>vestigation to establish whether they will need <strong>in</strong>sul<strong>in</strong>therapy, oral hypoglycaemics or <strong>in</strong>deed just diet control.Sometimes when the blood sugar has become very high,the patient becomes comatose (diabetic coma). It is vitalto correct this by adher<strong>in</strong>g to the general guidel<strong>in</strong>es andregimes already mentioned. Aim to reduce the sugar levelsto below 10 mmol/l. When this has happened over a fewdays, the body uses its own fat to produce energy, andthis results <strong>in</strong> high levels of waste products (ketones) <strong>in</strong>the blood and ur<strong>in</strong>e - this is called diabetic ketoacidiosisand is a medical emergency with a significant mortality.Diabetic ketoacidosisThis may be triggered by <strong>in</strong>fections or other illnesses suchas bowel perforations and myocardial <strong>in</strong>farction. Thepatient will be drowsy or even unconscious with fast, deepbreath<strong>in</strong>g due to acid <strong>in</strong> the blood. The ketones make theirbreath smell sweetly, like acetone. Ketones can also bedetected by the use of ur<strong>in</strong>e and blood test<strong>in</strong>g strips.Diarrhoea, vomit<strong>in</strong>g, gastric dilatation (<strong>in</strong>sert a nasogastrictube) or even severe abdom<strong>in</strong>al pa<strong>in</strong> may be present whichcan be mis<strong>in</strong>terpreted as an acute surgical problem! Assevere dehydration is usually present, surgery must bedelayed until fluid resuscitation has commenced <strong>in</strong> orderto avoid disastrous hypotension with <strong>in</strong>duction agents. Aur<strong>in</strong>ary catheter will help monitor fluid balance, and anECG and CVP l<strong>in</strong>e (to estimate the fluid deficit) are helpful.The aim is to slowly return the body chemistry to normal.Give high flow oxygen therapy.Although the blood potassium level is usually high, the bodyhas actually lost large amounts <strong>in</strong> the ur<strong>in</strong>e, and extrapotassium is required <strong>in</strong>travenously. It is important to lowerthe blood sugar level slowly, as reduc<strong>in</strong>g it too fast canresult <strong>in</strong> further complications such as bra<strong>in</strong> oedema andconvulsions. Search for <strong>in</strong>fections (chest X-ray, blood andur<strong>in</strong>e cultures) and treat with antibiotics. Blood gases andelectrolyte measurements may also help management. figure5 gives a regime for treatment.Anaesthetic technique.Intraoperative monitor<strong>in</strong>g - record blood pressure andpulse every 5 m<strong>in</strong>utes dur<strong>in</strong>g the operation, and watchsk<strong>in</strong> colour and temperature. If the patient is cold andsweaty, then suspect hypoglycaemia, check the bloodglucose and treat with <strong>in</strong>travenous glucoseGeneral anaesthesia - if gastric stasis is suspected thena rapid sequence <strong>in</strong>duction should be used. A nasogastrictube can be used to empty the stomach and allow a saferawaken<strong>in</strong>g. There are no contra<strong>in</strong>dications to standardanaesthetic <strong>in</strong>duction or <strong>in</strong>halational agents, but if the patientis dehydrated then hypotension will occur and should betreated promptly with <strong>in</strong>travenous fluids. Hartmannssolution (R<strong>in</strong>gers lactate) should not be used <strong>in</strong> diabeticpatients as the lactate it conta<strong>in</strong>s may be converted toglucose by the liver and cause hyperglycaemia.Sudden bradycardias should respond to atrop<strong>in</strong>e 0.3mgiv, repeated as necessary (maximum 2 mg). Tachycardias,if not due to light anaesthesia or pa<strong>in</strong>, may respond togentle massage on one side of the neck over the carotidartery. If not then consider a beta-blocker (propanolol1mg <strong>in</strong>crements: max 10mg total or labetalol 5mg<strong>in</strong>crements: max 200mg <strong>in</strong> total).IV <strong>in</strong>duction agents normally cause hypotension on<strong>in</strong>jection due to vasodilatation. If a patient has a damagedautonomic nervous system (and many diabetics do), thenthey cannot compensate by vasoconstrict<strong>in</strong>g, and thehypotension is worsened. Reduc<strong>in</strong>g the dose of drug andgiv<strong>in</strong>g it slowly helps to m<strong>in</strong>imise this effect.Regional techniques - are useful because they get overthe problem of regurgitation, possible aspiration and ofcourse difficult <strong>in</strong>tubation. However, the same attentionshould be paid to avoid<strong>in</strong>g hypotension by ensur<strong>in</strong>gadequate hydration. It is a wise precaution to chart anypre-exist<strong>in</strong>g nerve damage before your block is <strong>in</strong>serted.With sp<strong>in</strong>als and epidurals, autonomic nerve damagemeans the patient may not be able to keep their bloodpressure <strong>in</strong> a normal range. Intervene early with ephedr<strong>in</strong>e(6mg boluses) when the systolic pressure falls to 25%below normal.Postoperative therapy regimes are also given <strong>in</strong> figures 1 -4. It is not unusual to f<strong>in</strong>d that <strong>in</strong>sul<strong>in</strong> requirements arereduced once the patient beg<strong>in</strong>s to recover from surgery.


70<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Figure 1. Which regime for my patient ?1. Decide on the type of surgeryM<strong>in</strong>or - patients expected to eat and dr<strong>in</strong>k with<strong>in</strong> 4 hours of operationMajor - all other patients2. Then, is the patient Insul<strong>in</strong> or Non-<strong>in</strong>sul<strong>in</strong> dependent ?3. F<strong>in</strong>ally, are they - poorly controlled: delay surgery and change to soluble <strong>in</strong>sul<strong>in</strong> three times dailybut if surgery urgent, use Major surgery regime- well controlled: use the appropriate regime from the Major or M<strong>in</strong>orGeneral Measures for all diabetics:Measure random sugar preoperatively - 4 hourly for IDDM- 8 hourly for NIDDMTest ur<strong>in</strong>e 8 hourly for ketones and sugarPlace first on operat<strong>in</strong>g listAim for a blood glucose of 6 - 10mmol/lFigure 2.M<strong>in</strong>or SurgeryNon <strong>in</strong>sul<strong>in</strong> DependentPreoperatively - random blood sugarDiabetics on admission < 10 mmol/l Normal medication until day of op> 10 mmol/l Follow as for MAJOR SURGERYInsul<strong>in</strong> dependentDiabeticsThis regime only suitablefor patients whose randomsugar is < 10 mmol/l on admission,will only miss one meal preop &are first on the list for verym<strong>in</strong>or surgery eg cystoscopyDay of operationPostoperativelyPreoperativelyDay of operationOmit oral hypoglycaemicsBlood glucose- 1 hour preop andat least once dur<strong>in</strong>g op(hourly if op > 1 hour long)postop - 2 hourly until eat<strong>in</strong>gthen 8 hourlyRestart oral hypoglycaemics withfirst mealNormal medicationNo breakfast, no <strong>in</strong>sul<strong>in</strong>, place firston list.Blood glucose- 1 hour preop andat least once dur<strong>in</strong>g op(hourly if op > 1 hour long)postop - 2 hourly until eat<strong>in</strong>gthen 4 hourlyPostoperativelyRestart normal S/C <strong>in</strong>sul<strong>in</strong> regimewith first meal


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 71Figure 3.Major surgery All <strong>in</strong>sul<strong>in</strong> dependent and non-<strong>in</strong>sul<strong>in</strong> dependent who are poorly controlled (blood glucose >10mmol/l)(many NIDDM become <strong>in</strong>sul<strong>in</strong> dependent dur<strong>in</strong>g major surgery and will need manag<strong>in</strong>g as such. Regularglucose measurements will detect this). Normal medication until day of operationDay of operation - Omit oral hypoglycaemics and normal subcutaneous (S/C) <strong>in</strong>sul<strong>in</strong>Blood glucose - check blood sugar(and potassium) 1 hour preopthen 2 hourly from start of <strong>in</strong>fusionat least once dur<strong>in</strong>g operation(hourly if op > 1 hour long)at least once <strong>in</strong> recovery area2 hourly post operativelyRegime 1 - no <strong>in</strong>fusion pump available.Start <strong>in</strong>travenous <strong>in</strong>fusion of 5 or10 % dextrose (500 ml bags) over 4 - 6 hours and add Insul<strong>in</strong> and PotassiumChloride (KCl) to each 500 ml bag as below. Change bag accord<strong>in</strong>g to blood sugar level read<strong>in</strong>gs:-Blood glucose (mmol/l) Soluble <strong>in</strong>sul<strong>in</strong> (units) Blood potassium (mmol/l) KCl (mmol)to be added to bagto be added to bag< 4 No <strong>in</strong>sul<strong>in</strong>4 - 6 5 5 None> 20 20* If blood potassium level not available, add 10 mmol KClPostoperatively Non-<strong>in</strong>sul<strong>in</strong> dependent - stop <strong>in</strong>fusion and restart oral hypoglycaemics when eat<strong>in</strong>g and dr<strong>in</strong>k<strong>in</strong>g Insul<strong>in</strong> dependent - stop <strong>in</strong>fusion when eat<strong>in</strong>g and dr<strong>in</strong>k<strong>in</strong>g- calculate the total daily dose (units) of <strong>in</strong>sul<strong>in</strong> the patient was tak<strong>in</strong>g preoperatively- give this as S/C Soluble <strong>in</strong>sul<strong>in</strong> (Actrapid), divided <strong>in</strong>to 3 - 4 doses <strong>in</strong> 24 hours- this may need to be adjusted up or down until blood sugar levels stable.- once stable restart normal regimeRemember that the patient may need additional fluids depend<strong>in</strong>g on surgery, blood loss etc.Figure 4:Major surgery - alternative regimeRegime 2 - for use with <strong>in</strong>fusion pumpsThe <strong>in</strong>sul<strong>in</strong> and dextrose <strong>in</strong>fusions are given via separate <strong>in</strong>fusion pumps. This allows better control than regime 1,but care is needed to ensure the separate l<strong>in</strong>es do not become blocked, or that one <strong>in</strong>fusion runs out leav<strong>in</strong>g theother <strong>in</strong>fus<strong>in</strong>g alone.Insul<strong>in</strong> <strong>in</strong>fusion - 50 units <strong>in</strong>sul<strong>in</strong> made up to 50 ml with sal<strong>in</strong>e (i.e. concentration is 1 unit per ml)Blood glucose (mmol / l)Insul<strong>in</strong> <strong>in</strong>fused at (units / hour)< 5 05.1 - 10 <strong>11</strong>0.1 - 15 215.1 - 20 3> 20 6 & review * If it is prov<strong>in</strong>g difficult to reduce the blood sugar level, then consider <strong>in</strong>creas<strong>in</strong>g the rate of <strong>in</strong>sul<strong>in</strong> for eachglucose levelor also giv<strong>in</strong>g a bolus of Actrapid of 3 - 5 units. Patients normally on higher doses of <strong>in</strong>sul<strong>in</strong> will need higher rates of <strong>in</strong>sul<strong>in</strong> <strong>in</strong>fusion. Dextrose <strong>in</strong>fusion - 5 or 10 % dextrose <strong>in</strong>fused at 100 ml per hour. Add 10 mmol KCl to each 500 ml ofsolution. Post op - follow <strong>in</strong>structions as <strong>in</strong> figure 3.


72<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>SummaryThe diabetic patient presents the anaesthetist with manychallenges. Careful attention to cl<strong>in</strong>ical signs and rapidaction to prevent even suspected hypoglycaemiaperoperatively should see them safely through their surgery.The goal is to keep th<strong>in</strong>gs as normal as possible. Regionaltechniques are often safer than general anaesthesia, butrequire the same vigilance.References:1. Hirsch IB, McGill JB, Cryer PE, White PF. Perioperativemanagement of surgical patients with diabetes mellitus.Anesthesiology 1991; 74: 346 - 59.2. Alberti KGMM. Diabetes and surgery. Anesthesiology1991; 74: 209 - <strong>11</strong>.Figure 5.Aims -Treatment of Diabetic Ketoacidosisrehydration (water and salt)lower blood sugarcorrection of potassium depletionStart an <strong>in</strong>travenous <strong>in</strong>fusion of 0.9 % sal<strong>in</strong>e as follows-1 litre over 30 m<strong>in</strong>utesthen 1 litre over 1 hourthen 1 litre over 2 hours.Cont<strong>in</strong>ue 2 - 4 hourly until the blood glucose is below 15 mmol / l,then change to 5% glucose, 1 litre 2 - 4 hrlyUp to 6 -8 litres of fluid may be required or more. Use cl<strong>in</strong>ical signs BP, heart rate, CVP, conscious level to judgethe amount.Give soluble <strong>in</strong>sul<strong>in</strong> (Actrapid) <strong>in</strong>tramuscularly (IM) as follows-- 20 units IM first dose then 6 units IM hourly- measure the blood glucose hourly- when the blood glucose is below 15 mmol/l, change to 6 units IM every 2 hours.Once the patient has recovered and is eat<strong>in</strong>g/dr<strong>in</strong>k<strong>in</strong>g, change to S/C <strong>in</strong>sul<strong>in</strong>.Potassium (K + ) supplementation will be required-There may be a high blood potassium <strong>in</strong>itially, but this will fall as the sugar level comes down.Measure the potassium hourly. Put 10 mmol K + <strong>in</strong> the first litre of sal<strong>in</strong>e then 10 - 40 mmol <strong>in</strong> subsequent litres offluid, depend<strong>in</strong>g on the plasma level (normal 3.5 - 5.0 mmol/l).If potassium measurements are unavailable then put 10 mmol KCl <strong>in</strong> each litre of fluid.Other measures- 100 % O 2. Blood gas estimation-if pH < 7.10, give 50 mmol of 8.4% bicarbonate. Usuallyacidosis will correct itself slowly as the sugar comes down. Emergency surgery can start once the rehydration andlower<strong>in</strong>g of blood sugar is underway.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 73Table 3Cl<strong>in</strong>ical signs of dehydrationSign Water loss(% body weight)Thirst < 5 %Dry mouthCapillary refill > 2 seconds * 5 - 10 %Decreased sk<strong>in</strong> turgor *Orthostatic hypotension *Low <strong>in</strong>traocular pressure (soft eyes)Reduced ur<strong>in</strong>e outputLow CVP/JVPShock > 10 %Unconscious* Capillary refill - lift limb above level of heart, press on sk<strong>in</strong> for 5 seconds, release and observe colour return<strong>in</strong>g to area.Normal is < 2 seconds. Sk<strong>in</strong> turgor - p<strong>in</strong>ch sk<strong>in</strong> on back of hand and release. Normally the fold of sk<strong>in</strong> quickly falls backflat but if dehydrated stays folded or returns slowly. Orthostatic hypotension - a severe fall <strong>in</strong> BP when patient stands upcaus<strong>in</strong>g fa<strong>in</strong>t<strong>in</strong>g.THE APPLICATION OF BASIC SCIENCE TO PRACTICAL PAEDIATRICANAESTHESIADr Kester Brown , Childrens Hospital , Melbourne, AustraliaThis paper will attempt to show how a sound knowledgeof anatomy, physiology, pharmacology and psychology of<strong>in</strong>fants and children and how they differ from adults helpsto improve their care dur<strong>in</strong>g anaesthesia and theperioperative period.A baby can be taken from the parent without undue distressup to 6 to 7 months of age while an older <strong>in</strong>fant or youngchild will become very distressed and hence they shouldbe accompanied by a parent to <strong>in</strong>duction of anaesthesiaprovided the parent doesn’t exhibit undue anxiety. In suchcases it may be better to give the child some premedication.Older children can cope but many like to be accompaniedby a parent. Sometimes children, particularly boys of 8to10 years old, appear well adjusted when seenbeforehand but show signs of extreme apprehension whenthey reach the <strong>in</strong>duction room - this presents as almost<strong>in</strong>visible ve<strong>in</strong>s so that venepuncture is difficult. Aga<strong>in</strong>,premedication should be considered. Midazolam 0.2-0.3mg/kg given orally 30 to 45 m<strong>in</strong>utes before anaesthesiausually has a tranquilis<strong>in</strong>g effect. If a child is very distressedon arrival at the operat<strong>in</strong>g theatre 0.2mg/kg can be squirted<strong>in</strong>to the nose. It may st<strong>in</strong>g but it usually has an effect with<strong>in</strong>about 10 m<strong>in</strong>utes. In older children diazepam (0.3 mg/kg)or temazepam can be given an hour before <strong>in</strong>duction. Thismay be accompanied by an analgesic such as paracetamol(30mg/kg orally). An apprehensive patient has an <strong>in</strong>creasedcardiac output, which is largely redistributed to muscle sothat the <strong>in</strong>jected or <strong>in</strong>haled <strong>in</strong>duction agent does not reachthe target organ - the bra<strong>in</strong> - unless substantially <strong>in</strong>creaseddoses are given. The <strong>in</strong>creased ventilation through cry<strong>in</strong>gdoes not necessarily speed <strong>in</strong>duction - the <strong>in</strong>creased uptakemerely compensates for the drug which has beenredistributed to muscle.


74<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>It is often said that children are like small adults. This isnot so - for a start their proportions differ. Infants have arelatively large head and therefore bra<strong>in</strong>. It must receive agreater proportion of cardiac output as a consequence.The surface area is larger and thus heat loss is <strong>in</strong>creasedwhen it is exposed, especially <strong>in</strong> neurosurgery.The surface area: body weight ratio is double <strong>in</strong> <strong>in</strong>fantscompared to adults result<strong>in</strong>g <strong>in</strong> greater heat loss. Oxygenconsumption relative to body weight is also double(6-7 mls/kg/m<strong>in</strong>). This is another key to work<strong>in</strong>g outimportant differences because if they need double thevolume of oxygen then they have to double the amounttaken <strong>in</strong> and transported. This means the alveolar ventilationmust be <strong>in</strong>creased which is largely achieved by <strong>in</strong>creas<strong>in</strong>grespiratory rate. Cardiac output must also be doubled tocarry the oxygen around the body - this is achieved by<strong>in</strong>creas<strong>in</strong>g heart rate as babies have a very limited abilityto <strong>in</strong>crease stroke volume. Thus heart rates of 120 - 160are common. The <strong>in</strong>creased work of do<strong>in</strong>g this is m<strong>in</strong>imizedby hav<strong>in</strong>g a lower vascular resistance so that babiessystolic blood pressures are lower ( 70 - 80 mmHg ).The fixed stroke volume <strong>in</strong> <strong>in</strong>fants is also important becauseanyth<strong>in</strong>g that causes bradycardia such as hypoxia, deephalothane anaesthesia, or reflex bradycardia due to vagalstimulation, such as occurs dur<strong>in</strong>g laryngoscopy, will result<strong>in</strong> a decrease <strong>in</strong> cardiac output. When comb<strong>in</strong>ations ofthese occur serious decreases <strong>in</strong> output can result.Cardiac output can be assessed cl<strong>in</strong>ically with astethoscope because heart sounds become softer as theoutput decreases. Normally blood flow <strong>in</strong>to the ventriclesor <strong>in</strong>to the aorta and pulmonary artery causes expansionfollowed by an elastic recoil which slams the valves closedresult<strong>in</strong>g <strong>in</strong> loud heart sounds. If the volume decreases therecoil is dim<strong>in</strong>ished and the result<strong>in</strong>g heart sounds becomesoft. When the cause is corrected, such as by giv<strong>in</strong>g bloodor fluids <strong>in</strong> hypovolaemia, one can hear the soundsbecom<strong>in</strong>g louder. The stethoscope is thus a very usefuland sensitive monitor with which it is also easy todifferentiate between patient and equipment problems whena monitor such as an oximeter gives abnormal read<strong>in</strong>gs.Ventilation is greatly <strong>in</strong>fluenced by the anatomicaldifferences, especially the structure of the chest wall. Theribs <strong>in</strong> neonates are more horizontal limit<strong>in</strong>g anteroposteriorexpansion of the chest and they lack the buckethandle movement of the middle ribs that allows lateralexpansion of the thoracic cage <strong>in</strong> older patients. Theconsequence is that ventilation is much more dependenton diaphragmatic movement and hence anyth<strong>in</strong>g thatrestricts it (abdom<strong>in</strong>al distention or compression) will causerespiratory difficulties. This <strong>in</strong>cludes <strong>in</strong>flation of the stomachwith gas which can occur dur<strong>in</strong>g ventilation with a maskwhen too high a pressure is applied or the bag is squeezedtoo fast thereby forc<strong>in</strong>g gas down the oesophagus as wellas the trachea. In patients with oesophageal atresiastomach distention is more likely with positive pressureventilation when there is a large fistula. This can beenassessed beforehand with a lateral chest X ray whichshows the air conta<strong>in</strong><strong>in</strong>g fistula. Beware if this is more than2.5mm <strong>in</strong> diameter. Patients <strong>in</strong> the lithotomy position havetheir abdom<strong>in</strong>al contents compressed forc<strong>in</strong>g thediaphragm up and restrict<strong>in</strong>g ventilation.Intubation technique is important because <strong>in</strong>fants have ahigher oxygen consumption (6-7ml/kg/m<strong>in</strong>ute comparedto 3 <strong>in</strong> an adult ). This results <strong>in</strong> there be<strong>in</strong>g a shorter timebefore hypoxia beg<strong>in</strong>s to develop when a paralysed babyis not be<strong>in</strong>g ventilated. There are anatomical differences <strong>in</strong>the airway which are relevant. The larynx is situated at ahigher level relative to the vertebrae - C3 <strong>in</strong> the <strong>in</strong>fantcompared to C6 <strong>in</strong> the adult; the epiglottis is U shapedand relatively longer, the angle of the mandible is greater(120 degrees) and the trachea has an anterior <strong>in</strong>cl<strong>in</strong>ation.In addition the relatively large head does not need to beon a pillow but needs to be stabilized. This can be doneby slightly extend<strong>in</strong>g the neck, roll<strong>in</strong>g the thenar em<strong>in</strong>enceof the right hand on to the forehead to stabilize it, thenopen<strong>in</strong>g the mouth with the <strong>in</strong>dex f<strong>in</strong>ger and <strong>in</strong>sert<strong>in</strong>g thelaryngoscope with the left hand down the right hand sideof the mouth so that the tongue is kept out of the way. Ifthe laryngoscope is held between the thumb and <strong>in</strong>dexf<strong>in</strong>ger the little f<strong>in</strong>ger of the left hand can reach to pressthe larynx backwards thus br<strong>in</strong>g<strong>in</strong>g the larynx <strong>in</strong>to view(figures 1 - 3). The tube can then be passed from the rightcorner of the mouth so that it does not obstruct the viewof the larynx. The important anatomical po<strong>in</strong>ts <strong>in</strong> relationto the tube are that the cricoid cartilage forms thenarrowest part of the larnyx before puberty and becauseit is circular an uncuffed tube can be used until 10 -12years of age. Another convenient po<strong>in</strong>t is that the noseaccommodates the same size of tube as the larynx beforepuberty. Tracheal length is often quoted to be 4cms butAnneke Meurs<strong>in</strong>g showed that the mean length is 4.5cms<strong>in</strong> a 3 kg baby. The importance of tracheal length is toappreciate how far the tube can be passed without go<strong>in</strong>g<strong>in</strong>to the bronchus. The problem is that there are occasionalbabies who have short tracheas. It is thus important alwaysto check after <strong>in</strong>tubation that both lungs are be<strong>in</strong>g ventilated.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 75Figure 1Figure 2Figure 3Blood volume and haemoglob<strong>in</strong> are greater <strong>in</strong> newborns.The volume is about 80-85 ml.Haemoglob<strong>in</strong> at full term is about 180-200gm/l decreas<strong>in</strong>gto about <strong>11</strong>0gm/l at 3-6 months. This haemoglob<strong>in</strong> ispredom<strong>in</strong>antly fetal with alpha and gamma cha<strong>in</strong>s whichenable it to take up oxygen at low tensions such as exist <strong>in</strong>the placenta but do not release it as readily to the tissues.Gradually it changes to adult haemoglob<strong>in</strong> (alpha and betacha<strong>in</strong>s). As lower<strong>in</strong>g PaCO 2 shifts the oxygen dissociationcurve to the left, hyperventilation further reduces oxygendelivery to the tissues so that excessive hyperventilationshould be avoided even by <strong>in</strong>creas<strong>in</strong>g dead space <strong>in</strong> thecircuit - not shorten<strong>in</strong>g the endotracheal tube will help.In neonates with a high haemoglob<strong>in</strong>, album<strong>in</strong> rather thanblood can be used for early transfusion, when needed. Inpremature <strong>in</strong>fants haemoglob<strong>in</strong> tends to be low becausemost of the iron stores are laid down <strong>in</strong> the last threemonths of pregnancy.Several factors should be considered <strong>in</strong> decid<strong>in</strong>g that it isnecessary to start a blood transfusion. The haemoglob<strong>in</strong>should be at a level above that which supplies m<strong>in</strong>imaloxygen requirements for metabolism. In <strong>in</strong>fants metabolicrate is higher, the haemoglob<strong>in</strong> level may be higher <strong>in</strong> fullterm babies but lower <strong>in</strong> prematures and between 3-6months so that the tolerated blood loss will vary. A 20%loss is usually well tolerated provided fluids are given toma<strong>in</strong>ta<strong>in</strong> the circulat<strong>in</strong>g volume. At that po<strong>in</strong>t one mightconsider whether blood loss is likely to cont<strong>in</strong>ue and, ifhaemoglob<strong>in</strong> was low to start with, then blood may bestarted. On the other hand, cl<strong>in</strong>ical signs such as a ris<strong>in</strong>gpulse, when apparently adequate fluids have been givenor a bolus does not reduce the pulse <strong>in</strong> a patient who alsolooks pale, will usually suggest that it is time to start blood.The total body water is about 80% of body weight atbirth, gradually decreas<strong>in</strong>g with age to 60-65 % <strong>in</strong> adults.Premature <strong>in</strong>fants have relatively more, mak<strong>in</strong>g fluid lossan even more critical problem to them. When neonatesand <strong>in</strong>fants become dehydrated they <strong>in</strong>itially loseextracellular water. Because the extracellular space isrelatively larger at this age (about 50% of body weight)the losses will be proportionately greater.The relativelysmaller <strong>in</strong>tracellular compartment then has less fluid to shiftto the extracellular space when losses occur result<strong>in</strong>g <strong>in</strong> amuch sicker <strong>in</strong>fant than an adult might be <strong>in</strong> similarcircumstances.The other consequence of the relatively largeextracellular space is that drugs predom<strong>in</strong>antly distributed<strong>in</strong> the extracellular space will have to be given with a largerload<strong>in</strong>g dose. Also, extracellular electrolytes such aschloride will have to be given <strong>in</strong> larger amounts to correctdeficits which occur, for example <strong>in</strong> pyloric stenosis,because of the larger extracellular compartment.


76<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Kidney function is immature at birth and although thevarious functions develop at different rates there is a rapidimprovement <strong>in</strong> the first few weeks of life. The relevanceis that fluids ,electrolytes and drugs excreted by the kidneyare handled more slowly dur<strong>in</strong>g the early days and weeksof life. Glomerular filtration is less, the cortical tubules whichare important <strong>in</strong> sodium excretion are not fully developed,and the <strong>in</strong>terstitial urea concentration <strong>in</strong> the loops of Henleis low (because the am<strong>in</strong>o acids are be<strong>in</strong>g utilized to buildcells) and hence water reabsorption is reduced.The bra<strong>in</strong> is immature. Centrally act<strong>in</strong>g drugs such asmorph<strong>in</strong>e and barbiturates have a greater depressant effectand thus have to be used <strong>in</strong> reduced doses, if at all.The temperature regulat<strong>in</strong>g centres are also immature sothat body temperature control is less efficient. This problemis aggravated <strong>in</strong> neonates because they have a relativelylarge surface area (2-2.5 times relative to weight), th<strong>in</strong>sk<strong>in</strong> and subcutaneous fat so that they are poorly <strong>in</strong>sulatedand their body mass is less so that the body stores lessheat. Neonates do not shiver so that they cannot respondto a cold environment. Dur<strong>in</strong>g anaesthesia the temperaturecontrol mechanisms are depressed so that methods ofma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g body heat must be <strong>in</strong>stituted. These <strong>in</strong>cludeoverhead heaters, warm<strong>in</strong>g blankets, warm<strong>in</strong>g <strong>in</strong>spiredgases and fluids and cover<strong>in</strong>g parts of the body not be<strong>in</strong>goperated upon.Other anatomical po<strong>in</strong>ts are important <strong>in</strong> regional andlocal anaesthesia. The sp<strong>in</strong>al cord and dura mater reachlower levels <strong>in</strong> neonates (L3 and S3), the iliac crests arenot fully developed so that the l<strong>in</strong>e between them is onevertebral space lower. Fascia and aponeurosis are th<strong>in</strong>nerand therefore not as easily detected when used as depthmarkers dur<strong>in</strong>g nerve blocks. They can be located moreeasily mov<strong>in</strong>g the needle up and down until a scratch<strong>in</strong>gsensation is felt or by angl<strong>in</strong>g the needle so that the traversethrough the layer is thicker.An understand<strong>in</strong>g of the basic sciences is helpful <strong>in</strong>optimally manag<strong>in</strong>g our smallest patients dur<strong>in</strong>ganaesthesia. In the next section anaesthesia for somecommon operations will be considered highlight<strong>in</strong>g theapplication aspects of basic sciences to the cl<strong>in</strong>icalmanagement.Ingu<strong>in</strong>al hernia repair is a common operation <strong>in</strong> youngchildren, especially ex-premature <strong>in</strong>fants. In the latterpatients the abdom<strong>in</strong>al wall is weak and the normalobliteration of the sac has not occurred. The <strong>in</strong>fant bornprematurely has deficient iron and glycogen stores becausethese are laid down ma<strong>in</strong>ly <strong>in</strong> the last three months ofpregnancy. Thus they tend to be anaemic and susceptibleto hypoglycaemia unless glucose is adm<strong>in</strong>istered. Inaddition, the factors which <strong>in</strong>crease heat loss areexaggerated so that particular care is necessary to ma<strong>in</strong>ta<strong>in</strong>body temperature.There are several options for anaesthesia. Generalanaesthesia for hernia repair <strong>in</strong> <strong>in</strong>fants can be used ifthere is no history of apnoea. Even if there is thiscomplication can be largely avoided postoperatively if thepatient is ventilated with air <strong>in</strong>stead of nitrous oxide andPEEP of 2-3cm water is applied.The use of air prevents denitrogenation of the lungs and,together with PEEP, prevents atelectasis which results <strong>in</strong><strong>in</strong>creased work of breath<strong>in</strong>g and fatigue <strong>in</strong> ex-prematuresand is a major cause of postoperative hypoxaemia <strong>in</strong> manypatients. The anaesthetic consists of muscle relaxation,ventilation with an <strong>in</strong>halation agent and preferably a localanaesthetic block rather than opioids so that respiratorydepression is avoided.In prematures sp<strong>in</strong>al analgesia <strong>in</strong> advocated by someanaesthetists because there are fewer respiratory problemsif they are immobilised rather than be<strong>in</strong>g anaesthetised.The fact that the iliac crests are level with one <strong>in</strong>tervertebralspace lower is fortuitous as the sp<strong>in</strong>al cord also ends onespace lower. A 25 needle is often used to adm<strong>in</strong>isterbupivaca<strong>in</strong>e 0.5%. An alternative is to use caudalanaesthesia aim<strong>in</strong>g to reach at least T10.The ilio<strong>in</strong>gu<strong>in</strong>al block as orig<strong>in</strong>ally described <strong>in</strong>volvedplac<strong>in</strong>g local anaesthetic under the external obliqueaponeurosis thus block<strong>in</strong>g the ilio<strong>in</strong>gu<strong>in</strong>al andiliohypogastric nerves as they approach the sk<strong>in</strong>. Thisprovides adequate surface anaesthesia but does notanaesthetise the area around the <strong>in</strong>gu<strong>in</strong>al sac. This can beachieved by plac<strong>in</strong>g local anaesthetic <strong>in</strong> the layer betweenthe <strong>in</strong>ternal oblique and transversus abdom<strong>in</strong>is muscles. Ifa short bevelled needle is available it makes it easierto feel the loss of resistance as the aponeurosis ispenetrated 1-2 cm medial to the anterior superior iliacsp<strong>in</strong>e depend<strong>in</strong>g on the size of the patient. If one is notavailable the aponeurosis can be located by mov<strong>in</strong>g theneedle horizontally as it is gradually advanced until a grat<strong>in</strong>gor rough sensation is felt. The needle is then advancedthrough the aponeurosis and a pop may be felt especiallywith a short beveled needle. 0.25 ml/kg of 0.25%bupivaca<strong>in</strong>e can be <strong>in</strong>jected to produce surface analgesia.The needle is then advanced slowly with gentle pressureon the plunger of the syr<strong>in</strong>ge. It is difficult to <strong>in</strong>ject <strong>in</strong>to


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 77muscle but as soon as the needle emerges <strong>in</strong>to the spacebetween them it becomes easy to <strong>in</strong>ject and a similarvolume should be <strong>in</strong>jected as above.Circumcision is usually performed under light generalanaesthesia with a local anaesthetic block. The reason isthat under halothane alone laryngeal spasm often occurs.An understand<strong>in</strong>g of the anatomy is important. Caudalanaesthesia is commonly used. The key po<strong>in</strong>ts <strong>in</strong> locat<strong>in</strong>gthe caudal canal are to feel the sacral cornua and then pullthe sk<strong>in</strong> cephalad (upwards) until it is just above the apexof the sacral hiatus. The needle can then be <strong>in</strong>serted justdistal to the f<strong>in</strong>ger tip so that it passes through sk<strong>in</strong> whichhas not been touched s<strong>in</strong>ce be<strong>in</strong>g prepared with antiseptic.At this po<strong>in</strong>t the sacrococcygeal membrane is thickestand so more easily felt as the needle is <strong>in</strong>serted. It alsoenters the deepest part of the sacral epidural space andso it is not necessary to angle the needle <strong>in</strong>to the canalalthough many people do this to ensure that they are <strong>in</strong> thecorrect space. 0.5 ml/kg of 0.25% bupivaca<strong>in</strong>e will providean adequate block.The alternative is to perform a dorsal nerve of penis block.The sk<strong>in</strong> is put on a stretch and the needle is <strong>in</strong>serted <strong>in</strong>the midl<strong>in</strong>e below the symphysis pubis. It is safer to angleit 10 degrees from the entry po<strong>in</strong>t and to advance andmake <strong>in</strong>jections on both sides of pla<strong>in</strong> bupivaca<strong>in</strong>e 0.5%1ml + 0.1ml /kg. The needle has to penetrate the superficialfascia which can be felt with a short beveled needle or byscratch<strong>in</strong>g up and down as the needle is advanced until arough sensation is felt. The fascia divides to form thesuspensory ligament of the penis <strong>in</strong> the midl<strong>in</strong>e. This dividesover the body of the penis but the nerves and blood vesselslie <strong>in</strong> the midl<strong>in</strong>e deep to it. It is to avoid punctur<strong>in</strong>g thesevessels that it is recommended to <strong>in</strong>ject at an angle. As theneedle is advanced under the symphysis gentle pressureon the syr<strong>in</strong>ge plunger will be met at first by resistance.When it becomes easy to <strong>in</strong>ject the needle tip has entereda potential space which is pear shaped when filled and liesclose to the nerves. Injection should be made here whereit is easy to <strong>in</strong>ject. The local anaesthetic diffuses easilythrough the fascial layer separat<strong>in</strong>g it from the nerves andvessels. It is important to fill this space between thesymphysis and the corpora cavernosa so that the dorsalnerve and its ventral branch are both blocked as they comeforward under the symphysis. The volume suggestedusually achieves this.There are some important consequences ofhypovolaemia which may occur after trauma, burns, oras a result of post-operative bleed<strong>in</strong>g such as occasionallyhappens after tonsillectomy. The redistribution of cardiacoutput, as well as its reduction has important consequenceswhen anaesthesia is <strong>in</strong>duced or analgesia is given. Studentsand young doctors must have the pr<strong>in</strong>ciples <strong>in</strong>stilled <strong>in</strong>tothem because the consequences of not know<strong>in</strong>g that agreater proportion of the cardiac output goes to the bra<strong>in</strong>and heart <strong>in</strong> hypovolaemia may result <strong>in</strong> dangerousmyocardial or respiratory depression if depressant drugsare <strong>in</strong>jected <strong>in</strong> usual doses. In addition, it is important toknow that analgesics <strong>in</strong>jected <strong>in</strong>tramuscularly will not beeffective until muscle perfusion is improved after correctionof hypovolaemia .An understand<strong>in</strong>g of the application of basic sciences isimportant <strong>in</strong> the provision of high quality anaesthesia andcare of children undergo<strong>in</strong>g surgery.


78<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>VOLATILE ANAESTHETIC AGENTSProfessor P Fenton , Queen Elizabeth Central Hospital, Blantyre, MalawiOne of the prom<strong>in</strong>ent features of anaesthetic practice <strong>in</strong>develop<strong>in</strong>g countries is the widespread use of volatileanaesthetic agents. This is surpris<strong>in</strong>g, as they are relativelyexpensive. Even modest supplies of halothane, forexample, can cost several times more than the salary ofthe person us<strong>in</strong>g it but despite this burden on limitedbudgets, <strong>in</strong> most government hospitals cases are done us<strong>in</strong>ggeneral anaesthesia with halothane and no other drug.However, many mission hospitals favour sp<strong>in</strong>al anaesthesiafor reasons of cost.The demise of <strong>in</strong>halation anaesthesia is sometimespredicted, partly because of cost and partly because ofpollution of the atmosphere. Total <strong>in</strong>travenous anaesthesiamay one day replace it. This event is probably far awayand volatile agents will rema<strong>in</strong> a central part of anaesthesiapractice for many years to come.An important safety feature of all volatile agents is thatmost of what goes <strong>in</strong>to the patient via the lungs shouldcome out the same way. Therefore the anaesthetic effectis reversible, as long as the patient is breath<strong>in</strong>g. Also, withspontaneous breath<strong>in</strong>g, the patient adjusts his or her own“dose “ and respiratory depression will reduce the amountof vapour taken up and help prevent overdose. Withcontrolled ventilation it is very easy to give an overdose.A typical general anaesthetic (GA) us<strong>in</strong>g halothane orether and noth<strong>in</strong>g else is “bumpy”, often unpleasant forthe patient dur<strong>in</strong>g <strong>in</strong>duction and recovery, but reasonablysafe.The cost of some of the newer agents is very great andthey are not generally used <strong>in</strong> develop<strong>in</strong>g countries. Thecheaper, older agents, like ether, though widely used <strong>in</strong>poorer countries, are hardly ever used <strong>in</strong> the west. Mostanaesthetists <strong>in</strong> the western world today have never givenether anaesthesia.How do volatile agents work?An agent breathed <strong>in</strong>to the lungs will dissolve first <strong>in</strong> theblood and then be carried to all parts of the body anddissolve <strong>in</strong> the tissues. The agent that dissolves <strong>in</strong> the bra<strong>in</strong>produces the state of anaesthesia. The bra<strong>in</strong>, be<strong>in</strong>g mostlyfat, absorbs a lot of the agent. Many theories have beenconsidered to expla<strong>in</strong> how anaesthesia is produced. Onesuggests that the fat <strong>in</strong> the cell wall swells up. This reducesthe ability of the nerves to conduct impulses to each otherand activity is reduced, or stopped altogether if you givean overdose. Fortunately, the higher centres controll<strong>in</strong>gconsciousness are the first affected and the vital centressuch as the respiratory and vasomotor centres are moreresistant to this effect. Thus we take it almost for grantedthat the anaesthetised patient will go on breath<strong>in</strong>g with anear-normal pulse and blood pressure.There are four broad physical properties of any agent thatwill tell the anaesthetist how it behaves <strong>in</strong> and out of thebody and, therefore, how to use it to best advantage.1. Solubility and Uptake. The blood solubility of an agentis related to its blood-gas partition coefficient. The partitioncoefficient is a simple ratio of amounts: eg. the blood/gascoefficient is the ratio of the amount dissolved <strong>in</strong> blood tothe amount <strong>in</strong> the same volume of gas <strong>in</strong> contact with thatblood. The more blood-soluble the agent (high bloodgaspartition coefficient), the slower the onset of effectand the slower the patient goes to sleep. Thus a very solubleagent eg. ether will dissolve <strong>in</strong> large quantities <strong>in</strong> bloodbefore the bra<strong>in</strong> levels can rise sufficiently to produceanaesthesia. To understand this concept, th<strong>in</strong>k of thecirculat<strong>in</strong>g blood volume as a large pool, soak<strong>in</strong>g up agentand not allow<strong>in</strong>g the bra<strong>in</strong> to have any.An anaesthetic agent does not “target” the bra<strong>in</strong>: itdissolves <strong>in</strong> all tissues accord<strong>in</strong>g to the tissue/gas partitioncoefficient for the particular agent <strong>in</strong> a tissue type. Theblood flow to that tissue and the mass of tissue presentwill also determ<strong>in</strong>e the amount of agent reach<strong>in</strong>g it andaccumulat<strong>in</strong>g there. Fat stores, like the bra<strong>in</strong>, have a veryhigh aff<strong>in</strong>ity for anaesthetic agents. Luckily for the <strong>in</strong>ductionof anaesthesia, body fat has a very poor blood flow anddur<strong>in</strong>g a short or medium length operation, only a limitedamount of agent will have dissolved there.Similarly, a high cardiac output such as may be found <strong>in</strong>fever or fear will cause more agent to be dissolved <strong>in</strong> bloodand tissues other than bra<strong>in</strong>, thus delay<strong>in</strong>g the onset ofCNS effects. In all these <strong>in</strong>stances, there is said to be ahigh uptake of the agent <strong>in</strong>to the body, i.e. the venousblood return<strong>in</strong>g to the heart has a low concentration of theagent and there is room for lots more. Paradoxically, thougha high uptake means a lot of agent is disappear<strong>in</strong>g <strong>in</strong>tothe body, blood levels rise slowly and the patient takes along time to go to sleep by <strong>in</strong>halation.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 79High uptake will also mean slow recovery because dur<strong>in</strong>gthe process of <strong>in</strong>duction and ma<strong>in</strong>tenance, a large reservoirof the agent will have accumulated <strong>in</strong> blood, fat and othertissues like muscle. At the end of a long operation, thisreservoir will slowly give up its stores of anaesthetic agentand thus act like a depot, delay<strong>in</strong>g recovery. As ether isvery blood soluble, it leaves the blood slowly and thereforecirculates for a long time, before it is f<strong>in</strong>ally excreted outfrom the lungs. Blood levels fall slowly delay<strong>in</strong>g a return toconsciousness. Halothane, be<strong>in</strong>g fat soluble, also rema<strong>in</strong>sfor hours <strong>in</strong> the fat of an obese patient at sub-anaestheticlevels, slowly be<strong>in</strong>g washed out long after the operation isover. But, the blood solubility is lower than ether andtherefore blood levels fall more quickly. Thus the level <strong>in</strong>the bra<strong>in</strong> falls more quickly, as the blood is able to “wash”the agent out. The patient therefore recovers consciousnessmore quickly than when ether has been used. Tissue bloodflow and cardiac output are important determ<strong>in</strong>ants <strong>in</strong> theelim<strong>in</strong>ation of highly soluble agents.The opposite happens <strong>in</strong> shock, with a low cardiac output:<strong>in</strong> this case blood levels rise quickly, <strong>in</strong>duction is fast anduptake is low.It can now be understood what happens when an agentwith a very low blood solubility is used (low blood/gaspartition coefficient). Blood levels rise very rapidly, lead<strong>in</strong>gto a rapid <strong>in</strong>duction of anaesthesia. When the agent isstopped the reverse happens: blood levels fall very quicklyand recovery occurs after a short <strong>in</strong>terval, no matter howlong the agent has been used. Changes <strong>in</strong> cardiac outputhave little effect on the speed of <strong>in</strong>duction of anaesthesia.The gas, nitrous oxide and newer agents, sevoflurane anddesflurane are examples of very <strong>in</strong>soluble drugs.2. Volatility. An agent with a low boil<strong>in</strong>g po<strong>in</strong>t willevaporate easily and therefore be more available than onethat has a high boil<strong>in</strong>g po<strong>in</strong>t. Ether is highly volatile andthus there is almost no limit to the concentration that avaporiser can give. Ether is really too volatile to beconvenient and sometimes new, sealed bottles arrive withno agent <strong>in</strong>side, but at least it means we can give plenty ofit to counteract its slow onset. Trichloroethylene, on theother hand, only reluctantly becomes a vapour and wehave difficulty <strong>in</strong> gett<strong>in</strong>g it <strong>in</strong>to the patient <strong>in</strong> sufficientquantities. Halothane is <strong>in</strong> between and has a near-perfectprofile of physical properties.Another <strong>in</strong>dex of volatility is the Saturated Vapour Pressureor SVP. It <strong>in</strong>dicates the maximum proportion ofatmospheric pressure which can be occupied by the vapourof an agent. Ether has an SVP of 425 mmHg andtheoretically will allow a maximum concentration of 56%(425/760 x 100). SVP is dependant only on thetemperature and not on atmospheric pressure.3. Potency. Regardless of solubility and boil<strong>in</strong>g po<strong>in</strong>t,each agent will have its own potency value. This is calledthe MAC - the M<strong>in</strong>imum Alveolar Concentration. This isthe concentration at equilibrium required to prevent a reflexresponse to a sk<strong>in</strong> <strong>in</strong>cision <strong>in</strong> 50% of patients. Thus thepotency of different agents can be compared by show<strong>in</strong>ghow much you need to produce the effect you want,expressed as a percentage vapour strength.An agent with a low MAC, is a potent agent because onlya small amount is required to produce anaesthesia. A highMAC means the agent is weak because a lot of agent isrequired to produce anaesthesia. Ether has a high MAC,is a weak agent, while trichloroethylene has a very lowMAC, is potent and produces its effects at a fraction ofthe concentration of that needed for ether. Once aga<strong>in</strong>,halothane has the ideal MAC, somewhere <strong>in</strong> between. Ifthe agent is be<strong>in</strong>g used alone with spontaneous breath<strong>in</strong>g<strong>in</strong> a fit patient, you will need to set your vaporiser to atleast three times the MAC to keep the average patientsettled dur<strong>in</strong>g surgery.The MAC of any agent is broadly determ<strong>in</strong>ed by its fatsolubility: the more fat soluble, the greater the potency.4. Pharmacological effects. Although we say that etheris weak, it is difficult to believe this statement if you see apatient totally unrousable after ether anaesthesia, a commonoccurrence. To expla<strong>in</strong> this, one has to th<strong>in</strong>k of the differentways an agent works: the anaesthetic effect, the analgesiceffect. the volatility and correlate these with the propertiesoutl<strong>in</strong>ed above. Ether is very volatile, has good anaestheticand analgesic effects and these, with the large reservoireffect and slow recovery, make it an effective anaesthetic,despite its low potency.Halothane is a good anaesthetic, but a poor analgesic.Thus the comb<strong>in</strong>ation of low solubility, a small bloodreservoir and postoperative pa<strong>in</strong> causes the patient to wakeup quickly.Trichloroethylene is a good analgesic but the patientbreath<strong>in</strong>g this alone will never get to the state of anaesthesiaat all unless he is given the agent for several hours becauseit does not evaporate enough to give a sufficient <strong>in</strong>spiratoryconcentration and is rather blood soluble.The side effects of the <strong>in</strong>dividual agents are mentioned <strong>in</strong>more detail below. All volatile agents trigger MalignantHyperthermia.


80<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>What agents are available?The <strong>in</strong>halation agents that are commonly used <strong>in</strong> Africaand other places where resources are limited are etherand halothane. When it is available, trichloroethylene isalso used.In the West halothane has been displaced by newer agents:isoflurane and sevoflurane. (Halothane is still widely used<strong>in</strong> paediatric anaesthesia.) These are far more costly thanhalothane and will not be considered <strong>in</strong> detail, though ifyou get the chance to use isoflurane you will be impressedhow good the recovery is compared to halothane. Ether,of course, is never used <strong>in</strong> the western world andtrichloroethylene has a dim<strong>in</strong>ish<strong>in</strong>g number of users worldwideand is hard to get. Laboratory grade is still available.The <strong>in</strong>dividual agents that are used all over Africa andelsewhere will be described now <strong>in</strong> detail:ETHER (diethyl ether)This is a very cheap agent as it is non-halogenated, madefrom sugar cane via ethanol us<strong>in</strong>g recycled sulphuric acid.With suitable fire precautions, it could easily be made locally<strong>in</strong> any country with the will to be self-sufficient.W.T.G.Morton demonstrated its effects on a famousoccasion <strong>in</strong> Boston, USA, <strong>in</strong> 1846 and this event hasbecome recognised world-wide as the “first anaesthetic”.Physical properties: Low boil<strong>in</strong>g po<strong>in</strong>t: 35 deg C. HighSVP at 20 deg C : 425 mm Hg. Blood/Gas partitioncoefficient: 12 (high), MAC: 1.92% (low potency). Cost:from US$10/litre, accord<strong>in</strong>g to supplier. Ether is highlyvolatile and <strong>in</strong>flammable. In oxygen, it is explosive. It hasa very strong and characteristic smell.Advantages: stimulates respiration and cardiac output,ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g blood pressure and causes bronchodilatation,all due to its sympathomimetic effect mediated byTable 1Volatile agents and their physical properties.AGENT SVP <strong>in</strong> mmHg MAC Blood/Gas coefficient CommentsEther 425 1.92% 12 High volatilityLow potencyHigh solubilityTrichloroethylene 60 0.17% 9 Low volatilityHigh potencyHigh solubilityHalothane 243 0.75% 2.3 VolatileLow potencyLow solubilitySevoflurane 160 1.7 - 2% 0.6 VolatileLow potencyInsolubleIsoflurane 250 1.15% 1.4 VolatilePotentLow solubility


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 81adrenal<strong>in</strong>e release. A good sole anaesthetic agent becauseof its analgesic effect. Does not relax the uterus likehalothane but gives good abdom<strong>in</strong>al relaxation. A safeagent.Disadvantages: flammable, slow onset, slow recovery,secretions +++ need<strong>in</strong>g atrop<strong>in</strong>e. Bronchial irritation, so<strong>in</strong>halation <strong>in</strong>duction of anaesthesia by mask is very difficultbecause of cough<strong>in</strong>g. PONV (postoperative nausea andvomit<strong>in</strong>g) is sometimes seen <strong>in</strong> Africa but is a majordisadvantage <strong>in</strong> the West, where patients vomit much more.Indications: Any general anaesthetic, but especially goodfor Caesarean section (because the baby tolerates it andthe uterus contracts well), and major cases with <strong>in</strong>tubation.It is life sav<strong>in</strong>g for poor risk cases us<strong>in</strong>g a low dose. Also<strong>in</strong>dicated when no supplementary oxygen is available.Contra-<strong>in</strong>dications: There are no absolute contra<strong>in</strong>dicationsfor ether.Scaveng<strong>in</strong>g should be carried out (where possible) to avoidcontact between heavy <strong>in</strong>flammable ether vapour anddiathermy apparatus or other electrical devices that mayspark and also to prevent exhaled vapour blow<strong>in</strong>g at thesurgeon.Practice po<strong>in</strong>ts: The best method is to give a highconcentration to a paralysed, <strong>in</strong>tubated patient. Thus afteratrop<strong>in</strong>e, thiopentone, suxamethonium and <strong>in</strong>tubation,generous IPPV is commenced with ether 15-20% andthen accord<strong>in</strong>g to the patient’s needs, the ether is reducedafter about 5 m<strong>in</strong>utes to 6-8%. Remember vaporiserperformance is variable. Poor risk, septic or shockedpatients may need only 2%. Switch off well before theend of the operation to avoid a prolonged recovery. Withskill you can have your patients almost awake as they moveoff the table. If you have a big strong man for a herniarepair, save yourself a lot of embarrassment and give hima sp<strong>in</strong>al <strong>in</strong>stead!It seems to be purely fortuitous, but the patients that benefitmost from ether anaesthesia, such as Caesarean sectionand emergency laparotomy (which comprise over 90%of all major surgery <strong>in</strong> Africa 2 ) do not need diathermy.Where diathermy is essential, eg. <strong>in</strong> paediatric surgery,halothane is a better drug, so the conflict between etherand diathermy rarely arises. At our hospital, we do notallow ether to be used with diathermy.HALOTHANE (“Fluothane”)Physical properties: Boils at 50 o C, SVP at 20 o C:243mmHg. Blood /Gas partition coefficient:2.3, MAC0.75%. Cost: US$ 140/litre.Advantages: Well tolerated, non-irritant, potent (lowMAC) agent, which is relatively <strong>in</strong>soluble <strong>in</strong> blood, giv<strong>in</strong>grapid <strong>in</strong>duction, low dose ma<strong>in</strong>tenance and rapid recovery.There is predictable, dose-related depression of therespiratory and cardiovascular systems. The ideal <strong>in</strong>halation<strong>in</strong>duction agent.Disadvantages: Perhaps too potent, and overdose iseasy. Poor analgesic properties necessitat<strong>in</strong>g deep planesof anaesthesia before surgery and especially <strong>in</strong>tubation canbe tolerated. No post-operative analgesia. Uter<strong>in</strong>erelaxation and haemorrhage at concentrations above 2%.Hypotension, dysrhythmias and especially dangerous withadrenal<strong>in</strong>e where cardiac arrest <strong>in</strong> VF readily occurs. Postoperativeshiver<strong>in</strong>g. “Halothane hepatitis” may very rarelyoccur (I have never seen a case <strong>in</strong> Africa). It is extensivelymetabolised <strong>in</strong> the body and is best avoided with<strong>in</strong> threemonths of a previous halothane anaesthetic unless the<strong>in</strong>dications to use halothane are considered to overridethe risk of this rare condition.Indications: almost all general anaesthesia, especiallypaediatrics. Inhalation <strong>in</strong>duction especially <strong>in</strong> upper airwayobstruction.Contra-<strong>in</strong>dications: simultaneous adm<strong>in</strong>istration withadrenal<strong>in</strong>e, especially dur<strong>in</strong>g spontaneous breath<strong>in</strong>g. Highdose for Caesarean section or uter<strong>in</strong>e evacuation. Historyof unexpla<strong>in</strong>ed hepatitis follow<strong>in</strong>g a previous anaesthetic.Dosage: Induction with 3%, reduc<strong>in</strong>g to 1.5% forma<strong>in</strong>tenance. Children need 2% for ma<strong>in</strong>tenance. Over4% for more than a few m<strong>in</strong>utes will produce an overdose.Practice Po<strong>in</strong>ts: Halothane alone is not ideal because ithas no analgesic properties. You need high concentrationsto abolish reflex activity, eg. stra<strong>in</strong><strong>in</strong>g on the endotrachealtube. This becomes expensive and may also be unsafe.The common cl<strong>in</strong>ical situation of an <strong>in</strong>tubated patientbreath<strong>in</strong>g spontaneously high concentrations of halothane<strong>in</strong> oxygen and air is potentially hazardous <strong>in</strong> the presenceof heart disease. Many anaesthetists get away with it <strong>in</strong>ignorance, but only because heart disease is uncommon<strong>in</strong> Africa.A common arrangement is to have two draw-overvaporisers <strong>in</strong> series conta<strong>in</strong><strong>in</strong>g halothane andtrichloroethylene. Where available, nitrous oxide iscommonly used for analgesia; opioids or regional blocksare alternatives.Supplementary oxygen is mandatory when us<strong>in</strong>g halothaneto avoid hypoxia.


82<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>TRICHLOROETHYLENE (“Trilene”)Physical properties: Boils at 87 o C (high), SVP at 20 o C:60 mmHg. Blood/Gas partition coefficient: 9 (high), MAC0.17%Advantages: Non-irritant. Safe. Good analgesia dur<strong>in</strong>gand after surgery. Cardiovascularly stable. Very cheap,because one uses so little.Disadvantages: Low volatility, slow onset of effectbecause of high blood solubility and low boil<strong>in</strong>g po<strong>in</strong>tmak<strong>in</strong>g it impossible to get concentrations that are highenough. It is a potent agent because you need little toproduce an effect, BUT it is a weak anaesthetic because,despite this, vaporisers cannot produce high enoughconcentrations because the volatility is so low. Tachypnoeaused to be reported <strong>in</strong> the West but we don’t see it <strong>in</strong>Malawi. Dysrhythmias may occur with adrenal<strong>in</strong>e.Prolonged recovery, because of high blood solubility.Indications: analgesic supplement to halothane or usedon its own for m<strong>in</strong>or procedures such as fracturemanipulation, debridement etc.Contra<strong>in</strong>dications: overdosage <strong>in</strong> the elderly. Closedcircuit with soda-lime. Best avoided <strong>in</strong> very small babies.Dosage: 0.5 - 1% <strong>in</strong>itially, reduc<strong>in</strong>g to 0.2 - 0.5%.Practice Po<strong>in</strong>ts: Switch off 20-30 m<strong>in</strong>utes before theend of a long operation to avoid prolonged sedative effects.Its ideal function is to give background analgesia for longcases us<strong>in</strong>g halothane as the ma<strong>in</strong> anaesthetic but it is alsovery good given with halothane for a fast turn-over of shortcases us<strong>in</strong>g <strong>in</strong>halation <strong>in</strong>duction. We give it from a Goldmanhalothane vaporiser <strong>in</strong> series with a halothane vaporiser,us<strong>in</strong>g a gauze <strong>in</strong> the bowl to <strong>in</strong>crease evaporation. Thisgives about 0.7%.The newer agents:Enflurane: was a replacement for halothane, now used<strong>in</strong>frequently.Isoflurane: Boils at 48 o C. SVP at 20 o C: 250mmHg,Blood/Gas partition coefficient: 1.4, MAC: 1.15. Ingeneral use, good recovery because of relatively low bloodsolubility, but <strong>in</strong>duction difficult because of irritat<strong>in</strong>g badsmell, m<strong>in</strong>imal metabolism, no arrhythmias but causeshypotension, six times the cost of halothane. Big costreductions when used <strong>in</strong> a low flow system.Desflurane: Boils at 23.5 o C, SVP at 20 o C: 673 mmHg,Blood/Gas partition coefficient 0.4 (low), MAC: 5-10%.Replacement for enflurane, requires a specially designedvaporiser, has come and gone without me ever see<strong>in</strong>g it!Sevoflurane: Boils at 58.5 o C, SVP at 20 o C: 160 mmHg,Blood/Gas partition coefficient 0.6 (low), MAC: 1.7-2%.Fabulously expensive ($1000/litre), but costs can bereduced if used <strong>in</strong> a low flow system. There may beproblems with sevoflurane and carbon dioxide absorbers,baralyme <strong>in</strong> particular, but these are currently be<strong>in</strong>g<strong>in</strong>vestigated. Ultra low solubility result<strong>in</strong>g <strong>in</strong> ultra rapid<strong>in</strong>duction and recovery especially as it is non-irritant andsweet smell<strong>in</strong>g. High volatility and high percentage required.How should volatile agents be used?One way is to use them for <strong>in</strong>halation <strong>in</strong>duction ofanaesthesia followed by ma<strong>in</strong>tenance with the same oranother agent as your sole anaesthetic. The patient putshim or herself to sleep by breath<strong>in</strong>g via a close-fitt<strong>in</strong>g maskand provided the smell is accepted and the stage IIexcitement effects are not excessive, this is a verysatisfactory method of <strong>in</strong>duc<strong>in</strong>g general anaesthesia form<strong>in</strong>or cases without gastric aspiration risk. Lung disease,smok<strong>in</strong>g or dr<strong>in</strong>k<strong>in</strong>g habit, obesity and high uptakesituations (see above) will make this method slower andprolong stage II effects. Loss of airway <strong>in</strong> an obese patientmay be dangerous. Ideal for a fast turn-over of lots ofshort procedures on th<strong>in</strong> patients.The other way is to put up a drip and give an <strong>in</strong>travenous<strong>in</strong>duction followed by the volatile agent for ma<strong>in</strong>tenanceof anaesthesia. Very often the <strong>in</strong>travenous <strong>in</strong>duction will<strong>in</strong>clude <strong>in</strong>tubation of the trachea as well. All generalanaesthesia for major cases will be done this way.Further read<strong>in</strong>g1. Scurr C, Feldman S, Soni N. Scientific Foundations of<strong>Anaesthesia</strong>. Fourth Edition. Oxford: He<strong>in</strong>emann Medical Books19912. Fenton, P. M. Epidemiology of district surgery <strong>in</strong> Africa. Eastand Central African Journal of Surgery. 1997;3:33-41.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 83EXTRACTS FROM THE JOURNALSDr Henk Haisma, University Hospital Gron<strong>in</strong>gen, POBox 30001, 9700 RB Gron<strong>in</strong>gen, the Netherlandse-mail H.J.Haisma@anest.azg.nlPulmonary Artery Catheterization.Over the past decade, there has been vigorous debateconcern<strong>in</strong>g the <strong>in</strong>dication for, and cl<strong>in</strong>ical utility of, thePulmonary Artery Catheter (PAC). Recently, Connors etal.(1) reported an observational study of PAC useconducted <strong>in</strong> five teach<strong>in</strong>g hospitals <strong>in</strong> the United Statesbetween 1989 and 1994. In this study, the PAC wasassociated with both <strong>in</strong>creased mortality and utilisation ofresources when compared with case-matched controlpatients who did not undergo pulmonary arterycatheterisation. Despite the paper’s shortcom<strong>in</strong>gs (notprospective, nor randomised, nor a controlled trial) itserved as a catalyst to aga<strong>in</strong> <strong>in</strong>tensify heated debate overthe use of the PAC <strong>in</strong> the critically ill patient. Complicationsdirectly associated with the catheter itself does not seemto cause the problems but <strong>in</strong>correctly collectedhaemodynamic data may lead to improper therapeuticstrategies. Another factor is the documented significant<strong>in</strong>terobserver variability <strong>in</strong> <strong>in</strong>terpretation of pulmonary arterypressure trac<strong>in</strong>gs. Modification of care that PACs seemto provoke, like <strong>in</strong>creas<strong>in</strong>g the use of vasopressors,<strong>in</strong>otropes and <strong>in</strong>tensity of care, may, at times do moreharm than good. Also, disturb<strong>in</strong>g evidence exists suggest<strong>in</strong>gthat knowledge of basic pr<strong>in</strong>ciples of pulmonary arterycatheterization by physicians and nurses engaged <strong>in</strong> rout<strong>in</strong>euse of these devices is suboptimal.The study of Connors et al. led to a consensus conferencethat recommended guidel<strong>in</strong>es for the use of the PAC (2).Some of the f<strong>in</strong>al recommendations, which reflect thecollective op<strong>in</strong>ion of the participants, are: Cl<strong>in</strong>icians should cont<strong>in</strong>ue to carefully weigh therisks and benefits of the PAC.Cl<strong>in</strong>ician knowledge about the use of the PAC andits complications should be improved. The <strong>in</strong>dications and contra<strong>in</strong>dications for PAC use,where cl<strong>in</strong>ical evidence is lack<strong>in</strong>g, should bedeterm<strong>in</strong>ed.To summarise, most cl<strong>in</strong>icians believe that the PAC is useful<strong>in</strong> guid<strong>in</strong>g <strong>in</strong>travascular volume expansion andpharmacological <strong>in</strong>tervention <strong>in</strong> selected critically ill patients,however f<strong>in</strong>d<strong>in</strong>g clear evidence to substantiate this beliefis difficult, despite 25 years of PAC use!1. Connors Jr AF, Speroff T, Dawson NV, Thomas C, Harrell Jr FE,Wagner D, et al. The effectiveness of right heart catheterization<strong>in</strong> the <strong>in</strong>itial care of critically ill patients. JAMA 1996;276:889-8972. Pulmonary Artery Catheter Consensus Conference Participants.Pulmonary artery catheter consensus conference: consensusstatement. Crit Care Med 1997;25:910-925Management of Dural PunctureUn<strong>in</strong>tended dural punctures cont<strong>in</strong>ue to occur dur<strong>in</strong>g theattempted <strong>in</strong>sertion of epidural needles. Berger et al. (1)reported <strong>in</strong> a survey of 46 North American tertiary careobstetric centres on the management of dural puncturesoccurr<strong>in</strong>g with epidural analgesia dur<strong>in</strong>g labour. The<strong>in</strong>cidence of <strong>in</strong>advertant dural puncture was 0.4%-6%.Follow<strong>in</strong>g accidental dural puncture, 86% of patientsexperienced headache, <strong>in</strong> 63% of these patients it wassevere.Resit<strong>in</strong>g the epidural catheter at another level was the mostcommon <strong>in</strong>itial step (90%) after dural puncture. If anotherepidural catheter was successfully placed, most centresused their standard top up or <strong>in</strong>fusion regimes. Somecentres (ma<strong>in</strong>ly <strong>in</strong> the USA) considered cont<strong>in</strong>uous<strong>in</strong>trathecal catheters as an alternative if the epidural catheterproved difficult to place.Follow<strong>in</strong>g delivery 86% of centres allowed unrestrictedmobilisation. If headache occurred ly<strong>in</strong>g <strong>in</strong> bed was foundto be useful for pa<strong>in</strong> relief.Enhanced hydration, either orally or <strong>in</strong>travenously, to<strong>in</strong>crease CSF production, has not been shown to decreasethe risk of headache, but may lessen its severity. Thebeneficial effects of caffe<strong>in</strong>e are transient <strong>in</strong> many patients.17% of centres employed epidural sal<strong>in</strong>e boluses or<strong>in</strong>fusions.Prophylactic epidural blood patch (EBP) wasrecommended by 37% of centres, with twice as many USas Canadian centres do<strong>in</strong>g so. The EBP is still the mostefficacious treatment for a post dural puncture headachewith a reported success rate of greater than 90%. Theresolution of symptoms are thought to be caused by an<strong>in</strong>crease <strong>in</strong> CSF pressure from the <strong>in</strong>jection of an epiduralblood volume and formation of a clot at the site of thedural hole that seals and prevents further CSF leakage.1 Berger CW, Crosby ET, Groecki W. North American survey ofthe management of dural puncture occurr<strong>in</strong>g dur<strong>in</strong>g labourepidural analgesia. Can J Anaesth 1998; 45: <strong>11</strong>0-<strong>11</strong>4


84<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>SELF ASSESSMENT SECTIONDr Andrew Longmate, Stirl<strong>in</strong>g Royal Infirmary, Scotland, UK1. In significant aortic stenosis:A there is an early diastolic murmurB the ECG often shows evidence of left ventricularhypertrophyC can be caused by rheumatic feverD collapse may be the first manifestationE cannot be present if the patient is hypertensive2. With aortic stenosis:A a pulse rate of 40 per m<strong>in</strong>ute is good forhaemodynamicsB ketam<strong>in</strong>e is a useful anaesthetic agentC antibiotic prophylaxis is necessary for surgicalprocedures on the bladderD neuromuscular relaxation is contra<strong>in</strong>dicatedE hydralaz<strong>in</strong>e is a safe drug to use3. In cardiac tamponade there may be:A hypotensionB distended neck ve<strong>in</strong>sC Kussmaul’s signD pulsus paradoxusE cardiac arrest4. Concern<strong>in</strong>g cardiac tamponade:A may be caused by penetrat<strong>in</strong>g traumaB may be secondary to a pericardial effusionC general anaesthesia is required to dra<strong>in</strong> thepericardiumD can follow blunt traumaE ECG complexes may be small5. Constrictive pericarditis:A may be caused by TBB causes abdom<strong>in</strong>al swell<strong>in</strong>gC may lead to hepatomegalyD peripheral oedema may be m<strong>in</strong>imalE may cause peritonitis6. Rheumatic fever:A affects only the heart valvesB occurs after streptococcal <strong>in</strong>fectionC may cause a large jo<strong>in</strong>t polyarthritisD does not affect the mitral valveE may cause elevated ST segments on the ECG7. Elevated blood urea may occur:A <strong>in</strong> renal failureB after bleed<strong>in</strong>g <strong>in</strong>to the gutC <strong>in</strong> dehydrationD <strong>in</strong> liver failureE <strong>in</strong> overhydration8. Concern<strong>in</strong>g tuberculosis:A miliary TB may be associated with a negativemantoux testB the X-ray of miliary TB may mimickstapylococcal pneumoniaC primary TB can cause hilar adenopathy on chestX-rayD the primary complex causes upper lobe cavitationE may present <strong>in</strong> conjunction with malnutrition9. The Apgar score:A should be measured at 0 and 3 m<strong>in</strong>utesB has a maximum score of 8C <strong>in</strong>cludes assessment of respirationD <strong>in</strong>cludes assessment of colourE each measure is scored 0-<strong>11</strong>0. The GCS (Glasgow Coma Scale):A has a m<strong>in</strong>imum score of 0B scores pupil sizeC a confused patient would score 13D if reduced <strong>in</strong> presence of a skull fracture is aworry<strong>in</strong>g signE if 15 <strong>in</strong> presence of a skull fracture is reassur<strong>in</strong>g<strong>11</strong>. After head <strong>in</strong>jury:A a lucid <strong>in</strong>terval may occur with an extraduralhaematomaB craniotomy will take preference over surgery forabdom<strong>in</strong>al bleed<strong>in</strong>gC depressed skull fracture always requires operativerepairD wound toilet may be safely accomplished underlocal anaestheticE hypertension and bradycardia may occur with


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 85raised <strong>in</strong>tracranial pressureElow blood pressure and slow pulse12. Features of base of skull fracture <strong>in</strong>clude:A Battle’s signB “raccoon” or “panda” eyesC a haemotympanum (blood beh<strong>in</strong>d the ear drum)D normal GCSE lowered GCS13. After head <strong>in</strong>jury treatment of raised ICP(<strong>in</strong>tracranial) pressure can <strong>in</strong>clude:A 1000ml of 20% mannitolB 20mg of frusemideC <strong>in</strong>travenous colloid or 0.9% sal<strong>in</strong>e solutionD ma<strong>in</strong>tenance of nutrition with 5% dextrosesolutionE position<strong>in</strong>g the patient <strong>in</strong> slight head up posture14. After head <strong>in</strong>jury treatment of raised ICP(<strong>in</strong>tracranial pressure) can <strong>in</strong>clude:A surgical decompression of space occupy<strong>in</strong>g lesionB slight hyperventilationC apply<strong>in</strong>g atrop<strong>in</strong>e to the conjunctiva <strong>in</strong> order tosee optic discsD us<strong>in</strong>g tight bandages round the neck to secure anendotracheal tubeE ketam<strong>in</strong>e <strong>in</strong>fusion15. Instruments can be sterilised:A by thorough clean<strong>in</strong>g <strong>in</strong> hot soapy waterB by immersion <strong>in</strong> chlorhexid<strong>in</strong>e for one hourC by boil<strong>in</strong>g <strong>in</strong> water for 20 m<strong>in</strong>utesD by autoclav<strong>in</strong>g even if they are still dirtyE by autoclav<strong>in</strong>g if they have been cleanedthoroughly beforehand16. Sp<strong>in</strong>al <strong>in</strong>jury may be associated with:A flaccid paralysisB priapismC ur<strong>in</strong>ary retentionD loss of anal tone17. After blunt thoracic trauma:A fractured ribs 9-12 may be associated with liveror spleen <strong>in</strong>juryB myocardial <strong>in</strong>jury may occur <strong>in</strong> association with afractured manubriumC pulmonary contusion may be complicated withARDSD flail segment can be diagnosed cl<strong>in</strong>icallyE consider thoracotomy if there is > 1500ml bloodloss from chest dra<strong>in</strong>18. Concern<strong>in</strong>g failed <strong>in</strong>tubation:A never remove cricoid pressure if the stomach isfullB if you cannot <strong>in</strong>tubate or ventilate a surgicalairway is <strong>in</strong>dicatedC don’t worry how long it takes- try, try, try aga<strong>in</strong>until you are successful at <strong>in</strong>tubat<strong>in</strong>gD the safest plan is to wake the patient up beforeus<strong>in</strong>g an alternative approachE reposition<strong>in</strong>g the patient’s head and neck may beuseful manoevers19. Low serum potassium (hypokalaemia):A may occur <strong>in</strong> kwashiorkorB can occur after high dose salbutamolC may cause cardiac arrhythmiasD reduces digox<strong>in</strong> toxicityE may cause ileus20. High serum potassium (hyperkalaemia):A may cause cardiac arrestB should be treated with 50mls 50% dextrose plus50u of soluble <strong>in</strong>sul<strong>in</strong>C can be treated with sodium bicarbonateD may be caused by rhabdomyolysisE can occur with spironolactone


86<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>TECHNIQUES FROM AROUND THE WORLDThis is a new section of <strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> <strong>in</strong> whichanaesthetists from different countries and different hospitalsexpla<strong>in</strong> how they anaesthetise for certa<strong>in</strong> types of surgery.Techniques vary widely from one facility to the next andwe hope to illustrate the different methods of anaesthesiawhich are used. In this edition, anaesthetists from SouthAfrica, India and Indonesia describe how they wouldanaesthetise a previously fit patient for bowel resection.<strong>Anaesthesia</strong> for a patient scheduled foran elective bowel resectionDr. Natalie Hendricks, Registrar, Department of<strong>Anaesthesia</strong>, Groote Schuur Hospital and University ofCape Town, Cape Town, R.S.A.The anaesthetic course would vary depend<strong>in</strong>g on the typeof surgery to be undertaken. This patient is scheduled fora simple laparotomy for a bowel resection, and not a majorprocedure such as an anterior- posterior resection.Preoperative preparation and <strong>in</strong>vestigations: Rout<strong>in</strong>epreoperative <strong>in</strong>vestigations <strong>in</strong>clude a f<strong>in</strong>ger prickhaemoglob<strong>in</strong>. Any further <strong>in</strong>vestigations would dependon the case scenario and the patient’s pre-morbid state.Premedication: Temazepam 10-20 mg depend<strong>in</strong>g onthe patients weight. DVT prophylaxis (for prolongedprocedures) with 5000 units of hepar<strong>in</strong> adm<strong>in</strong>isteredsubcutaneously.Pre-<strong>in</strong>duction: Venous access is established by plac<strong>in</strong>ga large bore <strong>in</strong>travenous catheter and the adm<strong>in</strong>istrationof modified R<strong>in</strong>gers lactateInduction: In the absence of any <strong>in</strong>dication for a rapidsequence <strong>in</strong>duction, anaesthesia would be <strong>in</strong>duced with3-4mg/kg of thiopentone and 0.1mg/kg of vecuronium.The patient is then manually ventilated via a facemask with50% oxygen <strong>in</strong> air and 1.5% halothane for 3 m<strong>in</strong>utes afterwhich an oral endotracheal tube is <strong>in</strong>serted. A rapidsequence <strong>in</strong>duction would be performed if there was anyrisk of reflux and aspiration.Ma<strong>in</strong>tenance: The patient is ventilated with an oxygen/air/ halothane mixture. If the patient had received halothanewith<strong>in</strong> the last 6 months, isoflurane would be used <strong>in</strong>stead.A circle system is used with a total flow of about 1 litre /m<strong>in</strong>ute.A nasogastric tube would be <strong>in</strong>serted. Intermittent bolusesof vecuronium to ma<strong>in</strong>ta<strong>in</strong> surgical relaxation. Analgesiawould be provided by 10-15mg of morph<strong>in</strong>e <strong>in</strong>travenously.Monitor<strong>in</strong>g: 3 lead ECG, non-<strong>in</strong>vasive blood pressureat 3 m<strong>in</strong>ute <strong>in</strong>tervals, pulse oximetry, capnography, ur<strong>in</strong>arycatheter and peripheral nerve stimulator. Nasopharyngealtemperature probe is used with prolonged surgery. An<strong>in</strong>ternal jugular CVP l<strong>in</strong>e would be placed if large volumesof fluid shifts were anticipated.Fluids: Modified R<strong>in</strong>gers lactate at approximately 6-8mls/kg/hr. Additional colloids and crystalloids adm<strong>in</strong>isteredas required to replace fluid and blood loss and for thirdspace losses.Other measures: Temperature is ma<strong>in</strong>ta<strong>in</strong>ed with forcedair warm<strong>in</strong>g blanket for a prolonged procedure. Dynamiccalf compressors are used to prevent DVT. Antibioticswould be given i.v. <strong>in</strong> theatre - benzyl penicill<strong>in</strong> 2 millionunits, gentamic<strong>in</strong> 6mg/kg and metronidazole 500mg.End of anaesthesia: Discont<strong>in</strong>uation of volatile agent.Reverse muscle relaxation with 0.4mg glycopyrrolate and2.5mg of neostigm<strong>in</strong>e. Extubate patient and transfer tothe recovery room, with 40% oxygen via a Venturifacemask.Recovery Room: Patient nursed <strong>in</strong> the recovery positionand given 40% oxygen by facemask. Monitor non-<strong>in</strong>vasiveblood pressure and pulse oximetry.Pa<strong>in</strong> Management: Further <strong>in</strong>travenous boluses ofmorph<strong>in</strong>e as required to ensure adequate analgesia beforetransfer to ward.Recovery discharge criteria for ward: Patient awake and able to cough Susta<strong>in</strong>ed head lift for 5 seconds Pa<strong>in</strong> free Haemodynamically stable No nausea or vomit<strong>in</strong>g Haemostasis as assessed via surgical dress<strong>in</strong>gPostoperative InstructionsMonitor<strong>in</strong>g: Rout<strong>in</strong>e postoperative monitor<strong>in</strong>g to <strong>in</strong>cludeheart rate, respiratory rate, blood pressure every 15m<strong>in</strong>utes for 2 hours and then 4 hourly if patient stable.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 87Fluids: 5 % dextrose <strong>in</strong> 0.45% sal<strong>in</strong>e; 1000mls each8hrsAnalgesia: Morph<strong>in</strong>e <strong>in</strong>fusion 20mg of morph<strong>in</strong>e <strong>in</strong>200mls of sal<strong>in</strong>e @ 10-15mls/hr titrated to effectHow would you anaesthetise a 50 year old previouslyhealthy patient scheduled for elective laparotomy andbowel resection?Dr Eddy Rahardjo, Dr.Sutomo Hospital, AirlanggaUniversity, School of Medic<strong>in</strong>e, Surabaya , IndonesiaPatients scheduled for bowel resection <strong>in</strong>variably have somedegree of bowel obstruction and malnutrition. Causes<strong>in</strong>clude malignancy, <strong>in</strong>flammatory bowel disease or morerarely cases of amoebiasis or extra-lumen abscessconstrict<strong>in</strong>g the bowel.Preoperative evaluation <strong>in</strong>cludes physical exam<strong>in</strong>ation,vital signs evaluation and laboratory evaluation of Hb, Hct,album<strong>in</strong>, creat<strong>in</strong><strong>in</strong>e, K + , Na + and blood glucose wheneverposssible. A chest X-ray will provide important data forthe lung conditions, possible lung metastases and heartconfiguration. ECG record<strong>in</strong>g is useful <strong>in</strong> identify<strong>in</strong>garrhythmias, coronary ischemia and hypertrophy.Premedication is determ<strong>in</strong>ed by the patient’spsychological state as assessed at the preoperative visit.A dose of midazolam 2.5 - 5mg i.m. will help relax thepatient; promethaz<strong>in</strong>e 1mg/kg i.m. or diazepam 0.2mg/kgi.m. are alternatives. This sedation applies for both generalor regional anaesthesia.When ether anaesthesia is planned, atrop<strong>in</strong>e 0.25mg i.mis given preoperatively followed by 0.25mg i.v. on<strong>in</strong>duction to prevent hypersecretion of the salivary andbronchial glands. Opioid analgesia should be providedwhen the plan <strong>in</strong>cludes halothane which has a low analgesicproperty (e.g. pethid<strong>in</strong>e 1mg/kg or morph<strong>in</strong>e 0.1 mg/kg).<strong>Anaesthesia</strong>: Some surgeons are capable of perform<strong>in</strong>gbowel resection very quickly. With such a surgeon epiduralanesthesia can sometimes be used for lower abdom<strong>in</strong>aloperations. A cont<strong>in</strong>uous lumbar epidural with the catheter<strong>in</strong>serted at the lumbar 2-3 <strong>in</strong>tervertebral space usuallyworks well. Lignoca<strong>in</strong>e 1.5% to 2.0% with 1:100,000adrenal<strong>in</strong>e is used to produce anaesthesia up to the sensorylevel of thoracic segment 4-6th. However regionalanaesthesia is not safer for this type of surgery and generalanaesthesia is usually preferred.Induction is usually with thiopentone or ketam<strong>in</strong>e andsuxamethonium followed by tracheal <strong>in</strong>tubation. This isfollowed by an <strong>in</strong>halational agent (halothane or ether)adm<strong>in</strong>istered with a non-depolaris<strong>in</strong>g muscle relaxant suchas pancuronium and controlled ventilation. Although deepether may be used with spontaneous or assisted ventilation(stage III plane 2 or 3), light ether anaesthesia (stage II orI) with pancuronium is preferred because the patient willrecover very quickly.Basic vital sign monitor<strong>in</strong>g <strong>in</strong>cludes blood pressure,pulse rate, temperature (usually rectal). A precordialstethoscope and a f<strong>in</strong>ger on the pulse is compulsory.Ventilation is usually manual, but when a simple ventilatoris used chest movement is observed cont<strong>in</strong>uously.Intravenous fluids: Preoperative hydration is 1000 mlof R<strong>in</strong>ger dextrose or R<strong>in</strong>ger’s lactate start<strong>in</strong>g before bowelpreparation and cont<strong>in</strong>ued up to the time of <strong>in</strong>duction.Dur<strong>in</strong>g surgery R<strong>in</strong>ger’s lactate or NaCl 0.9% is given at10ml/kg/hour via a 16G or 18G i.v.catheter placed <strong>in</strong> thearm.Blood loss <strong>in</strong> excess of 15% - 20% of estimated bloodvolume is replaced with blood transfusion. In my <strong>in</strong>stitutionwe try to delay transfusion until the postoperative periodif the circulation is stable. This allows the patient to compla<strong>in</strong>of any adverse effect from the transfusion. When transfusionis delayed, R<strong>in</strong>ger’s lactate 2-3 times the measured loss isgiven.Postoperatively: At the end of the procedure the patientis extubated and supplemental oxygen is given for 4-6hours postoperatively. The patient stays <strong>in</strong> the recoveryroom before be<strong>in</strong>g transferred to the ward. In manyhospitals there is a new trend of keep<strong>in</strong>g these patients <strong>in</strong>a high dependency care area so that the vital signs, fluidbalance and pa<strong>in</strong> management can be optimized.Postoperative <strong>in</strong>structions <strong>in</strong>clude pa<strong>in</strong> management,which is often oversimplified and not effective. Opioidsare frequently <strong>in</strong> short supply and this form of analgesiamay be impossible. Alternatively, i.v. NSAIDS are morereadily available but more expensive.R<strong>in</strong>ger’s lactate and dextrose 5% 40-50 ml/kg/day is givenpostoperatively tak<strong>in</strong>g <strong>in</strong>to account the high ambienttemperature <strong>in</strong> the ward. As soon as possible gradualoral alimentation is started and normal diet is resumedaround day 5 with most patients.Malnutrition occurs commonly <strong>in</strong> develop<strong>in</strong>g countries and<strong>in</strong>creases the risk of surgery considerably. Althoughparenteral nutrition has not been proved to be beneficial<strong>in</strong> these circumstances, we believe that giv<strong>in</strong>g some nutritionis better than none. The cost of dextrose 10% is exactlythe same as dextrose 5%, and some brands of am<strong>in</strong>o acid


88<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>preparations are reasonable compared to the risk ofdehiscence (wound breakdown). Many centres thereforegive peripheral parenteral nutrition us<strong>in</strong>g dextrose 10%plus am<strong>in</strong>o acids, particularly to those patients who areunlikely to be able to eat for more than 7 days.Management of a case of small bowel obstructionfor resection <strong>in</strong> IndiaDr Ashok S<strong>in</strong>ha, B M Birla Heart Research Centre,Calcutta, 700027 India.The management <strong>in</strong> India would vary widely, from thelimited facilities <strong>in</strong> remote regions to standard anaesthetictechniques <strong>in</strong> the cities and towns. However a patientrequir<strong>in</strong>g such <strong>in</strong>tervention is likely to be taken 20 -200kms to the nearest large town or city where the facilitiesavailable would be either a Government hospital or aprivate nurs<strong>in</strong>g home.Preoperative preparationInvestigations: Hb, urea, creat<strong>in</strong><strong>in</strong>e and electrolyteswhenever available, blood group<strong>in</strong>g and crossmatch<strong>in</strong>g if<strong>in</strong>dicated. An ECG is usually performed over the age of40 years. A chest X-ray is only performed if there is cl<strong>in</strong>icalevidence of cardiac or respiratory disease.Preoperative fluid resuscitation is usually with R<strong>in</strong>ger’slactate and organised by the surgeons. A nasogastric tubeis usually <strong>in</strong>serted on the ward. It is common for patientscom<strong>in</strong>g from remote areas to be taken for surgery with<strong>in</strong>adequate resuscitation and <strong>in</strong>vestigations.Anaesthetic technique: Intravenous access is securedus<strong>in</strong>g a cannula or Butterfly needle. Premedication, whengiven, is usually i.v. pethid<strong>in</strong>e (25-50mg), buprenorph<strong>in</strong>eor pentazoc<strong>in</strong>e. Morph<strong>in</strong>e is rarely available. Intravenousatrop<strong>in</strong>e 0.6mg and metoclopramide 10mg are given bysome anaesthetists.Induction is carried out <strong>in</strong> the operat<strong>in</strong>g theatre us<strong>in</strong>gthiopentone and suxamethonium. If an assistant is availablecricoid pressure is applied and the patient <strong>in</strong>tubated us<strong>in</strong>ga red rubber endotracheal tube.The patient is ma<strong>in</strong>ta<strong>in</strong>ed on a mixture of oxygen, nitrousoxide and halothane and relaxation cont<strong>in</strong>ued us<strong>in</strong>gpancuronium. Further doses of 10mg pethid<strong>in</strong>e are givenas required. In poor risk patients diazepam or midazolammay be used <strong>in</strong> small doses to supplement <strong>in</strong>duction.Occasionally sp<strong>in</strong>al anaesthesia is used where generalanaesthetic techniques are not available.Reversal: The patient is given neostigm<strong>in</strong>e and atrop<strong>in</strong>e(2.5mg+1.2mg) and the patient extubated on the tablewhen there is adequate respiratory effort. Once theanaesthetist is satisfied with the ability of the patient toma<strong>in</strong>ta<strong>in</strong> their airway and respiration the patient is movedto the recovery area.Recovery: The pulse, respiration and BP is recordedevery 15 m<strong>in</strong>utes (manually) by a tra<strong>in</strong>ed nurse or operat<strong>in</strong>gdepartment assistant. Before mov<strong>in</strong>g the patient to the wardthe anaesthetist is contacted and approval obta<strong>in</strong>ed.Post Operative InstructionsObservations: Record pulse, respiration, BP every 15m<strong>in</strong>utes for 2 hours, then every 1/2 hour or as required.Analgesia is i.m. pethid<strong>in</strong>e 50 mg 6 to 8 hourly. Thismay be comb<strong>in</strong>ed with i.m. diclofenac 50mg bd.Buprenorph<strong>in</strong>e is also used and occasionally morph<strong>in</strong>e.Tramadol is becom<strong>in</strong>g popular.Intravenous fluids are given as advised by the surgeonand is usually of the order of 2000mL R<strong>in</strong>ger’s lactatesolution over the next 12 hours.Note that postoperative <strong>in</strong>structions are usually written upby the surgeon as they supervise the postoperative care,and the anaesthetist is usually not <strong>in</strong>volved. The <strong>in</strong>cidenceof deep ve<strong>in</strong> thrombosis (DVT) appears to be lowtherefore prophylaxis is unusual.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 89ANSWERS TO ASSESSMENT SECTION ON PAGE 831. FTTTF2. FTTFFThe murmur is systolic. Blood pressure depends on cardiacoutput and systemic vascular resistance (SVR). In aorticstenosis there is often a reduced cardiac output but highcompensatory vasoconstriction. Depend<strong>in</strong>g on the balancebetween the two, there may be normotension, hypotension(as is classically described) or even hypertension.Vasodilation can cause potentially fatal downward spiralof blood pressure, so vasodilat<strong>in</strong>g drugs (such ashydralaz<strong>in</strong>e) are dangerous. A fixed stroke volume meanscardiac output cannot be ma<strong>in</strong>ta<strong>in</strong>ed at very slow heartrates. By <strong>in</strong>creas<strong>in</strong>g heart rate and systemic vascularresistance, ketam<strong>in</strong>e may prove useful. Voltage criteria forleft ventricular hypertrophy is often seen on the ECGbecause the heart has been pump<strong>in</strong>g aga<strong>in</strong>st an <strong>in</strong>creasedresistance (or “afterload”).3. TTTTTKussmauls sign is the rise <strong>in</strong> JVP (jugular venous pulsation)on <strong>in</strong>spiration, and is associated with impaired heart fill<strong>in</strong>gas occurs <strong>in</strong> constrictive pericarditis or cardiac tamponade.Normally the neck ve<strong>in</strong>s collapse and JVP falls on<strong>in</strong>siration.4. TTFTTFluid <strong>in</strong> the pericardium should be dra<strong>in</strong>ed beforeanaesthesia as severe hypotension can occur at <strong>in</strong>duction.A fast heart-rate and adequate preload maximize cardiacoutput <strong>in</strong> cardiac tamponade.5. TTTTFConstrictive pericarditis can be caused by a number ofconditions <strong>in</strong>clud<strong>in</strong>g TB. The cl<strong>in</strong>ical features are essentiallythose of right sided heart failure, <strong>in</strong>clud<strong>in</strong>g elevated JVP,massive liver enlargement and ascites. Dependent oedemais also usually a feature of right sided heart failure but isoften absent, m<strong>in</strong>imal or much less pronounced than thehepatomegaly and ascites <strong>in</strong> this particular condition.6. FTTFTRheumatic fever causes a pan-carditis and can causepericarditis which may be heard as a rub or seen on theECG as concave elevated ST segments7. TTTFFBlood urea level reflects three th<strong>in</strong>gs: i) production (it isproduced by the liver as prote<strong>in</strong>s are broken down). Thuslevels are low <strong>in</strong> liver failure and high after a gastro-<strong>in</strong>test<strong>in</strong>albleed (effectively a large prote<strong>in</strong> load). ii) clearance fromthe body, which is done by the kidneys. iii) body waterlevels - so simplistically the urea will be raised <strong>in</strong> dehydrationand diluted or lowered <strong>in</strong> over-hydration.8. TTTFTPost-primary TB may cause cavitation but the primarycomplex does not.9. FFTTFThe Apgar score <strong>in</strong>cludes assessment of 5 parameters witha maximum score of 1010. FFFTTM<strong>in</strong>imum GCS score is 3. Not<strong>in</strong>g pupil size is crucial<strong>in</strong> the assessment of head <strong>in</strong>jury, but is not part of theGCS score. A reduced GCS <strong>in</strong> association with a skullfracture means that there is a significant possibility (about1 <strong>in</strong> 4) of an <strong>in</strong>tracranial haematoma.<strong>11</strong>. TFFTTWhen deal<strong>in</strong>g with a head <strong>in</strong>jured patient, you need toconsider the whole patient. If they are at risk of bleed<strong>in</strong>gto death from another <strong>in</strong>jury, then this should be treatedfirst. “Secondary <strong>in</strong>sults” such as hypovolaemia,hypotension and hypoxaemia should be correctedaggressively.12. TTTTTWith fractured base of skull the fracture may be difficultor impossible to see on X-ray but can be diagnosedcl<strong>in</strong>ically <strong>in</strong> the presence of bruis<strong>in</strong>g over the mastoid(Battle’s sign), blood beh<strong>in</strong>d the tympanic membrane (orat the external auditory meatus)or periorbital bruis<strong>in</strong>g(Raccoon/Panda eyes). The fracture of bone alerts us tothe possibility of damage to the underly<strong>in</strong>g bra<strong>in</strong> whichneeds to be assessed cl<strong>in</strong>ically by GCS measurement andneurological exam<strong>in</strong>ation.13. FTTFTIntracranial pressure (ICP) can be reduced with a dose of100ml of 20% mannitol but 1000ml <strong>in</strong> one dose is toomuch. Frusemide augments the effects of mannitol <strong>in</strong>


90<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>reduc<strong>in</strong>g <strong>in</strong>tracranial pressure. Head <strong>in</strong>jured patients nearlyalways require <strong>in</strong>travenous fluids (especially after mannitolwhich will dehydrate them), but dextrose will worsencerebral swell<strong>in</strong>g and should not be used. ICP can also bereduced by plac<strong>in</strong>g the patient slightly head up (about 20-30 degrees) and avoid<strong>in</strong>g compression or obstruction ofthe neck ve<strong>in</strong>s which will worsen <strong>in</strong>tracranial congestion.(Hav<strong>in</strong>g said that it is important to secure the endotrachealtube well - try tap<strong>in</strong>g it <strong>in</strong>)14. TTFFFNot<strong>in</strong>g pupil size is crucial <strong>in</strong> the assessment of head <strong>in</strong>juryso do not dilate the pupils with atrop<strong>in</strong>e.15. FFFFTAutoclav<strong>in</strong>g does not work if the <strong>in</strong>struments have not beengiven a thorough “social” clean<strong>in</strong>g beforehand. Foreignmatter must be removed from the <strong>in</strong>struments beforeautoclav<strong>in</strong>g.16. TTTTT17. TTTTT18. FTFTTVentilation of the patient is more important than prevent<strong>in</strong>gaspiration - so if cricoid pressure is prevent<strong>in</strong>g ventilation,remove it! Decide early that <strong>in</strong>tubation has failed andconcentrate of ventilat<strong>in</strong>g the patient until they recoverspontaneous ventilation.19. TTTFT20. TFTTTHigh or low potassium will cause cardiac arrhythmias anddisturbances <strong>in</strong> balance can occur after a variety of drugsand conditions.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 91ARTICLE REPRODUCED BY KIND PERMISSION OF IASPPAIN Cl<strong>in</strong>ical<strong>Update</strong>sINTERNATIONAL ASSOCIATION FOR THE STUDY OF PAINVolume VI, Issue 2 July 1998EDITORIAL BOARDEditor-<strong>in</strong>-ChiefDaniel B. Carr, MDInternal Medic<strong>in</strong>e, Endocr<strong>in</strong>ology,AnesthesiologyUSAAdvisory BoardLars Arendt-Nielsen, PhDNeurophysiologyDenmarkKay Brune, MDPharmacologyGermanyJames R. Fricton, DDS, MSDentistry, Orofacial Pa<strong>in</strong>USAVictoria R. Hard<strong>in</strong>g, MCSP, SRP,GradDipPhysPhysical TherapyUnited K<strong>in</strong>gdomAlejandro R. Jadad, MD, PhDAnesthesiology, Evidence-BasedMedic<strong>in</strong>e and Consumer IssuesCanadaIrena Madjar, RGON, PhDNurs<strong>in</strong>gAustraliaPatricia A. McGrath, PhDPsychology, Pediatric Pa<strong>in</strong>CanadaBengt H. Sjolund, MD, PhDNeurosurgery, RehabilitationSwedenMasaya Tohyama, MD, PhDMolecular BiologyJapanProduction EditorLeslie N. BondUPCOMING ISSUESPa<strong>in</strong> and MemoryPhysiotherapy of Pa<strong>in</strong>Headache SyndromesPa<strong>in</strong> and Rehabilitation from Landm<strong>in</strong>e InjuryInternational pacts such as the Geneva and Ottawa Conventions forbidweapons that cause <strong>in</strong>discrim<strong>in</strong>ate, unnecessary mutilation 1 . Still, theseweapons are used worldwide and create victims long after peace agreementshave been signed.Pa<strong>in</strong>, particularly phantom limb pa<strong>in</strong> (PLP), is highly prevalent <strong>in</strong> landm<strong>in</strong>evictims. These victims, often poor and rural, have much to lose from <strong>in</strong>jury anddisability. Relief agencies such as the Red Cross are ill equipped to deal with pa<strong>in</strong>problems, and specialist pa<strong>in</strong> relief organizations such as Douleur Sans Frontièreshave limited resources. The worst-hit countries lack IASP chapters. Healthprofessionals, particularly members of IASP, have a responsibility not only totreat these victims but also, under the n<strong>in</strong>th item of the IASP constitution, to<strong>in</strong>form governments and the public about the suffer<strong>in</strong>g caused by these weaponsand the measures needed to prevent their use 2–10 .Medical needs are divided between <strong>in</strong>itial acute care and long-term rehabilitationand pa<strong>in</strong> management, particularly of PLP. Many factors, however, may limitcare. Among these are extremes of geography and terra<strong>in</strong>; dangers of traveldur<strong>in</strong>g conflict; and loot<strong>in</strong>g of hospitals, sometimes with <strong>in</strong>jury or death ofworkers. There may be great poverty, with poor education and social structures.Health care fund<strong>in</strong>g may be <strong>in</strong>adequate or limited by donor-derived constra<strong>in</strong>ts 3 .Medical needs are divided between <strong>in</strong>itial acute care and long-termrehabilitation and pa<strong>in</strong> management, particularly of phantom limb pa<strong>in</strong>.EpidemiologyThe lack of quantitative data precludes a precise and complete account of thehealth effects of landm<strong>in</strong>es, but estimates can be made. The InternationalCommittee of the Red Cross (ICRC) has collected data on immediate <strong>in</strong>juriesamong m<strong>in</strong>e survivors 5 . Several demographic surveys have tried to document thesocial consequences and frequency of m<strong>in</strong>e-related <strong>in</strong>juries 8–10 . All available datasuggest that the impact of landm<strong>in</strong>es may be grossly underestimated, as only thefittest survivors reach treatment.M<strong>in</strong>e <strong>in</strong>juries. Between 1995 and 1996 the ICRC registered 9384 landm<strong>in</strong>ecasualties 3,5 . That accounted for 27 % of surgical patients seen by the ICRC <strong>in</strong>three countries. Non-combatants (women, men >50 years, and children


92<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>kill<strong>in</strong>g zone of 25 m, and have an <strong>in</strong>jury zone of 200 m.Injuries to head, neck, chest, or abdomen are often fatal.• III (5%) from handl<strong>in</strong>g a m<strong>in</strong>e. The victim, often a child,susta<strong>in</strong>s severe upper limb <strong>in</strong>juries with associated face<strong>in</strong>juries.The rema<strong>in</strong><strong>in</strong>g 15% follow no particular pattern 5 . Coexist<strong>in</strong>glong-term <strong>in</strong>juries may <strong>in</strong>volve the eyes and peripheral nerves.Social impact. A study of 206 communities <strong>in</strong> Afghanistan,Mozambique, Cambodia, and Bosnia found a heavy toll<strong>in</strong> physical, mental, and economic disability 8 . The WHO GlobalBurden of Disease—which assesses the impact of social,economic, and physical handicap on the <strong>in</strong>dividual, the family,and society—rates below-knee amputation as the midpo<strong>in</strong>t ofseverity. Limb amputation impairs physical and hence earn<strong>in</strong>gcapacity and may be accompanied by profound psychiatricproblems and ostracism. Loss of <strong>in</strong>come occurs through lossof land and livestock, and reduced access to food andwater supplies. Agricultural production might be tripled <strong>in</strong>some areas by removal of landm<strong>in</strong>es 8 .Numbers of amputees. Fatality rates average around 40%.For each person killed, 1.5 are <strong>in</strong>jured 4,5,9 . Every year landm<strong>in</strong>eskill 15,000 people, ma<strong>in</strong>ly civilians of whom 20% are childrenyounger than 15 years 7,5 . Thus a decade from now, there will beabout 250,000 documented landm<strong>in</strong>e-related amputees. Theremay be many more, as there are 100,000 amputees <strong>in</strong> Angolaalready (J. Meynadier, personal observation). A retrospectiveanalysis of 720 patients <strong>in</strong>jured by m<strong>in</strong>es suggests an overallamputation rate of 28 %. By comb<strong>in</strong><strong>in</strong>g ICRC data 5 aboutresidual disability with the above-cited survey of landm<strong>in</strong>e<strong>in</strong>jury prevalence 8 , one may estimate the number of amputees<strong>in</strong> the four countries studied. Further data on the numbers ofm<strong>in</strong>es per square mile <strong>in</strong> these and other countries 7 re<strong>in</strong>forcethese weapons’ potential health problems <strong>in</strong> terms of amputeesper 1000 <strong>in</strong>habitants (Table 1).Medical NeedsLandm<strong>in</strong>e <strong>in</strong>jury victims are one group among many seek<strong>in</strong>gmedical care <strong>in</strong> those countries where m<strong>in</strong>es have been used.Their relatively small annual needs are compounded overtime because their long-term medical attention dra<strong>in</strong>s scarceresources, particularly as victims accumulate.Table 1: M<strong>in</strong>e <strong>in</strong>juries per year (from Ref. 8).Estimated numbers of amputees per 1000 population <strong>in</strong> parenthesesAge (yrs) Miles per45 square mileAfghanistan 40male 9.0 (2.5) 95.4 (26) 37.1 (10)female 8.0 (2.2) 4.5 (1.2) 18.1 (5.0)Bosnia 152male 0.7 (0.19) 8.1 (2.2) 2.3 (0.64)female 0.0 (0) 0.0 (0) 0.5 (0.1)Cambodia 142male 4.0 (1.1) 51.3 (14.6) 29.4 (8.23)female 0.4 (0.<strong>11</strong>) 2.3 (0.64) 3.7 (1.0)Mozambique 7male 1.4 (0.39) 14.3 (4.0) 10.6 (2.9)female 1.0 (0.28) 3.2 (0.89) 5.6 (1.5)Acute care 3 . Evacuation of the <strong>in</strong>jured from the m<strong>in</strong>efield,control of bleed<strong>in</strong>g by pressure dress<strong>in</strong>g or tourniquet, andspl<strong>in</strong>t<strong>in</strong>g of fractures are immediate needs. In wartime anepidemiological approach based upon first aid, tetanusvacc<strong>in</strong>ation, and antibiotic prophylaxis is more cost-effectivethan the traditional approach of urgent surgery. Basic nurs<strong>in</strong>gcare saves more lives than heroic surgical <strong>in</strong>terventions and ismore easily available locally. A chest dra<strong>in</strong> should be <strong>in</strong>sertedif penetrat<strong>in</strong>g chest <strong>in</strong>juries are suspected. Antibiotic prophylaxis(benzylpenicill<strong>in</strong>) and tetanus prophylaxis should beadm<strong>in</strong>istered. Delayed surgical <strong>in</strong>tervention <strong>in</strong>fluences overallquality of survival 6 . Traumatic bilateral above-knee amputationand/or signs of <strong>in</strong>tra-abdom<strong>in</strong>al bleed<strong>in</strong>g are om<strong>in</strong>ous andjustify an aggressive approach 4 .Rehabilitation and pa<strong>in</strong> control for landm<strong>in</strong>e survivorshave ga<strong>in</strong>ed little attention so far. Instructions for thetreatment of postamputation pa<strong>in</strong> and PLP should bemade available for use by relief agencies and localhealth care workers.Evacuation may be slow. Only 25% of those treated by theICRC arrived with<strong>in</strong> six hours of <strong>in</strong>jury; 15% traveled more thanthree days. In-hospital care is often limited by <strong>in</strong>adequatepersonnel and resources that can make surgery lifethreaten<strong>in</strong>g.After excision of dead and contam<strong>in</strong>ated tissuethe wound should be left open for five days. Repeatedoperations and sk<strong>in</strong> graft<strong>in</strong>g may be necessary to achievesecondary closure. Sophisticated anesthetic practice may notbe possible <strong>in</strong> areas where landm<strong>in</strong>es are most common.Ketam<strong>in</strong>e and local anesthetics are generally available <strong>in</strong> suchsett<strong>in</strong>gs and potentially offer effective postoperative pa<strong>in</strong>relief. Sp<strong>in</strong>al anesthesia can be adm<strong>in</strong>istered safely by tra<strong>in</strong>ednonmedical personnel and is used frequently for subsequentoperations. Adequate pa<strong>in</strong> relief improves outcome byreduc<strong>in</strong>g complications and facilitat<strong>in</strong>g early recovery <strong>11</strong>–14 .Rout<strong>in</strong>e pa<strong>in</strong> assessment and organized provision of simpleanalgesic techniques will optimize postoperative analgesia <strong>11</strong> .Fig. 1, a modification of the WHO analgesic ladder forcancer pa<strong>in</strong>, depicts suggestions for the treatment of acutepostoperative pa<strong>in</strong>, burns, and trauma from a review publishedjo<strong>in</strong>tly by IASP and the World Federation of Societies ofAnaesthesiologists (<strong>WFSA</strong>) 12 . This review is available <strong>in</strong>French, Russian, and Arabic 15 .The <strong>WFSA</strong> “acute pa<strong>in</strong> treatment ladder” uses wellknownand simple techniques of regional anesthesia and alimited number of analgesics <strong>in</strong> a three-step approach. Itsapplication depends upon on-site availability of theseagents. Regional anesthesia provides excellent operat<strong>in</strong>gconditions and postoperative pa<strong>in</strong> relief. S<strong>in</strong>gle-shottechniques or long-act<strong>in</strong>g (>24 hour) blockade with dilutesolutions of bupivaca<strong>in</strong>e at plexus or peripheral nerves arealternatives when opioids are unavailable and pose less riskof hypotension, ur<strong>in</strong>ary retention, and immobilization thancentral axis blockade. Peripheral blockade requires lesssupervision postoperatively.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 93Strong opioidsby <strong>in</strong>jection,localanesthesia, andNSAIDs(early)Weakopioids bymouth andm<strong>in</strong>oranalgesics(as pa<strong>in</strong>decreases)Aspir<strong>in</strong>,acetam<strong>in</strong>ophen/paracetamol, andNSAIDs(chronic)Figure 1. The <strong>WFSA</strong> acute pa<strong>in</strong> treatment ladderPatients with PLP may suffer from an exacerbation of theirpa<strong>in</strong> dur<strong>in</strong>g regional anesthesia, but this problem subsides asthe block wears off 14 . If this problem occurs dur<strong>in</strong>gan operation on an amputee, it does not usually respond toopioids, but lignoca<strong>in</strong>e, diazepam, or thiopentone have beensuccessful 17 .Rehabilitation. Rehabilitation starts from day 1 withpassive movement and active mobilization on crutches as soonas possible. In the case of lower limb amputation, restorationof function requires a prosthesis to rega<strong>in</strong> mobility and makecrutches unnecessary 18 . All too often PLP prohibits use of aprosthesis and creates a vicious circle of depression,isolation, and cont<strong>in</strong>ued suffer<strong>in</strong>g. Psychological rehabilitationand recovery of self-esteem are dependent on social re<strong>in</strong>tegration19 .If you give someone a leg - you are giv<strong>in</strong>g him hands.—Jacques MeynadierThe use of a prosthesis is vital to the rehabilitationprocess. Because of cont<strong>in</strong>ued bone growth, prostheses forchildren need to be refitted every six months. Sk<strong>in</strong> breakdowncaused by grow<strong>in</strong>g bone may make reamputation necessary.Phantom Limb Pa<strong>in</strong>Incidence and characteristics. It is helpful to dist<strong>in</strong>guishbetween pa<strong>in</strong>less phantom sensations, stump pa<strong>in</strong>, and pa<strong>in</strong> <strong>in</strong>the amputated parts of the body as there are implications forpathophysiology, outcome, and treatment 20 . Few studies havelooked at traumatic amputees and most trials are <strong>in</strong> elderlyarteriopaths, but the reason for amputation does not seem to<strong>in</strong>fluence the long-term complication rate. Military casualtiessuffer the same type and frequency of problem as civilians 21 .Phantom sensations are experiences of the miss<strong>in</strong>g limb asthough it were still present. Like PLP, they can start at the timeof operation or much later. They can vary from vivid sensationsmov<strong>in</strong>g <strong>in</strong> a complex fashion, to a vague and fixedawareness of f<strong>in</strong>gers or toes attached to the stump (“telescop<strong>in</strong>g”).Stump pa<strong>in</strong> is pa<strong>in</strong> felt <strong>in</strong> the stump only and not theabsent limb. Phantom limb pa<strong>in</strong> occurs commonly both <strong>in</strong>children 22,23 and <strong>in</strong> adults 20,23–25 . Patients may not mention it forfear of be<strong>in</strong>g ridiculed.PLP varies greatly <strong>in</strong> frequency and <strong>in</strong>tensity 21 . Emotionaland autonomic <strong>in</strong>fluences can provoke or reduce it. The pa<strong>in</strong> isgenerally felt <strong>in</strong> the more distal part of the amputated limb(toes, f<strong>in</strong>gers) and has been described by Jensen et al. 20 aseither exteroceptive (stabb<strong>in</strong>g, burn<strong>in</strong>g) or proprioceptive(squeez<strong>in</strong>g, cramp-like) <strong>in</strong> nature. It can be cont<strong>in</strong>uous or<strong>in</strong>termittent, and its <strong>in</strong>tensity may be mild to excruciat<strong>in</strong>g.Phantom sensations, stump pa<strong>in</strong>, and PLP are closely associated.PLP usually is less severe <strong>in</strong> amputees without phantomsensations or stump pa<strong>in</strong> 24,25 . It seems to be less likely if the <strong>in</strong>itialamputation is treated actively and a prosthesis promptly used 26 .A recent survey <strong>in</strong> 590 ex-servicemen found that PLPpersisted <strong>in</strong> 47% of the amputees, disappeared <strong>in</strong> 16%, andrequired treatment <strong>in</strong> 55%. In this survey PLP was so severe(VAS 8.7) <strong>in</strong> 25% that they sought pa<strong>in</strong> consultation. A large,older military survey found nearly identical figures 25 .Predispos<strong>in</strong>g factors. Age, site of amputation, or preamputationpa<strong>in</strong> <strong>in</strong>tensity seem not to <strong>in</strong>fluence the persistenceof late (>6 months) PLP 20,23–25,27 . No conclusive data l<strong>in</strong>kthe type of anesthetic used dur<strong>in</strong>g amputation and the<strong>in</strong>cidence of PLP.Despite earlier claims 28,29 , a well-controlled, randomizedtrial did not show a reduction <strong>in</strong> the <strong>in</strong>cidence of PLP bypreemptive epidural analgesia 30 . This question is important aspreamputation epidural analgesia is not without risk. Thestudy did, however, show that active pa<strong>in</strong> control decreasedthe <strong>in</strong>cidence and severity of chronic pa<strong>in</strong> problems.Treatment. Treatments must reflect solid cl<strong>in</strong>ical experienceor experimental evidence. No s<strong>in</strong>gle form of treatmentclaims success 19 .Recently it has been suggested that transcutaneouselectrical nerve stimulation (TENS), paracetamol (with orwithout a weak opioid), and nonsteroidal anti-<strong>in</strong>flammatorydrugs (NSAIDs) are more effective for PLP than <strong>in</strong>jections,“centrally act<strong>in</strong>g” analgesics like tricyclics or anticonvulsants,and strong opioids 24 . Simpler methods of pa<strong>in</strong> relief appear tobe more effective and are more accessible <strong>in</strong> countries withlandm<strong>in</strong>e problems. Cl<strong>in</strong>ical experience 31 and that of thevoluntary agency Douleur Sans Frontières <strong>in</strong> the develop<strong>in</strong>gworld suggests that neurolytic blockade of neuromas mayreduce stump pa<strong>in</strong> and that TENS can reduce PLP 32 .Evidence for efficacy of second-l<strong>in</strong>e therapies for PLPusually is based on small numbers and limited follow-up 33–39 .These treatments <strong>in</strong>clude calciton<strong>in</strong>, beta-blockers, neuroleptics,<strong>in</strong>jection of local anesthetic drugs <strong>in</strong>to the contralateralside, neurosurgery, and central stimulation. Other treatmentmethods may have been tried unsuccessfully and not reported,or not published ow<strong>in</strong>g to negative results.There is <strong>in</strong>creased <strong>in</strong>terest <strong>in</strong> the use of NMDA antagonists<strong>in</strong> chronic pa<strong>in</strong> conditions even though side effects limittheir current use. They may also have a place <strong>in</strong> the preemptivemanagement of postamputation pa<strong>in</strong> problems. The wide useof ketam<strong>in</strong>e <strong>in</strong> develop<strong>in</strong>g countries may yield data about therole of this NMDA antagonist to reduce PLP 40,41 .Sympathetic blockade has been used diagnostically andtherapeutically. However, neurolytic block normally requiresradiologic control and its effect gradually wears off 42 .DiscussionThose who produce and use armaments rarely consider theirlong-term effects upon health. From a military po<strong>in</strong>t of viewlandm<strong>in</strong>es cont<strong>in</strong>ue to be considered an effective weapon, dueto their low cost and deterrent capabilities.


94<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>Implementation of a total ban on production, sale, stockpil<strong>in</strong>g,and use of these weapons will prove difficult if not impossible,as has been the case with biological and chemical weapons.Accord<strong>in</strong>g to the World Health Organization (WHO), at currentrates more than ten centuries would be required to remove themore than 100 million landm<strong>in</strong>es already scattered around theglobe.Preventive measures <strong>in</strong> the countries afflicted with largenumbers of m<strong>in</strong>es <strong>in</strong>clude awareness programs on the risk ofhandl<strong>in</strong>g and efforts to clear or recover m<strong>in</strong>es for commercialga<strong>in</strong>. Treatment and rehabilitation of victims will cont<strong>in</strong>ue to bethe pr<strong>in</strong>cipal humanitarian action needed. Rehabilitation andpa<strong>in</strong> control for landm<strong>in</strong>e survivors have ga<strong>in</strong>ed little attentionso far. Instructions for the treatment of postamputation pa<strong>in</strong>and PLP should be made available for use by relief agenciesand local health care workers.The precise impact of PLP on the outcome of rehabilitationof m<strong>in</strong>efield victims <strong>in</strong> the develop<strong>in</strong>g world must be assessedbefore we can estimate the response needed. However, datacollection must not impede cont<strong>in</strong>ued efforts by relief andmedical agencies such as Douleur Sans Frontières. The<strong>in</strong>cidence of severe PLP is at least 25 % <strong>in</strong> published surveys.PLP may prevent use of prostheses. In the case of s<strong>in</strong>gle lowerlimb amputation, <strong>in</strong>jury to the rema<strong>in</strong><strong>in</strong>g limb may make weightbear<strong>in</strong>gmore hazardous, further jeopardiz<strong>in</strong>g rehabilitation.The importance of pa<strong>in</strong> control for optimal quality of lifeand long-term rehabilitation is <strong>in</strong>creas<strong>in</strong>gly obvious.Treat<strong>in</strong>g the <strong>in</strong>dividual with relatively <strong>in</strong>expensive andeffective treatments is possible, and neurolytic blockade ofneuromas and TENS have been shown to be effective underthese circumstances (J. Meynadier, personal observation). Theauthors’ observations support the multimodal treatment planadvocated by Sherman and colleagues 19,21 . They encourage asympathetic discussion between health care worker andpatient about phantom sensation and PLP and emphasize useof a prosthesis. They also advocate use of TENS and m<strong>in</strong>oranalgesics to disrupt the pa<strong>in</strong>-anxiety-tension cycle. Theirrecommendation for referral to multidiscipl<strong>in</strong>ary pa<strong>in</strong> treatment,however, is often difficult to carry out <strong>in</strong> practice.Public discussion of landm<strong>in</strong>es has taken place more as apolitical than a medical dialogue 43 . For other sources of pa<strong>in</strong>such as cancer, burns, or operation, society’s perspective isevolv<strong>in</strong>g from a view of the <strong>in</strong>dividual as an anonymous hostof a pathophysiological process toward a patient-centeredfocus. As this evolution advances, the importance of pa<strong>in</strong>control for optimal quality of life and long-term rehabilitation is<strong>in</strong>creas<strong>in</strong>gly obvious. In parallel fashion, the crucial yet stillunmet need for pa<strong>in</strong> control among victims of landm<strong>in</strong>e <strong>in</strong>jurymust now receive the attention of pa<strong>in</strong> specialists worldwide.Johan de SmetJ. Edmond CharltonConsultant <strong>in</strong> Pa<strong>in</strong> Management Consultant <strong>in</strong> Pa<strong>in</strong> Managementand Anesthesiaand AnesthesiaLeuven, BelgiumNewcastle upon Tyne, UnitedK<strong>in</strong>gdomJacques MeynadierConsultant <strong>in</strong> Pa<strong>in</strong> Management and AnesthesiaLille, FranceReferences1. ICRC. The Geneva Conventions of August 12, 1949. Geneva 1986.2. Coupland RM, Russbach R. Medic<strong>in</strong>e and Global Survival 1994; 1:1.3. Coupland RM. ICRC, Geneva 1997.4. Adams DB. J Trauma 1988; 28:S159–S162.5. Coupland RM. BMJ 1991; 303:1509–12.6. Coupland RM. BMJ 1994; 308:1693–7.7. Strada G. Scientific American May 1996; 26–31.8. Anderson N et al. BMJ 1995; 3<strong>11</strong>:718–21.9. Ascherio A et al. Lancet 1995; 346:721–724.10. Stover E et al. JAMA 1994; 272:331–36.<strong>11</strong>. American Pa<strong>in</strong> Society: Quality of Care Committee. JAMA 1995;274:1874–1880.12. Charlton JE. <strong>WFSA</strong> <strong>Update</strong> <strong>in</strong> Anesthesia 1997;7:2–17.13. Hill CS. JAMA 1995; 274:1881–2.14. Carr DB. Pa<strong>in</strong>: Cl<strong>in</strong>ical <strong>Update</strong>s 1993; 1(1).15. <strong>WFSA</strong>, Level 8, Imperial House, 15–18 K<strong>in</strong>gsway, london WC2B 6TH, United K<strong>in</strong>gdom.16. Tessler MJ, Kleimann SJ. <strong>Anaesthesia</strong> 1994; 49:439–41.17. Uncles DR, Glynn CJ. <strong>Anaesthesia</strong> 1996; 51:69–70.18. Malone JM et al. Arch Surg. 1981; <strong>11</strong>6:93–102.19. Sherman R et al. Pa<strong>in</strong> 1980; 8:85–99.20. Jensen TS et al. Pa<strong>in</strong> 1985; 21:267–278.21. Sherman RA. Phantom Pa<strong>in</strong>. New York: Plenum, 1997.22. Melzack R et al. Bra<strong>in</strong> 1997; 120:1603–1620.23. Krane EJ et al. Anesthesiology 1991; 75:A691.24. Wartan SW et al. Br J Anesthesia 1997; 78:652–659.25. Sherman R et al. Pa<strong>in</strong> 1984; 18:83–95.26. Merskey H, Bogduk N. Classification of Chronic Pa<strong>in</strong> 2 nd ed. Seattle: IASP Press, 1994.27. Nikolajsen L et al. Pa<strong>in</strong> 1997; 72:393–405.28. Bach S et al. Pa<strong>in</strong> 1988; 33:297–301.29. Jahangiri M et al. Ann Roy College Surgeons of England 1994; 76:324–326.30. Nikolajsen L et al. Lancet 350; 1997:1353–1357.31. Kirvela O, Niem<strong>in</strong>en S. Pa<strong>in</strong> 1990; 41:161–165.32. Meynardier J. Developpement et Santé 1997; 131:33–34.33. F<strong>in</strong>sen V et al. J Bone Jo<strong>in</strong>t Surg (Br) 1988; 70-B:109–12.34. Jaeger H, Maier C. Pa<strong>in</strong> 1992; 48:21–27.35. Nikolajsen L et al. Pa<strong>in</strong> 1996; 67:69–77.36. Gross D. Pa<strong>in</strong> 1982; 13:313–320.37. W<strong>in</strong>kelmuller M, W<strong>in</strong>kelmuller W. J Neurosurg 1996; 85:458–467.38. North R et al. Neurosurgery 1993; 32:384–394.39. Wester K. Acta Neurol Scand 1987; 75:151–153.40. Knox DJ et al. Anaesth Intens Care 1995; 23:620.41. Walker SM, Cous<strong>in</strong>s MJ. J Pa<strong>in</strong> Symptom Manage 1997; 14:129–133.42. Lema MJ. Pa<strong>in</strong>: Cl<strong>in</strong>ical <strong>Update</strong>s 1998; 6(1).43. Krug EG et al. JAMA 1998; 280:465–466.International Association for the Study of Pa<strong>in</strong> (IASP) / 9th World Congress on Pa<strong>in</strong>, Vienna, Austria, August 22–27, 1999IASP was founded <strong>in</strong> 1973 as a nonprofit organization to foster and encourage research on pa<strong>in</strong> mechanisms and pa<strong>in</strong> syndromes, and to help improve themanagement of patients with acute and chronic pa<strong>in</strong>. The Association br<strong>in</strong>gs together basic scientists, physicians, dentists, nurses, psychologists, physicaltherapists, and other health professionals who work <strong>in</strong> or have an <strong>in</strong>terest <strong>in</strong> pa<strong>in</strong> research and management. Benefits of membership <strong>in</strong>clude: subscription to themonthly journal Pa<strong>in</strong> • receipt of a bimonthly newsletter conta<strong>in</strong><strong>in</strong>g technical articles, comprehensive meet<strong>in</strong>gs calendar, list of new books <strong>in</strong> the field of pa<strong>in</strong> • receiptof a triannual cl<strong>in</strong>ical newsletter • receipt of an annual directory of members • reduced rate on IASP book purchases • reduced registration fees for Congresses. Formembership <strong>in</strong>formation contact IASP at the address below.Timely topics <strong>in</strong> pa<strong>in</strong> research and treatment have been selected for publication but the <strong>in</strong>formation provided and op<strong>in</strong>ions expressed have not <strong>in</strong>volved anyverification of the f<strong>in</strong>d<strong>in</strong>gs, conclusions, and op<strong>in</strong>ions by IASP. Thus, op<strong>in</strong>ions expressed <strong>in</strong> Pa<strong>in</strong>: Cl<strong>in</strong>ical <strong>Update</strong>s do not necessarily reflect those of IASP or ofthe Officers or Councillors. No responsibility is assumed by IASP for any <strong>in</strong>jury and/or damage to persons or property as a matter of product liability, negligence,or from any use of any methods, products, <strong>in</strong>struction, or ideas conta<strong>in</strong>ed <strong>in</strong> the material here<strong>in</strong>. Because of the rapid advances <strong>in</strong> the medical sciences, thepublisher recommends that there should be <strong>in</strong>dependent verification of diagnoses and drug dosages.For permission to repr<strong>in</strong>t or translate this article, contact:International Association for the Study of Pa<strong>in</strong> • 909 NE 43rd St, Suite 306, Seattle, WA 98105 USATel: 206-547-6409 • Fax: 206-547-1703 • email: IASP@locke.hs.wash<strong>in</strong>gton.edu • http://www.halcyon.com/iaspCopyright © 1998. All rights reserved. ISSN 1083-0707.Pr<strong>in</strong>ted <strong>in</strong> the U.S.A.


<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 95Editor: Dr Ia<strong>in</strong> Wilson. Sub Editors: Drs Henry Bulwirwa, David Conn, Mike Dobson, Frank Walters and Mr Mike Yeats.Designed and Typeset by: Angela Frost<strong>WFSA</strong> Representative: Dr Roger Eltr<strong>in</strong>ghamSponsored by: World Federation of Societies of AnaesthesiologistsLevel 8, Imperial House, 15-19 K<strong>in</strong>gsway, London WC2B 6TH, United K<strong>in</strong>gdom.Tel: +44 171 836 5652. Fax: +44 171 836 5616E-mail: wfsa@compuserve.comPr<strong>in</strong>ted <strong>in</strong> Great Brita<strong>in</strong> by: Media Publish<strong>in</strong>gCorrespondence to: Dr I H Wilson, Anaesthetics Dept., Royal Devon and Exeter Healthcare NHS Trust,Barrack Road, Exeter, EX2 5DW, UK. E-mail: ia<strong>in</strong>.wilson5@virg<strong>in</strong>.net

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!